Biospecimen Analytes by Outcome and Study ID

Fields can be sorted or filtered by hovering over the field heading; once the arrow appears to the right of the column heading, click to reveal sorting and filtering options. In addition, there is a search option that can be used to complete whole-word searches only (e.g., a search for "Controls" must include the entire word; partial-text matches will not be returned).

Anc id	Studies	Status	Funded	Outcome	Test Name	Short Name	Specimen	Blood	Lab	Ppts
83	OS	Complete	Y	CHD	CRP	CRP	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	CHD	DDIM	D-dimers	Citrate	Y	Boston-Children	650
83	OS	Complete	Y	CHD	HDLC	HDLC	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	CHD	HOMC	Homocysteine	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	CHD	LDLC	LDLC	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	CHD	LPA	Lp(a)	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	CHD	SICAM-1	SICAM-1	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	CHD	TCHO	Cholesterol	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	CHD	TPA	tPA	Citrate	Y	Boston-Children	650
83	OS	Complete	Y	CHD	TRI	Trig	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	Controls	CRP	CRP	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	Controls	DDIM	D-dimers	Citrate	Y	Boston-Children	650
83	OS	Complete	Y	Controls	HDLC	HDLC	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	Controls	HOMC	Homocysteine	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	Controls	LDLC	LDLC	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	Controls	LPA	Lp(a)	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	Controls	SICAM-1	SICAM-1	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	Controls	TCHO	Cholesterol	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	Controls	TPA	tPA	Citrate	Y	Boston-Children	650
83	OS	Complete	Y	Controls	TRI	Trig	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	CHD	IL-6	IL-6	EDTA	Y	Boston-Children	650
83	OS	Complete	Y	Controls	IL-6	IL-6	EDTA	Y	Boston-Children	650
90	OS	Analysis	Y	Controls	APOE4	Apo E4	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Controls	AR-DNA	AR-DNA	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Controls	COL1A1SP1	COL1A1SP1	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Controls	CYP19-DNA	CYP19A1	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Controls	Cystatin-C	Cystatin-C	Serum	Y	PPD	400
90	OS	Analysis	Y	Controls	ESR1	ESR1	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Controls	ESR2	ESR2	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Controls	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Controls	FE2	Estradiol, free	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Controls	FT	Testosterone, free	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Controls	FT_AT	Testosterone, bioavail	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Controls	HOMC	Homocysteine	Serum	Y	PPD	400
90	OS	Analysis	Y	Controls	IGF-I	IGF-I	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Controls	IGFBP-3	IGFBP-3	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Controls	LRP5	LRP5	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Controls	SHBG	SHBG	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Controls	SHBG-DNA	SHBG-DNA	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Controls	T4FREE	T4, free	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Controls	TGFB-LEU10	TGFB-LEU10	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Controls	TPO-AB	TPO-AB	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Controls	TSH	TSH	Serum	Y	PPD	400
90	OS	Analysis	Y	Controls	TSTO	Testosterone	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Controls	VDRFOK1	VDR	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Hip Fracture	APOE4	Apo E4	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Hip Fracture	AR-DNA	AR-DNA	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Hip Fracture	COL1A1SP1	COL1A1SP1	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Hip Fracture	CYP19-DNA	CYP19A1	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Hip Fracture	Cystatin-C	Cystatin-C	Serum	Y	PPD	400
90	OS	Analysis	Y	Hip Fracture	ESR1	ESR1	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Hip Fracture	ESR2	ESR2	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Hip Fracture	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Hip Fracture	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Hip Fracture	FE2	Estradiol, free	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Hip Fracture	FT	Testosterone, free	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Hip Fracture	FT_AT	Testosterone, bioavail	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Hip Fracture	HOMC	Homocysteine	Serum	Y	PPD	400
90	OS	Analysis	Y	Hip Fracture	IGF-I	IGF-I	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Hip Fracture	IGFBP-3	IGFBP-3	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Hip Fracture	LRP5	LRP5	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Hip Fracture	SHBG	SHBG	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Hip Fracture	SHBG-DNA	SHBG-DNA	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Hip Fracture	T4FREE	T4, free	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Hip Fracture	TGFB-LEU10	TGFB-LEU10	DNA	N	Pitts-Ferrell	400
90	OS	Analysis	Y	Hip Fracture	TPO-AB	TPO-AB	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Hip Fracture	TSH	TSH	Serum	Y	PPD	400
90	OS	Analysis	Y	Hip Fracture	TSTO	Testosterone	Serum	Y	Hormone Lab	400
90	OS	Analysis	Y	Hip Fracture	VDRFOK1	VDR	DNA	N	Pitts-Ferrell	400
97	OS	Analysis	Y	Controls	CA-125	CA 125	Serum	Y	FH-PHS Core	558
97	OS	Analysis	Y	Controls	HE4	HE4 Serum marker	Serum	Y	FH-PHS Core	558
97	OS	Analysis	Y	Controls	MSLN	Mesothelin	Serum	Y	FH-PHS Core	558
97	OS	Analysis	Y	Ovarian Cancer	CA-125	CA 125	Serum	Y	FH-PHS Core	280
97	OS	Analysis	Y	Ovarian Cancer	HE4	HE4 Serum marker	Serum	Y	FH-PHS Core	280
97	OS	Analysis	Y	Ovarian Cancer	MSLN	Mesothelin	Serum	Y	FH-PHS Core	280
105	OS	Complete	Y	Controls	ACAR	Carotene, alpha	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	ATOC	Tocopherol, alpha	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	BCAR13CIS	Carotene, beta 13cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	BCAR9CIS	Carotene, beta 9cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	BCARTRANS	Carotene, all trans	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	CRP	CRP	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	CRYPTX	Cryptoxan (a+b)	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	GTOC	Tocopherol, gamma	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	LUTEIN	Lutein, all trans	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	LUTEIN1	Lutein, cis isomer 1	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	LUTEIN2	Lutein, cis isomer 2	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	LUTEIN3	Lutein, cis isomer 3	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	LYCP13CIS	Lycopene, 13 cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	LYCP15CIS	Lycopene, 15 cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	LYCP5CIS	Lycopene, 5 cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	LYCP9CIS	Lycopene, 9 cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	LYCPTOTAL	Lycopene, total	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	LYCPTRANS	Lycopene, all trans	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	RETI	Retinol	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	RETI-P	Retinyl palmitate	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	TCHO	Cholesterol	Serum	Y	PPD	1,000
105	OS	Complete	Y	Controls	TRI	Trig	Serum	Y	PPD	1,000
105	OS	Complete	Y	Controls	VITD	Vit D 25-OH	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	ZEAXAN	Zeaxanthin	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	ZEAXANCIS	Zeax, cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	ACAR	Carotene, alpha	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	ATOC	Tocopherol, alpha	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	BCAR13CIS	Carotene, beta 13cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	BCAR9CIS	Carotene, beta 9cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	BCARTRANS	Carotene, all trans	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	CRP	CRP	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	CRYPTX	Cryptoxan (a+b)	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	GTOC	Tocopherol, gamma	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	LUTEIN	Lutein, all trans	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	LUTEIN1	Lutein, cis isomer 1	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	LUTEIN2	Lutein, cis isomer 2	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	LUTEIN3	Lutein, cis isomer 3	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	LYCP13CIS	Lycopene, 13 cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	LYCP15CIS	Lycopene, 15 cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	LYCP5CIS	Lycopene, 5 cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	LYCP9CIS	Lycopene, 9 cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	LYCPTOTAL	Lycopene, total	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	LYCPTRANS	Lycopene, all trans	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	RETI	Retinol	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	RETI-P	Retinyl palmitate	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	TCHO	Cholesterol	Serum	Y	PPD	1,000
105	OS	Complete	Y	Eye	TRI	Trig	Serum	Y	PPD	1,000
105	OS	Complete	Y	Eye	VITD	Vit D 25-OH	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	ZEAXAN	Zeaxanthin	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	ZEAXANCIS	Zeax, cis	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Controls	DTOC	Tocopherol, delta	Serum	Y	Tufts	1,000
105	OS	Complete	Y	Eye	DTOC	Tocopherol, delta	Serum	Y	Tufts	1,000
108	OS	Complete	Y	Colorectal Cancer	PTGS2-COX2	PTGS2-COX2	DNA	N	Torrance-Lin	50
108	OS	Complete	Y	Colorectal Cancer	VAL187ILE	PTGDS	DNA	N	Torrance-Lin	50
108	OS	Complete	Y	Controls	PTGS2-COX2	PTGS2-COX2	DNA	N	Torrance-Lin	150
108	OS	Complete	Y	Controls	VAL187ILE	PTGDS	DNA	N	Torrance-Lin	150
110	OS	Analysis	Y	CHD	DHES	DHES	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	CHD	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	CHD	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	CHD	ESTS	Estrone sulfate	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	CHD	F7AG	FVII Ag	Citrate	Y	PPD	385
110	OS	Analysis	Y	CHD	F7C	FVII Conc	Citrate	Y	PPD	385
110	OS	Analysis	Y	CHD	FE2	Estradiol, free	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	CHD	FIBR	Fibrinogen	Citrate	Y	PPD	385
110	OS	Analysis	Y	CHD	FT	Testosterone, free	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	CHD	FT_AT	Testosterone, bioavail	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	CHD	GLUC	Glucose	Serum	Y	PPD	385
110	OS	Analysis	Y	CHD	HDL2	HDL2	EDTA	Y	PPD	385
110	OS	Analysis	Y	CHD	HDL3	HDL3	EDTA	Y	PPD	385
110	OS	Analysis	Y	CHD	HDLC	HDLC	EDTA	Y	PPD	385
110	OS	Analysis	Y	CHD	INSU	Insulin	Serum	Y	PPD	385
110	OS	Analysis	Y	CHD	LDLC	LDLC	EDTA	Y	PPD	385
110	OS	Analysis	Y	CHD	LPA	Lp(a)	EDTA	Y	PPD	385
110	OS	Analysis	Y	CHD	SHBG	SHBG	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	CHD	TCHO	Cholesterol	EDTA	Y	PPD	385
110	OS	Analysis	Y	CHD	TRI	Trig	EDTA	Y	PPD	385
110	OS	Analysis	Y	CHD	TSTO	Testosterone	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	Controls	DHES	DHES	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	Controls	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	Controls	ESTS	Estrone sulfate	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	Controls	F7AG	FVII Ag	Citrate	Y	PPD	385
110	OS	Analysis	Y	Controls	F7C	FVII Conc	Citrate	Y	PPD	385
110	OS	Analysis	Y	Controls	FE2	Estradiol, free	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	Controls	FIBR	Fibrinogen	Citrate	Y	PPD	385
110	OS	Analysis	Y	Controls	FT	Testosterone, free	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	Controls	FT_AT	Testosterone, bioavail	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	Controls	GLUC	Glucose	Serum	Y	PPD	385
110	OS	Analysis	Y	Controls	HDL2	HDL2	EDTA	Y	PPD	385
110	OS	Analysis	Y	Controls	HDL3	HDL3	EDTA	Y	PPD	385
110	OS	Analysis	Y	Controls	HDLC	HDLC	EDTA	Y	PPD	385
110	OS	Analysis	Y	Controls	INSU	Insulin	Serum	Y	PPD	385
110	OS	Analysis	Y	Controls	LDLC	LDLC	EDTA	Y	PPD	385
110	OS	Analysis	Y	Controls	LPA	Lp(a)	EDTA	Y	PPD	385
110	OS	Analysis	Y	Controls	SHBG	SHBG	Serum	Y	Hormone Lab	385
110	OS	Analysis	Y	Controls	TCHO	Cholesterol	EDTA	Y	PPD	385
110	OS	Analysis	Y	Controls	TRI	Trig	EDTA	Y	PPD	385
110	OS	Analysis	Y	Controls	TSTO	Testosterone	Serum	Y	Hormone Lab	385
121	OS	Complete	Y	Controls	GLUC	Glucose	Serum	Y	PPD	225
121	OS	Complete	Y	Controls	IGF-I	IGF-I	Serum	Y	St Joe Bangor	225
121	OS	Complete	Y	Controls	IGFBP-1	IGFBP-1	Serum	Y	St Joe Bangor	225
121	OS	Complete	Y	Controls	IGFBP-3	IGFBP-3	Serum	Y	St Joe Bangor	225
121	OS	Complete	Y	Controls	INSU	Insulin	Serum	Y	PPD	225
121	OS	Complete	Y	Ovarian Cancer	GLUC	Glucose	Serum	Y	PPD	225
121	OS	Complete	Y	Ovarian Cancer	IGF-I	IGF-I	Serum	Y	St Joe Bangor	225
121	OS	Complete	Y	Ovarian Cancer	IGFBP-1	IGFBP-1	Serum	Y	St Joe Bangor	225
121	OS	Complete	Y	Ovarian Cancer	IGFBP-3	IGFBP-3	Serum	Y	St Joe Bangor	225
121	OS	Complete	Y	Ovarian Cancer	INSU	Insulin	Serum	Y	PPD	225
126	OS	Analysis	Y	Controls	ADIPHMW	Adip HMW	EDTA	Y	U Michigan	972
126	OS	Analysis	Y	Controls	AI	Lp(a)-1	EDTA	Y	PPD	486
126	OS	Analysis	Y	Controls	CRP	CRP	EDTA	Y	PPD	972
126	OS	Analysis	Y	Controls	DDIM	D-dimers	Citrate	Y	PPD	972
126	OS	Analysis	Y	Controls	ESEL	E-Selectin	Citrate	Y	PPD	972
126	OS	Analysis	Y	Controls	F1_2	F1+2	Citrate	Y	PPD	722
126	OS	Analysis	Y	Controls	F7C	FVII Conc	Citrate	Y	PPD	972
126	OS	Analysis	Y	Controls	FIBR	Fibrinogen	Citrate	Y	PPD	972
126	OS	Analysis	Y	Controls	GLUC	Glucose	EDTA	Y	PPD	972
126	OS	Analysis	Y	Controls	HDLC	HDLC	EDTA	Y	PPD	972
126	OS	Analysis	Y	Controls	HOMC	Homocysteine	EDTA	Y	PPD	972
126	OS	Analysis	Y	Controls	INSU	Insulin	EDTA	Y	PPD	972
126	OS	Analysis	Y	Controls	LPA	Lp(a)	EDTA	Y	PPD	972
126	OS	Analysis	Y	Controls	NEOP	Neopterin	EDTA	Y	PPD	972
126	OS	Analysis	Y	Controls	NMR_LIPID	NMR Lipids	EDTA	Y	LipoScience	972
126	OS	Analysis	Y	Controls	PAIA	PAI-1 Ag	Citrate	Y	PPD	972
126	OS	Analysis	Y	Controls	PLAC	Lp-PLA2	EDTA	Y	DiaDexus	972
126	OS	Analysis	Y	Controls	TCHO	Cholesterol	EDTA	Y	PPD	972
126	OS	Analysis	Y	Controls	TPA	tPA	Citrate	Y	PPD	972
126	OS	Analysis	Y	Controls	TRI	Trig	EDTA	Y	PPD	972
126	OS	Analysis	Y	Controls	VCAM1	VCAM-1	EDTA	Y	PPD	972
126	OS	Analysis	Y	Stroke	ADIPHMW	Adip HMW	EDTA	Y	U Michigan	972
126	OS	Analysis	Y	Stroke	AI	Lp(a)-1	EDTA	Y	PPD	486
126	OS	Analysis	Y	Stroke	CRP	CRP	EDTA	Y	PPD	972
126	OS	Analysis	Y	Stroke	DDIM	D-dimers	Citrate	Y	PPD	972
126	OS	Analysis	Y	Stroke	ESEL	E-Selectin	Citrate	Y	PPD	972
126	OS	Analysis	Y	Stroke	F1_2	F1+2	Citrate	Y	PPD	722
126	OS	Analysis	Y	Stroke	F7C	FVII Conc	Citrate	Y	PPD	972
126	OS	Analysis	Y	Stroke	FIBR	Fibrinogen	Citrate	Y	PPD	972
126	OS	Analysis	Y	Stroke	GLUC	Glucose	EDTA	Y	PPD	972
126	OS	Analysis	Y	Stroke	HDLC	HDLC	EDTA	Y	PPD	972
126	OS	Analysis	Y	Stroke	HOMC	Homocysteine	EDTA	Y	PPD	972
126	OS	Analysis	Y	Stroke	INSU	Insulin	EDTA	Y	PPD	972
126	OS	Analysis	Y	Stroke	LPA	Lp(a)	EDTA	Y	PPD	972
126	OS	Analysis	Y	Stroke	NEOP	Neopterin	EDTA	Y	PPD	972
126	OS	Analysis	Y	Stroke	NMR_LIPID	NMR Lipids	EDTA	Y	LipoScience	972
126	OS	Analysis	Y	Stroke	PAIA	PAI-1 Ag	Citrate	Y	PPD	972
126	OS	Analysis	Y	Stroke	PLAC	Lp-PLA2	EDTA	Y	DiaDexus	972
126	OS	Analysis	Y	Stroke	TCHO	Cholesterol	EDTA	Y	PPD	972
126	OS	Analysis	Y	Stroke	TPA	tPA	Citrate	Y	PPD	972
126	OS	Analysis	Y	Stroke	TRI	Trig	EDTA	Y	PPD	972
126	OS	Analysis	Y	Stroke	VCAM1	VCAM-1	EDTA	Y	PPD	972
126	OS	Analysis	Y	Controls	IL-6	IL-6	EDTA	Y	PPD	972
126	OS	Analysis	Y	Controls	TNF-A	TNF-A	Citrate	Y	PPD	972
126	OS	Analysis	Y	Stroke	IL-6	IL-6	EDTA	Y	PPD	972
126	OS	Analysis	Y	Stroke	TNF-A	TNF-A	Citrate	Y	PPD	972
129	OS	Analysis	Y	Breast Cancer	ESTDV	Estradiol-Vitros	Serum	Y	Esoterix	900
129	OS	Analysis	Y	Breast Cancer	GLUC	Glucose	Serum	Y	PPD	900
129	OS	Analysis	Y	Breast Cancer	IGF-1-TOT	IGF-I Total	Serum	Y	Yu	900
129	OS	Analysis	Y	Breast Cancer	IGFBP-3	IGFBP-3	Serum	Y	Yu	900
129	OS	Analysis	Y	Breast Cancer	IGFDSL	IGF by DSL	Serum	Y	Yu	900
129	OS	Analysis	Y	Breast Cancer	IGFFREE	IGF Free	Serum	Y	Yu	900
129	OS	Analysis	Y	Breast Cancer	INSU	Insulin	Serum	Y	PPD	900
129	OS	Analysis	Y	Colorectal Cancer	ESTDV	Estradiol-Vitros	Serum	Y	Esoterix	500
129	OS	Analysis	Y	Colorectal Cancer	GLUC	Glucose	Serum	Y	PPD	500
129	OS	Analysis	Y	Colorectal Cancer	IGF-1-TOT	IGF-I Total	Serum	Y	Yu	500
129	OS	Analysis	Y	Colorectal Cancer	IGFBP-3	IGFBP-3	Serum	Y	Yu	500
129	OS	Analysis	Y	Colorectal Cancer	IGFDSL	IGF by DSL	Serum	Y	Yu	500
129	OS	Analysis	Y	Colorectal Cancer	IGFFREE	IGF Free	Serum	Y	Yu	500
129	OS	Analysis	Y	Colorectal Cancer	INSU	Insulin	Serum	Y	PPD	500
129	OS	Analysis	Y	Controls	ESTDV	Estradiol-Vitros	Serum	Y	Esoterix	900
129	OS	Analysis	Y	Controls	GLUC	Glucose	Serum	Y	PPD	900
129	OS	Analysis	Y	Controls	IGF-1-TOT	IGF-I Total	Serum	Y	Yu	900
129	OS	Analysis	Y	Controls	IGFBP-3	IGFBP-3	Serum	Y	Yu	900
129	OS	Analysis	Y	Controls	IGFDSL	IGF by DSL	Serum	Y	Yu	900
129	OS	Analysis	Y	Controls	IGFFREE	IGF Free	Serum	Y	Yu	900
129	OS	Analysis	Y	Controls	INSU	Insulin	Serum	Y	PPD	900
129	OS	Analysis	Y	Endometrial Cancer	ESTDV	Estradiol-Vitros	Serum	Y	Esoterix	300
129	OS	Analysis	Y	Endometrial Cancer	GLUC	Glucose	Serum	Y	PPD	300
129	OS	Analysis	Y	Endometrial Cancer	IGF-1-TOT	IGF-I Total	Serum	Y	Yu	300
129	OS	Analysis	Y	Endometrial Cancer	IGFBP-3	IGFBP-3	Serum	Y	Yu	300
129	OS	Analysis	Y	Endometrial Cancer	IGFDSL	IGF by DSL	Serum	Y	Yu	300
129	OS	Analysis	Y	Endometrial Cancer	IGFFREE	IGF Free	Serum	Y	Yu	300
129	OS	Analysis	Y	Endometrial Cancer	INSU	Insulin	Serum	Y	PPD	300
132	OS	Analysis	Y	Controls	CAPN10	Calpain 10 gene	DNA	N	Boston-Niu	2,500
132	OS	Analysis	Y	Controls	CRP	CRP	EDTA	Y	Boston-Children	2,500
132	OS	Analysis	Y	Controls	ESEL	E-Selectin	EDTA	Y	Boston-Children	2,500
132	OS	Analysis	Y	Controls	FTO	FTO	DNA	N	Boston-Niu	2,500
132	OS	Analysis	Y	Controls	GLUC	Glucose	EDTA	Y	Boston-Children	2,500
132	OS	Analysis	Y	Controls	INSU	Insulin	EDTA	Y	Boston-Children	2,500
132	OS	Analysis	Y	Controls	SICAM-1	SICAM-1	EDTA	Y	Boston-Children	2,500
132	OS	Analysis	Y	Controls	UCP2	UCP2	DNA	N	Boston-Niu	2,500
132	OS	Analysis	Y	Controls	VCAM1	VCAM-1	EDTA	Y	Boston-Children	2,500
132	OS	Analysis	Y	Type 2 Diabetes	CAPN10	Calpain 10 gene	DNA	N	Boston-Niu	1,800
132	OS	Analysis	Y	Type 2 Diabetes	CRP	CRP	EDTA	Y	Boston-Children	1,800
132	OS	Analysis	Y	Type 2 Diabetes	ESEL	E-Selectin	EDTA	Y	Boston-Children	1,800
132	OS	Analysis	Y	Type 2 Diabetes	FTO	FTO	DNA	N	Boston-Niu	1,800
132	OS	Analysis	Y	Type 2 Diabetes	GLUC	Glucose	EDTA	Y	Boston-Children	1,800
132	OS	Analysis	Y	Type 2 Diabetes	INSU	Insulin	EDTA	Y	Boston-Children	1,800
132	OS	Analysis	Y	Type 2 Diabetes	SICAM-1	SICAM-1	EDTA	Y	Boston-Children	1,800
132	OS	Analysis	Y	Type 2 Diabetes	UCP2	UCP2	DNA	N	Boston-Niu	1,800
132	OS	Analysis	Y	Type 2 Diabetes	VCAM1	VCAM-1	EDTA	Y	Boston-Children	1,800
132	OS	Analysis	Y	Controls	IL-6	IL-6	EDTA	Y	Boston-Children	2,500
132	OS	Analysis	Y	Controls	TNF-A	TNF-A	EDTA	Y	Boston-Children	2,500
132	OS	Analysis	Y	Type 2 Diabetes	IL-6	IL-6	EDTA	Y	Boston-Children	1,800
132	OS	Analysis	Y	Type 2 Diabetes	TNF-A	TNF-A	EDTA	Y	Boston-Children	1,800
133	OS	Analysis	Y	Controls	ADIP	Adiponectin	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Controls	CRP	CRP	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Controls	GLUC	Glucose	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Controls	HDLC	HDLC	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Controls	SICAM-1	SICAM-1	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Controls	TCHO	Cholesterol	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Controls	TNF-R2	TNF-R2	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Hypertension	ADIP	Adiponectin	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Hypertension	CRP	CRP	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Hypertension	GLUC	Glucose	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Hypertension	HDLC	HDLC	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Hypertension	SICAM-1	SICAM-1	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Hypertension	TCHO	Cholesterol	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Hypertension	TNF-R2	TNF-R2	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Controls	IL-1B	IL-1B	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Controls	IL-6	IL-6	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Controls	IL-6_DNA	IL-6 (DNA)	DNA	N	Boston-Genotype	800
133	OS	Analysis	Y	Controls	TNF-A_DNA	TNFA (DNA)	DNA	N	Boston-Genotype	800
133	OS	Analysis	Y	Controls	TNF-R2_DNA	TNF-R2 (DNA)	DNA	N	Boston-Genotype	800
133	OS	Analysis	Y	Hypertension	IL-1B	IL-1B	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Hypertension	IL-6	IL-6	EDTA	Y	Boston-Children	800
133	OS	Analysis	Y	Hypertension	IL-6_DNA	IL-6 (DNA)	DNA	N	Boston-Genotype	800
133	OS	Analysis	Y	Hypertension	TNF-A_DNA	TNFA (DNA)	DNA	N	Boston-Genotype	800
133	OS	Analysis	Y	Hypertension	TNF-R2_DNA	TNF-R2 (DNA)	DNA	N	Boston-Genotype	800
134	OS	Complete	Y	Breast Cancer	16-OHE1	Estrone, 16a-OH	Serum	Y	Immuna	200
134	OS	Complete	Y	Breast Cancer	2-OHE1	Estrone, 2-OH	Serum	Y	Immuna	200
134	OS	Complete	Y	Controls	16-OHE1	Estrone, 16a-OH	Serum	Y	Immuna	200
134	OS	Complete	Y	Controls	2-OHE1	Estrone, 2-OH	Serum	Y	Immuna	200
137	OS	Analysis	Y	CHD	ADRA2A	AdRA2A	DNA	N	Baylor-Bray	1,060
137	OS	Analysis	Y	CHD	GP1BA	GP1-B	DNA	N	Baylor-Bray	1,060
137	OS	Analysis	Y	CHD	GP6	GPVI	DNA	N	Baylor-Bray	1,060
137	OS	Analysis	Y	CHD	HSD17B3	HSD-17B	DNA	N	Baylor-Bray	1,060
137	OS	Analysis	Y	CHD	ITGB3	Integrin-B3	DNA	N	Baylor-Bray	1,060
137	OS	Analysis	Y	CHD	P2RY12	P2RY-12 G protein	DNA	N	Baylor-Bray	1,060
137	OS	Analysis	Y	CHD	PGRMCI	PGR MC1	DNA	N	Baylor-Bray	1,060
137	OS	Analysis	Y	CHD	PLA2G2A	PL-A2-GIIA	DNA	N	Baylor-Bray	1,060
137	OS	Analysis	Y	CHD	THBD	Thrombomodulin	DNA	N	Baylor-Bray	1,060
137	OS	Analysis	Y	Controls	ADRA2A	AdRA2A	DNA	N	Baylor-Bray	2,120
137	OS	Analysis	Y	Controls	GP1BA	GP1-B	DNA	N	Baylor-Bray	2,120
137	OS	Analysis	Y	Controls	GP6	GPVI	DNA	N	Baylor-Bray	2,120
137	OS	Analysis	Y	Controls	HSD17B3	HSD-17B	DNA	N	Baylor-Bray	2,120
137	OS	Analysis	Y	Controls	ITGB3	Integrin-B3	DNA	N	Baylor-Bray	2,120
137	OS	Analysis	Y	Controls	P2RY12	P2RY-12 G protein	DNA	N	Baylor-Bray	2,120
137	OS	Analysis	Y	Controls	PGRMCI	PGR MC1	DNA	N	Baylor-Bray	2,120
137	OS	Analysis	Y	Controls	PLA2G2A	PL-A2-GIIA	DNA	N	Baylor-Bray	2,120
137	OS	Analysis	Y	Controls	THBD	Thrombomodulin	DNA	N	Baylor-Bray	2,120
146	OS	Complete	Y	Controls	C-PEPTIDE	C-peptide	EDTA	Y	Boston-Channing	312
146	OS	Complete	Y	Controls	CYP1A1	CYP1A1	DNA	N	Boston-Channing	312
146	OS	Complete	Y	Controls	FOLA	Folate	EDTA	Y	Boston-Channing	312
146	OS	Complete	Y	Controls	GSTM1	GSTM1	DNA	N	Boston-Channing	312
146	OS	Complete	Y	Controls	HOMC	Homocysteine	EDTA	Y	Boston-Channing	312
146	OS	Complete	Y	Controls	IGF-2	Insulin growth factor 2	EDTA	Y	Boston-Channing	312
146	OS	Complete	Y	Controls	IGF-I	IGF-I	EDTA	Y	Boston-Channing	312
146	OS	Complete	Y	Controls	IGFBP-1	IGFBP-1	EDTA	Y	Boston-Channing	312
146	OS	Complete	Y	Controls	IGFBP-3	IGFBP-3	EDTA	Y	Boston-Channing	312
146	OS	Complete	Y	Controls	INSU	Insulin	EDTA	Y	Boston-Channing	312
146	OS	Complete	Y	Controls	MTHF-1287	MTHF-1287	DNA	N	Boston-Channing	312
146	OS	Complete	Y	Controls	MTHF-667	MTHF-667	DNA	N	Boston-Channing	312
146	OS	Complete	Y	Controls	NAT1	NAT-1	DNA	N	Boston-Channing	312
146	OS	Complete	Y	Controls	NAT2	NAT-2	DNA	N	Boston-Channing	312
146	OS	Complete	Y	Controls	P5P	P5P	EDTA	Y	Boston-Channing	312
146	OS	Complete	Y	Controls	VTB12	Vit B12	EDTA	Y	Boston-Channing	312
146	OS	Complete	Y	Pancreas Cancer	C-PEPTIDE	C-peptide	EDTA	Y	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	CYP1A1	CYP1A1	DNA	N	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	FOLA	Folate	EDTA	Y	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	GSTM1	GSTM1	DNA	N	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	HOMC	Homocysteine	EDTA	Y	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	IGF-2	Insulin growth factor 2	EDTA	Y	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	IGF-I	IGF-I	EDTA	Y	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	IGFBP-1	IGFBP-1	EDTA	Y	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	IGFBP-3	IGFBP-3	EDTA	Y	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	INSU	Insulin	EDTA	Y	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	MTHF-1287	MTHF-1287	DNA	N	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	MTHF-667	MTHF-667	DNA	N	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	NAT1	NAT-1	DNA	N	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	NAT2	NAT-2	DNA	N	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	P5P	P5P	EDTA	Y	Boston-Channing	104
146	OS	Complete	Y	Pancreas Cancer	VTB12	Vit B12	EDTA	Y	Boston-Channing	104
152	OS	Analysis	Y	Breast Cancer	AKT1	AKT1	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Breast Cancer	AKT2	AKT2	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Breast Cancer	ERK1	ERK1	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Breast Cancer	ERK2	ERK2	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Breast Cancer	IGF-1-DNA	IGF1-DNA	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Breast Cancer	IGFBP3-DNA	IGFBP3-DNA	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Breast Cancer	INSU-DNA	Insulin-DNA	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Breast Cancer	IRS1	IRS1	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Breast Cancer	PIK3R1	PIK3R1	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Breast Cancer	TCF7L2	TCF7-L2	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Colorectal Cancer	AKT1	AKT1	DNA	N	Wake Forest	500
152	OS	Analysis	Y	Colorectal Cancer	AKT2	AKT2	DNA	N	Wake Forest	500
152	OS	Analysis	Y	Colorectal Cancer	ERK1	ERK1	DNA	N	Wake Forest	500
152	OS	Analysis	Y	Colorectal Cancer	ERK2	ERK2	DNA	N	Wake Forest	500
152	OS	Analysis	Y	Colorectal Cancer	IGF-1-DNA	IGF1-DNA	DNA	N	Wake Forest	500
152	OS	Analysis	Y	Colorectal Cancer	IGFBP3-DNA	IGFBP3-DNA	DNA	N	Wake Forest	500
152	OS	Analysis	Y	Colorectal Cancer	INSU-DNA	Insulin-DNA	DNA	N	Wake Forest	500
152	OS	Analysis	Y	Colorectal Cancer	IRS1	IRS1	DNA	N	Wake Forest	500
152	OS	Analysis	Y	Colorectal Cancer	PIK3R1	PIK3R1	DNA	N	Wake Forest	500
152	OS	Analysis	Y	Colorectal Cancer	TCF7L2	TCF7-L2	DNA	N	Wake Forest	500
152	OS	Analysis	Y	Controls	AKT1	AKT1	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Controls	AKT2	AKT2	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Controls	ERK1	ERK1	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Controls	ERK2	ERK2	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Controls	IGF-1-DNA	IGF1-DNA	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Controls	IGFBP3-DNA	IGFBP3-DNA	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Controls	INSU-DNA	Insulin-DNA	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Controls	IRS1	IRS1	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Controls	PIK3R1	PIK3R1	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Controls	TCF7L2	TCF7-L2	DNA	N	Wake Forest	900
152	OS	Analysis	Y	Endometrial Cancer	AKT1	AKT1	DNA	N	Wake Forest	300
152	OS	Analysis	Y	Endometrial Cancer	AKT2	AKT2	DNA	N	Wake Forest	300
152	OS	Analysis	Y	Endometrial Cancer	ERK1	ERK1	DNA	N	Wake Forest	300
152	OS	Analysis	Y	Endometrial Cancer	ERK2	ERK2	DNA	N	Wake Forest	300
152	OS	Analysis	Y	Endometrial Cancer	IGF-1-DNA	IGF1-DNA	DNA	N	Wake Forest	300
152	OS	Analysis	Y	Endometrial Cancer	IGFBP3-DNA	IGFBP3-DNA	DNA	N	Wake Forest	300
152	OS	Analysis	Y	Endometrial Cancer	INSU-DNA	Insulin-DNA	DNA	N	Wake Forest	300
152	OS	Analysis	Y	Endometrial Cancer	IRS1	IRS1	DNA	N	Wake Forest	300
152	OS	Analysis	Y	Endometrial Cancer	PIK3R1	PIK3R1	DNA	N	Wake Forest	300
152	OS	Analysis	Y	Endometrial Cancer	TCF7L2	TCF7-L2	DNA	N	Wake Forest	300
165	OS	Analysis	Y	CHD	T4FREE	T4, free	Serum	Y	U Minn Phys	88
165	OS	Analysis	Y	CHD	TPO-AB	TPO-AB	Serum	Y	U Minn Phys	88
165	OS	Analysis	Y	CHD	TSH	TSH	Serum	Y	UNC Hosp	800
165	OS	Analysis	Y	Controls	T4FREE	T4, free	Serum	Y	U Minn Phys	345
165	OS	Analysis	Y	Controls	TPO-AB	TPO-AB	Serum	Y	U Minn Phys	345
165	OS	Analysis	Y	Controls	TSH	TSH	Serum	Y	UNC Hosp	3,136
165	OS	Analysis	Y	Stroke	T4FREE	T4, free	Serum	Y	U Minn Phys	65
165	OS	Analysis	Y	Stroke	TPO-AB	TPO-AB	Serum	Y	U Minn Phys	65
165	OS	Analysis	Y	Stroke	TSH	TSH	Serum	Y	UNC Hosp	591
167	OS	Complete	Y	Breast Cancer	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	311
167	OS	Complete	Y	Breast Cancer	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	311
167	OS	Complete	Y	Breast Cancer	FE2	Estradiol, free	Serum	Y	Hormone Lab	311
167	OS	Complete	Y	Breast Cancer	FT	Testosterone, free	Serum	Y	Hormone Lab	311
167	OS	Complete	Y	Breast Cancer	FT_AT	Testosterone, bioavail	Serum	Y	Hormone Lab	311
167	OS	Complete	Y	Breast Cancer	SHBG	SHBG	Serum	Y	Hormone Lab	311
167	OS	Complete	Y	Breast Cancer	TSTO	Testosterone	Serum	Y	Hormone Lab	311
167	OS	Complete	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	592
167	OS	Complete	Y	Controls	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	592
167	OS	Complete	Y	Controls	FE2	Estradiol, free	Serum	Y	Hormone Lab	592
167	OS	Complete	Y	Controls	FT	Testosterone, free	Serum	Y	Hormone Lab	592
167	OS	Complete	Y	Controls	FT_AT	Testosterone, bioavail	Serum	Y	Hormone Lab	592
167	OS	Complete	Y	Controls	SHBG	SHBG	Serum	Y	Hormone Lab	592
167	OS	Complete	Y	Controls	TSTO	Testosterone	Serum	Y	Hormone Lab	592
179	OS	Complete	Y	Controls	ACE_DNA	ACE gene insertion	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	CEBPB	CEBP-b	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	CRP	CRP	EDTA	Y	UW-Immunology	900
179	OS	Complete	Y	Controls	CRP-DNA	CRP (DNA)	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	DDIM	D-dimers	Citrate	Y	UW-Coagulation	900
179	OS	Complete	Y	Controls	F8	FVIII Activity	Citrate	Y	UW-Coagulation	900
179	OS	Complete	Y	Controls	FIBR	Fibrinogen	Citrate	Y	UW-Coagulation	900
179	OS	Complete	Y	Controls	FIBR_DNA	Fibrinogen	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	IKBKB	IKBKB	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	IL-10_DNA	IL-10 (DNA)	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	IL1B_DNA	IL-1B (DNA)	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	IRAK4	IRAK4	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	MAP3K14	MAP3K14	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	MAP3K7	MAP3K7	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	MIF	MIF	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	MYD88	MYD88	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	NFKB1	NFKB1	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	NFKBIA	NFKBIA	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	RELA	RELA	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	RIPK1	RIPK1	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	STAT3	STAT3	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	TLR4	TLR4	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	TPA	tPA	Citrate	Y	UW-Coagulation	900
179	OS	Complete	Y	Controls	TRADD	TRADD	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	TRAF2	TRAF2	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	TRAF6	TRAF6	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	ACE_DNA	ACE gene insertion	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	CEBPB	CEBP-b	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	CRP	CRP	EDTA	Y	UW-Immunology	900
179	OS	Complete	Y	Fraility-disability	CRP-DNA	CRP (DNA)	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	DDIM	D-dimers	Citrate	Y	UW-Coagulation	900
179	OS	Complete	Y	Fraility-disability	F8	FVIII Activity	Citrate	Y	UW-Coagulation	900
179	OS	Complete	Y	Fraility-disability	FIBR	Fibrinogen	Citrate	Y	UW-Coagulation	900
179	OS	Complete	Y	Fraility-disability	FIBR_DNA	Fibrinogen	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	IKBKB	IKBKB	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	IL-10_DNA	IL-10 (DNA)	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	IL1B_DNA	IL-1B (DNA)	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	IRAK4	IRAK4	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	MAP3K14	MAP3K14	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	MAP3K7	MAP3K7	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	MIF	MIF	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	MYD88	MYD88	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	NFKB1	NFKB1	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	NFKBIA	NFKBIA	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	RELA	RELA	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	RIPK1	RIPK1	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	STAT3	STAT3	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	TLR4	TLR4	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	TPA	tPA	Citrate	Y	UW-Coagulation	900
179	OS	Complete	Y	Fraility-disability	TRADD	TRADD	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	TRAF2	TRAF2	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	TRAF6	TRAF6	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	IL-1R1	IL1R1	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	IL-6	IL-6	EDTA	Y	UW-Immunology	900
179	OS	Complete	Y	Controls	IL-6ST	IL-6ST	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	IL-6_DNA	IL-6 (DNA)	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	TNF-AIP3	TNFAPI3	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	TNF-A_DNA	TNFA (DNA)	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Controls	TNF-R1_DNA	TNF-R1 (DNA)	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	IL-1R1	IL1R1	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	IL-6	IL-6	EDTA	Y	UW-Immunology	900
179	OS	Complete	Y	Fraility-disability	IL-6ST	IL-6ST	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	IL-6_DNA	IL-6 (DNA)	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	TNF-AIP3	TNFAPI3	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	TNF-A_DNA	TNFA (DNA)	DNA	N	FH - Genomics	900
179	OS	Complete	Y	Fraility-disability	TNF-R1_DNA	TNF-R1 (DNA)	DNA	N	FH - Genomics	900
181	OS	Analysis	Y	Controls	CTX	CTx	Serum	Y	Synarc	400
181	OS	Analysis	Y	Controls	OPG	OPG	Serum	Y	Vermont	400
181	OS	Analysis	Y	Controls	PINP	PINP	Serum	Y	Synarc	400
181	OS	Analysis	Y	Controls	TNF-R1	TNF-R1	Serum	Y	Vermont	400
181	OS	Analysis	Y	Controls	TNF-R2	TNF-R2	Serum	Y	Vermont	400
181	OS	Analysis	Y	Controls	VITD	Vit D 25-OH	Serum	Y	Hormone Lab	400
181	OS	Analysis	Y	Hip Fracture	CTX	CTx	Serum	Y	Synarc	400
181	OS	Analysis	Y	Hip Fracture	OPG	OPG	Serum	Y	Vermont	400
181	OS	Analysis	Y	Hip Fracture	PINP	PINP	Serum	Y	Synarc	400
181	OS	Analysis	Y	Hip Fracture	TNF-R1	TNF-R1	Serum	Y	Vermont	400
181	OS	Analysis	Y	Hip Fracture	TNF-R2	TNF-R2	Serum	Y	Vermont	400
181	OS	Analysis	Y	Hip Fracture	VITD	Vit D 25-OH	Serum	Y	Hormone Lab	400
181	OS	Analysis	Y	Controls	IL-6SR	IL-6SR	Serum	Y	Vermont	400
181	OS	Analysis	Y	Hip Fracture	IL-6SR	IL-6SR	Serum	Y	Vermont	400
187	OS	Analysis	Y	Controls	FA 14:0	FA Myristic Acid FA 14:0	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 15:0	FA Pentanoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 16:0	FA Palmitic Acid FA 16:0	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 16:1N-7	FA 7 Hexadecenoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 16:1T	FA Palmitelaidic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 17:0	FA Margaric Acid 17:0	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:0	FA Stearic Acid FA 18:0	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:1N-7	FA Vaccenic Acid FA 18:1n-7	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:1N-9	FA Oleic Acid FA 18:1n-9	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:1T-1	FA 18:1T-1	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:1T-2	FA 18:1T-2	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:1T-3	FA 18:1T-3	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:1T-4	FA 18:1T-4	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:1T-5	FA 18:1T-5 Elaidic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:2N-6	FA Linoleic Acid FA 18:2N-6	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:2TT	FA 18:2TT Linelaidic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:3N-3	FA Alpha Linolenic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 18:3N-6	FA Gamma Linolenic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 20:1N-9	FA Eicosenoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 20:2N-6	FA Eicosadienoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 20:3N-6	FA DGLA	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 20:4N-3	FA Eicosatetraenoic Acid n3	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 20:4N-6	FA Arachidonic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 20:5N-3	FA Eicosapentanoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 22:4N-6	FA Adrenic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 22:5N-3	FA Docosapentanoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 22:5N-6	FA Docosapentanoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 22:6N-3	FA Docosahexanoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Controls	FA 24:1	FA Nervonic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 14:0	FA Myristic Acid FA 14:0	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 15:0	FA Pentanoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 16:0	FA Palmitic Acid FA 16:0	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 16:1N-7	FA 7 Hexadecenoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 16:1T	FA Palmitelaidic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 17:0	FA Margaric Acid 17:0	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:0	FA Stearic Acid FA 18:0	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:1N-7	FA Vaccenic Acid FA 18:1n-7	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:1N-9	FA Oleic Acid FA 18:1n-9	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:1T-1	FA 18:1T-1	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:1T-2	FA 18:1T-2	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:1T-3	FA 18:1T-3	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:1T-4	FA 18:1T-4	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:1T-5	FA 18:1T-5 Elaidic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:2N-6	FA Linoleic Acid FA 18:2N-6	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:2TT	FA 18:2TT Linelaidic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:3N-3	FA Alpha Linolenic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 18:3N-6	FA Gamma Linolenic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 20:1N-9	FA Eicosenoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 20:2N-6	FA Eicosadienoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 20:3N-6	FA DGLA	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 20:4N-3	FA Eicosatetraenoic Acid n3	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 20:4N-6	FA Arachidonic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 20:5N-3	FA Eicosapentanoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 22:4N-6	FA Adrenic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 22:5N-3	FA Docosapentanoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 22:5N-6	FA Docosapentanoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 22:6N-3	FA Docosahexanoic Acid	Serum	Y	ENL-Pitts	971
187	OS	Analysis	Y	Stroke	FA 24:1	FA Nervonic Acid	Serum	Y	ENL-Pitts	971
189	OS	Analysis	Y	CHD	ADIP	Adiponectin	Serum	Y	ENL-Pitts	144
189	OS	Analysis	Y	CHD	ADIPHMW	Adip HMW	Serum	Y	ENL-Pitts	144
189	OS	Analysis	Y	CHD	GHRELIN	Ghrelin	Serum	Y	ENL-Pitts	144
189	OS	Analysis	Y	CHD	GLUC	Glucose	Serum	Y	ENL-Pitts	144
189	OS	Analysis	Y	CHD	INSU	Insulin	Serum	Y	ENL-Pitts	144
189	OS	Analysis	Y	CHD	LEPTIN	Leptin	Serum	Y	ENL-Pitts	144
189	OS	Analysis	Y	CHD	NMR_LIPID	NMR Lipids	EDTA	Y	LipoScience	144
189	OS	Analysis	Y	Controls	ADIP	Adiponectin	Serum	Y	ENL-Pitts	1,172
189	OS	Analysis	Y	Controls	ADIPHMW	Adip HMW	Serum	Y	ENL-Pitts	1,172
189	OS	Analysis	Y	Controls	GHRELIN	Ghrelin	Serum	Y	ENL-Pitts	1,172
189	OS	Analysis	Y	Controls	GLUC	Glucose	Serum	Y	ENL-Pitts	1,172
189	OS	Analysis	Y	Controls	INSU	Insulin	Serum	Y	ENL-Pitts	1,172
189	OS	Analysis	Y	Controls	LEPTIN	Leptin	Serum	Y	ENL-Pitts	1,172
189	OS	Analysis	Y	Controls	NMR_LIPID	NMR Lipids	EDTA	Y	LipoScience	1,172
191	OS	Funded	Y	Sarcopenia	A1-TRYP	Alpha-1-Antitrypsin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	A2-MACR	Alpha-2-Macroglobulin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	ADIP	Adiponectin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	AFP	Alpha-Fetoprotein	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	APOA	Apolipoprotein(a)	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	APOA1	Apo A1	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	APOC-3	Apolipoprotein C-III	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	APOH	Apolipoprotein H	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	B2M	B2M	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	BDNF	BDNF	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	CA-125	CA 125	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	CA-19	Cancer Antigen 19-9	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	CALC	Calcitonin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	CD40AG	CD 40 antigen	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	CD40LG	CD40 Ligand	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	CEA	CEA	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	COMPC3	Complement C3	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	CREA-K	Creatine Kinase-MB	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	CRP	CRP	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	EDNAP78	ED Neutrophil-Activating Prot	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	EGF	Epidermal Growth Factor	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	ENDO1	Endothelin-1	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	ENRAGE	EN-RAGE	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	EOTAXIN	Eotaxin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	ERYTHRO	Erythropoietin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	F7	Factor VII	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	FABP-H	Fatty Acid-Binding Protein, ht	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	FERR	Ferritin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	FGF	Fibroblast Growth Factor	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	FIBR	Fibrinogen	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	G-CSF	Granulocyte Colony-Stim Fctr	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	GH	GH	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	GH1_DNA	GH1 (DNA)	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	GHR_DNA	GHR (DNA)	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	GM-CSF	GM-CSF	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	HP	HP	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	ICAM-1	ICAM-1	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IFNG	interferon, gamma	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IG-A	Immunoglobulin A	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IG-E	Immunoglobulin E	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IG-M	Immunoglobulin M	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IGF-1-DNA	IGF1-DNA	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	IGF-1R	IGF1R	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	IGF-I	IGF-I	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IGFALS_DNA	IGFALS (DNA)	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	IGFBP3-DNA	IGFBP3-DNA	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	IL-10	IL-10	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-12P40	IL-12p40	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-12P70	IL-12p70	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-13	IL-13	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-15	IL-15	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-16	Interleukin-16	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-1A	IL-1A	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-1RA	IL-1RA	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-2	IL-2	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-3	Interleukin-3	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-4	IL-4	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-5	IL-5	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-7	Interleukin-7	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-8	Interleukin-8	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL1B_DNA	IL-1B (DNA)	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	INSU	Insulin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	LEPTIN	Leptin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	LYMP	Lymphotactin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	MCP-1	MCP-1	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	MDC	Macrophage-Derived Chemokine	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	MIP-1A	Macrophage Inflammatory Prt1 A	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	MIP-1B	Macrophage Inflammatory Prt1 B	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	MMP2	MMP-2	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	MMP3	Matrix Metalloproteinase-3	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	MMP9	MMP-9	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	MYLO	Myeloperoxidase	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	MYO	Myoglobin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	PAI1	PAI-1	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	PAPP-A	Pregnancy-Associated Pls PrtA	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	PRO AP	Prostatic Acid Phosphatase	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	PSA-F	Prostate-Specific Antigen Fr	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	RANTES	RANTES	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	SAP-C	Serum Amyloid P-Component	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	SCF	Stem Cell Factor	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	SGOT	SG Oxaloacetic Transaminase	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	SHBG	SHBG	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	TBG	Thyroxine-Binding Globulin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	TF	TF	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	THBP	Thrombopoietin	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	TIMP-1	TIMP-1	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	TNF-R2	TNF-R2	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	TSH	TSH	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	VCAM1	VCAM-1	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	VEGF	VEGR	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	VWF	vWF	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-1A	IL-1Alpha	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	IL-1B	IL-1B	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-1R1	IL1R1	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	IL-1RN	IL-1RN	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	IL-6	IL-6	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-6_DNA	IL-6 (DNA)	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	TNF-A	TNF-A	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	TNF-A_DNA	TNFA (DNA)	DNA	N	Arizona	2,800
191	OS	Funded	Y	Sarcopenia	TNF-B	TNF-B	Serum	Y	RBM	2,800
191	OS	Funded	Y	Sarcopenia	IL-18	IL-18	Serum	Y	RBM	2,800
192	OS	Analysis	Y	Colorectal Cancer	COMT	COMT	DNA	N	Harvard-Geno	644
192	OS	Analysis	Y	Colorectal Cancer	CYP17A1	CYP17A1	DNA	N	Harvard-Geno	644
192	OS	Analysis	Y	Colorectal Cancer	CYP19-DNA	CYP19A1	DNA	N	Harvard-Geno	644
192	OS	Analysis	Y	Colorectal Cancer	CYP1A1	CYP1A1	DNA	N	Harvard-Geno	644
192	OS	Analysis	Y	Colorectal Cancer	CYP1B1	CYP1B1	DNA	N	Harvard-Geno	644
192	OS	Analysis	Y	Colorectal Cancer	ESR1	ESR1	DNA	N	Harvard-Geno	644
192	OS	Analysis	Y	Colorectal Cancer	ESR2	ESR2	DNA	N	Harvard-Geno	644
192	OS	Analysis	Y	Colorectal Cancer	HSD17B1	HSD17B1	DNA	N	Harvard-Geno	644
192	OS	Analysis	Y	Colorectal Cancer	HSD17B2	HSD17B2	DNA	N	Harvard-Geno	644
192	OS	Analysis	Y	Colorectal Cancer	HSD17B4	HSD17B4	DNA	N	Harvard-Geno	644
192	OS	Analysis	Y	Colorectal Cancer	PGR	PGR	DNA	N	Harvard-Geno	644
192	OS	Analysis	Y	Controls	COMT	COMT	DNA	N	Harvard-Geno	1,288
192	OS	Analysis	Y	Controls	CYP17A1	CYP17A1	DNA	N	Harvard-Geno	1,288
192	OS	Analysis	Y	Controls	CYP19-DNA	CYP19A1	DNA	N	Harvard-Geno	1,288
192	OS	Analysis	Y	Controls	CYP1A1	CYP1A1	DNA	N	Harvard-Geno	1,288
192	OS	Analysis	Y	Controls	CYP1B1	CYP1B1	DNA	N	Harvard-Geno	1,288
192	OS	Analysis	Y	Controls	ESR1	ESR1	DNA	N	Harvard-Geno	1,288
192	OS	Analysis	Y	Controls	ESR2	ESR2	DNA	N	Harvard-Geno	1,288
192	OS	Analysis	Y	Controls	HSD17B1	HSD17B1	DNA	N	Harvard-Geno	1,288
192	OS	Analysis	Y	Controls	HSD17B2	HSD17B2	DNA	N	Harvard-Geno	1,288
192	OS	Analysis	Y	Controls	HSD17B4	HSD17B4	DNA	N	Harvard-Geno	1,288
192	OS	Analysis	Y	Controls	PGR	PGR	DNA	N	Harvard-Geno	1,288
195	OS	Funded	Y	Colorectal Cancer	ALOX5-RP	ALOX5-RP	DNA	N	FH - Makar	988
195	OS	Funded	Y	Colorectal Cancer	ALOX5-SIZE	ALOX5-SIZE	DNA	N	FH - Makar	988
195	OS	Funded	Y	Colorectal Cancer	BET	Betaine	EDTA	Y	Univ of Florida	0
195	OS	Funded	Y	Colorectal Cancer	BET	Betaine	RBC	RBC	Univ of Florida	0
195	OS	Funded	Y	Colorectal Cancer	CHOLINE	Choline	EDTA	Y	Univ of Florida	0
195	OS	Funded	Y	Colorectal Cancer	CHOLINE	Choline	RBC	RBC	Univ of Florida	0
195	OS	Funded	Y	Colorectal Cancer	CREA	CREA	EDTA	Y	UW-Immunology	988
195	OS	Funded	Y	Colorectal Cancer	CRP	CRP	Serum	Y	UW-Immunology	988
195	OS	Funded	Y	Colorectal Cancer	CYP8A1-RP	CYP8A1-RP	DNA	N	FH - Makar	988
195	OS	Funded	Y	Colorectal Cancer	CYP8A1-SZE	CYP8A1-SZE	DNA	N	FH - Makar	988
195	OS	Funded	Y	Colorectal Cancer	CYST	Cysteine	EDTA	Y	UC Davis-Miller	988
195	OS	Funded	Y	Colorectal Cancer	FLAP-RP	FLAP-RP	DNA	N	FH - Makar	988
195	OS	Funded	Y	Colorectal Cancer	FOLA	Folate	EDTA	Y	Song Lab	988
195	OS	Funded	Y	Colorectal Cancer	FOLA %CV	Folate %CV	EDTA	Y	Song Lab	988
195	OS	Funded	Y	Colorectal Cancer	FOLA-RBC	Folate-RBC	RBC	RBC	UC Davis-Miller	988
195	OS	Funded	Y	Colorectal Cancer	HOMC	Homocysteine	EDTA	Y	UC Davis-Miller	988
195	OS	Funded	Y	Colorectal Cancer	METGLOB	Global Methylation	DNA	N	Cornell	988
195	OS	Funded	Y	Colorectal Cancer	METHI	Methionine	EDTA	Y	Univ of Florida	0
195	OS	Funded	Y	Colorectal Cancer	METHI	Methionine	RBC	RBC	Univ of Florida	0
195	OS	Funded	Y	Colorectal Cancer	MMA	Methylmalonic Acid	EDTA	Y	UC Davis-Miller	988
195	OS	Funded	Y	Colorectal Cancer	P5P	P5P	EDTA	Y	UC Davis-Miller	988
195	OS	Funded	Y	Colorectal Cancer	PL	PL	EDTA	Y	UC Davis-Miller	988
195	OS	Funded	Y	Colorectal Cancer	SAA	Amyloid A, serum	Serum	Y	UW-Immunology	988
195	OS	Funded	Y	Colorectal Cancer	SNPS 378	SNPS 378	DNA	N	TGen	988
195	OS	Funded	Y	Colorectal Cancer	SNPS 379	snps 379	DNA	N	TGen	988
195	OS	Funded	Y	Colorectal Cancer	TS-RP	TS-RP	DNA	N	FH - Makar	988
195	OS	Funded	Y	Colorectal Cancer	VTB12	Vit B12	EDTA	Y	Song Lab	988
195	OS	Funded	Y	Colorectal Cancer	VTB12 %CV	Vit B12 %CV	EDTA	Y	Song Lab	988
195	OS	Funded	Y	Controls	ALOX5-RP	ALOX5-RP	DNA	N	FH - Makar	988
195	OS	Funded	Y	Controls	ALOX5-SIZE	ALOX5-SIZE	DNA	N	FH - Makar	988
195	OS	Funded	Y	Controls	BET	Betaine	EDTA	Y	Univ of Florida	400
195	OS	Funded	Y	Controls	BET	Betaine	RBC	RBC	Univ of Florida	400
195	OS	Funded	Y	Controls	CHOLINE	Choline	EDTA	Y	Univ of Florida	400
195	OS	Funded	Y	Controls	CHOLINE	Choline	RBC	RBC	Univ of Florida	400
195	OS	Funded	Y	Controls	CREA	CREA	EDTA	Y	UW-Immunology	988
195	OS	Funded	Y	Controls	CRP	CRP	Serum	Y	UW-Immunology	988
195	OS	Funded	Y	Controls	CYP8A1-RP	CYP8A1-RP	DNA	N	FH - Makar	988
195	OS	Funded	Y	Controls	CYP8A1-SZE	CYP8A1-SZE	DNA	N	FH - Makar	988
195	OS	Funded	Y	Controls	CYST	Cysteine	EDTA	Y	UC Davis-Miller	988
195	OS	Funded	Y	Controls	FLAP-RP	FLAP-RP	DNA	N	FH - Makar	988
195	OS	Funded	Y	Controls	FOLA	Folate	EDTA	Y	Song Lab	988
195	OS	Funded	Y	Controls	FOLA %CV	Folate %CV	EDTA	Y	Song Lab	988
195	OS	Funded	Y	Controls	FOLA-RBC	Folate-RBC	RBC	RBC	UC Davis-Miller	988
195	OS	Funded	Y	Controls	HOMC	Homocysteine	EDTA	Y	UC Davis-Miller	988
195	OS	Funded	Y	Controls	METGLOB	Global Methylation	DNA	N	Cornell	988
195	OS	Funded	Y	Controls	METHI	Methionine	EDTA	Y	Univ of Florida	400
195	OS	Funded	Y	Controls	METHI	Methionine	RBC	RBC	Univ of Florida	400
195	OS	Funded	Y	Controls	MMA	Methylmalonic Acid	EDTA	Y	UC Davis-Miller	988
195	OS	Funded	Y	Controls	P5P	P5P	EDTA	Y	UC Davis-Miller	988
195	OS	Funded	Y	Controls	PL	PL	EDTA	Y	UC Davis-Miller	988
195	OS	Funded	Y	Controls	SAA	Amyloid A, serum	Serum	Y	UW-Immunology	988
195	OS	Funded	Y	Controls	SNPS 378	SNPS 378	DNA	N	TGen	988
195	OS	Funded	Y	Controls	SNPS 379	snps 379	DNA	N	TGen	988
195	OS	Funded	Y	Controls	TS-RP	TS-RP	DNA	N	FH - Makar	988
195	OS	Funded	Y	Controls	VTB12	Vit B12	EDTA	Y	Song Lab	988
195	OS	Funded	Y	Controls	VTB12 %CV	Vit B12 %CV	EDTA	Y	Song Lab	988
206	OS	Analysis	Y	Colorectal Cancer	8Q24	8q24 gene region	DNA	N	TGen	805
206	OS	Analysis	Y	Colorectal Cancer	9P24	9p24 gene region	DNA	N	TGen	805
206	OS	Analysis	Y	Colorectal Cancer	GPX1	GPX1	DNA	N	TGen	805
206	OS	Analysis	Y	Colorectal Cancer	GPX2	GPX2	DNA	N	TGen	805
206	OS	Analysis	Y	Colorectal Cancer	GPX3	GPX3	DNA	N	TGen	805
206	OS	Analysis	Y	Colorectal Cancer	GPX4	GPX4	DNA	N	TGen	805
206	OS	Analysis	Y	Colorectal Cancer	SEL	Selenium	Serum	Y	Song Lab	805
206	OS	Analysis	Y	Colorectal Cancer	SEPP1	Selenoprotein P	DNA	N	TGen	805
206	OS	Analysis	Y	Colorectal Cancer	TXNRD1	TXNRD1	DNA	N	TGen	805
206	OS	Analysis	Y	Controls	8Q24	8q24 gene region	DNA	N	TGen	805
206	OS	Analysis	Y	Controls	9P24	9p24 gene region	DNA	N	TGen	805
206	OS	Analysis	Y	Controls	GPX1	GPX1	DNA	N	TGen	805
206	OS	Analysis	Y	Controls	GPX2	GPX2	DNA	N	TGen	805
206	OS	Analysis	Y	Controls	GPX3	GPX3	DNA	N	TGen	805
206	OS	Analysis	Y	Controls	GPX4	GPX4	DNA	N	TGen	805
206	OS	Analysis	Y	Controls	SEL	Selenium	Serum	Y	Song Lab	805
206	OS	Analysis	Y	Controls	SEPP1	Selenoprotein P	DNA	N	TGen	805
206	OS	Analysis	Y	Controls	TXNRD1	TXNRD1	DNA	N	TGen	805
207	General population	Funded	Y	Controls	C-PEPTIDE	C-peptide	EDTA	Y	Pollak	394
207	General population	Funded	Y	Controls	CRP	CRP	EDTA	Y	Harvard-Rifai	394
207	General population	Funded	Y	Controls	IGF-1-DNA	IGF1-DNA	DNA	N	Harvard-Geno	394
207	General population	Funded	Y	Controls	IGF-I	IGF-I	EDTA	Y	Pollak	394
207	General population	Funded	Y	Controls	IGFBP-1	IGFBP-1	EDTA	Y	Pollak	394
207	General population	Funded	Y	Controls	IGFBP-3	IGFBP-3	EDTA	Y	Pollak	394
207	General population	Funded	Y	Controls	IGFBP3-DNA	IGFBP3-DNA	DNA	N	Harvard-Geno	394
207	General population	Funded	Y	Controls	IRS1	IRS1	DNA	N	Harvard-Geno	394
207	General population	Funded	Y	Controls	IRS2	IRS2	DNA	N	Harvard-Geno	394
207	General population	Funded	Y	Multiple Myeloma	C-PEPTIDE	C-peptide	EDTA	Y	Pollak	197
207	General population	Funded	Y	Multiple Myeloma	CRP	CRP	EDTA	Y	Harvard-Rifai	197
207	General population	Funded	Y	Multiple Myeloma	IGF-1-DNA	IGF1-DNA	DNA	N	Harvard-Geno	197
207	General population	Funded	Y	Multiple Myeloma	IGF-I	IGF-I	EDTA	Y	Pollak	197
207	General population	Funded	Y	Multiple Myeloma	IGFBP-1	IGFBP-1	EDTA	Y	Pollak	197
207	General population	Funded	Y	Multiple Myeloma	IGFBP-3	IGFBP-3	EDTA	Y	Pollak	197
207	General population	Funded	Y	Multiple Myeloma	IGFBP3-DNA	IGFBP3-DNA	DNA	N	Harvard-Geno	197
207	General population	Funded	Y	Multiple Myeloma	IRS1	IRS1	DNA	N	Harvard-Geno	197
207	General population	Funded	Y	Multiple Myeloma	IRS2	IRS2	DNA	N	Harvard-Geno	197
207	General population	Funded	Y	Controls	IL-6	IL-6	EDTA	Y	Harvard-Rifai	394
207	General population	Funded	Y	Controls	IL-6	IL-6	Serum	Y	Harvard-Rifai	394
207	General population	Funded	Y	Controls	IL-6R_DNA	IL-6 R (DNA)	DNA	N	Harvard-Geno	394
207	General population	Funded	Y	Controls	IL-6SR	IL-6SR	EDTA	Y	Harvard-Rifai	394
207	General population	Funded	Y	Controls	IL-6SR	IL-6SR	Serum	Y	Harvard-Rifai	394
207	General population	Funded	Y	Controls	IL-6ST	IL-6ST	DNA	N	Harvard-Geno	394
207	General population	Funded	Y	Controls	IL-6_DNA	IL-6 (DNA)	DNA	N	Harvard-Geno	394
207	General population	Funded	Y	Multiple Myeloma	IL-6	IL-6	EDTA	Y	Harvard-Rifai	197
207	General population	Funded	Y	Multiple Myeloma	IL-6	IL-6	Serum	Y	Harvard-Rifai	197
207	General population	Funded	Y	Multiple Myeloma	IL-6R_DNA	IL-6 R (DNA)	DNA	N	Harvard-Geno	197
207	General population	Funded	Y	Multiple Myeloma	IL-6SR	IL-6SR	EDTA	Y	Harvard-Rifai	197
207	General population	Funded	Y	Multiple Myeloma	IL-6SR	IL-6SR	Serum	Y	Harvard-Rifai	197
207	General population	Funded	Y	Multiple Myeloma	IL-6ST	IL-6ST	DNA	N	Harvard-Geno	197
207	General population	Funded	Y	Multiple Myeloma	IL-6_DNA	IL-6 (DNA)	DNA	N	Harvard-Geno	197
208	OS	Funded	Y	Colorectal Cancer	AKT1	AKT1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	AKT2	AKT2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	AKT3	AKT3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	APAF1	APAF1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	ARAF	ARAF	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	ATF1	ATF1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	ATF2	ATF2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	ATF3	ATF3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	ATF4	ATF4	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	BAD	BAD	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	BCL2	BCL2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	BID	BID	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	BIRC2	BIRC2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	BIRC3	BIRC3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	BRAF	BRAF	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	CASP1	CASP1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	CASP2	CASP2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	CASP3	CASP3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	CASP6	CASP6	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	CASP7	CASP7	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	CASP8	CASP8	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	CASP9	CASP9	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	CHUK	CHUK	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	CRADD	CRADD	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	CYCS	CYCS	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	ELK1	ELK1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	FADD	FADD	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	FOS	FOS	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	FRAP1	FRAP1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	GAB1	GAB1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	GP130	GP130	EDTA	Y	Vermont	500
208	OS	Funded	Y	Colorectal Cancer	GRB2	GRB2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	HRAS	HRAS	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IFNG	interferon, gamma	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IFNGR1	IFNGR1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IFNGR2	IFNGR2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IKBKB	IKBKB	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IKBKG	IKBKG	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IL-1R2	IL-1R2	EDTA	Y	Vermont	500
208	OS	Funded	Y	Colorectal Cancer	IL-1RA	IL-1RA	EDTA	Y	Vermont	500
208	OS	Funded	Y	Colorectal Cancer	IL1B_DNA	IL-1B (DNA)	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IRAK1	IRAK1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IRAK2	IRAK2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IRAK3	IRAK3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IRAK4	IRAK4	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	JAK1	JAK1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	JAK2	JAK2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	JAK3	JAK3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	JUN	JUN	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	KRAS	KRAS	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MADD	MADD	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP2K1	MAP2K1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP2K2	MAP2K2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP2K3	MAP2K3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP2K4	MAP2K4	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP2K6	MAP2K6	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP2K7	MAP2K7	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP3K1	MAP3K1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP3K14	MAP3K14	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP3K3	MAP3K3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP3K7	MAP3K7	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP3K7IP1	MAP3K7IP1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAP3K7IP2	MAP3K7IP2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAPK1	MAPK1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAPK11	MAPK11	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAPK12	MAPK12	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAPK13	MAPK13	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAPK14	MAPK14	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAPK3	MAPK3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAPK8	MAPK8	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MAPK9	MAPK9	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	MYD88	MYD88	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	NFKB1	NFKB1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	NFKB2	NFKB2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	NFKBIA	NFKBIA	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	NFKBIB	NFKBIB	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	NFKBIE	NFKBIE	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	NRAS	NRAS	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	PIAS3	PIAS3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	PIK3CA	PIK3CA	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	PIK3CB	PIK3CB	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	PIK3CD	PIK3CD	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	PIK3R1	PIK3R1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	PIK3R2	PIK3R2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	PIK3R3	PIK3R3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	PIK3R5	PIK3R5	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	PRKCD	PRKCD	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	PTPN11	PTPN11	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	PTPN6	PTPN6	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	RAF1	RAF1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	REL	REL	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	RELA	RELA	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	RELB	RELB	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	RIPK1	RIPK1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	SHC1	SHC1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	SOCS1	SOCS1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	SOCS2	SOCS2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	SOCS3	SOCS3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	SOCS5	SOCS5	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	SOCS6	SOCS6	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	SOS1	SOS1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	SOS2	SOS2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	STAT1	STAT1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	STAT3	STAT3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	TANK	TANK	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	TNF	TNF	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	TNF-R1	TNF-R1	EDTA	Y	Vermont	500
208	OS	Funded	Y	Colorectal Cancer	TNF-R2	TNF-R2	EDTA	Y	Vermont	500
208	OS	Funded	Y	Colorectal Cancer	TOLLIP	TollIP	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	TRADD	TRADD	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	TRAF2	TRAF2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	TRAF3	TRAF3	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	TRAF6	TRAF6	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	TYK2	TYK2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Controls	AKT1	AKT1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	AKT2	AKT2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	AKT3	AKT3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	APAF1	APAF1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	ARAF	ARAF	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	ATF1	ATF1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	ATF2	ATF2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	ATF3	ATF3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	ATF4	ATF4	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	BAD	BAD	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	BCL2	BCL2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	BID	BID	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	BIRC2	BIRC2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	BIRC3	BIRC3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	BRAF	BRAF	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	CASP1	CASP1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	CASP2	CASP2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	CASP3	CASP3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	CASP6	CASP6	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	CASP7	CASP7	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	CASP8	CASP8	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	CASP9	CASP9	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	CHUK	CHUK	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	CRADD	CRADD	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	CYCS	CYCS	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	ELK1	ELK1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	FADD	FADD	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	FOS	FOS	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	FRAP1	FRAP1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	GAB1	GAB1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	GP130	GP130	EDTA	Y	Vermont	900
208	OS	Funded	Y	Controls	GRB2	GRB2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	HRAS	HRAS	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IFNG	interferon, gamma	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IFNGR1	IFNGR1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IFNGR2	IFNGR2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IKBKB	IKBKB	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IKBKG	IKBKG	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IL-1R2	IL-1R2	EDTA	Y	Vermont	900
208	OS	Funded	Y	Controls	IL-1RA	IL-1RA	EDTA	Y	Vermont	900
208	OS	Funded	Y	Controls	IL1B_DNA	IL-1B (DNA)	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IRAK1	IRAK1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IRAK2	IRAK2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IRAK3	IRAK3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IRAK4	IRAK4	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	JAK1	JAK1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	JAK2	JAK2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	JAK3	JAK3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	JUN	JUN	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	KRAS	KRAS	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MADD	MADD	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP2K1	MAP2K1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP2K2	MAP2K2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP2K3	MAP2K3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP2K4	MAP2K4	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP2K6	MAP2K6	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP2K7	MAP2K7	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP3K1	MAP3K1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP3K14	MAP3K14	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP3K3	MAP3K3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP3K7	MAP3K7	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP3K7IP1	MAP3K7IP1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAP3K7IP2	MAP3K7IP2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAPK1	MAPK1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAPK11	MAPK11	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAPK12	MAPK12	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAPK13	MAPK13	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAPK14	MAPK14	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAPK3	MAPK3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAPK8	MAPK8	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MAPK9	MAPK9	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	MYD88	MYD88	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	NFKB1	NFKB1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	NFKB2	NFKB2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	NFKBIA	NFKBIA	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	NFKBIB	NFKBIB	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	NFKBIE	NFKBIE	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	NRAS	NRAS	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	PIAS3	PIAS3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	PIK3CA	PIK3CA	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	PIK3CB	PIK3CB	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	PIK3CD	PIK3CD	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	PIK3R1	PIK3R1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	PIK3R2	PIK3R2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	PIK3R3	PIK3R3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	PIK3R5	PIK3R5	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	PRKCD	PRKCD	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	PTPN11	PTPN11	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	PTPN6	PTPN6	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	RAF1	RAF1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	REL	REL	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	RELA	RELA	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	RELB	RELB	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	RIPK1	RIPK1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	SHC1	SHC1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	SOCS1	SOCS1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	SOCS2	SOCS2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	SOCS3	SOCS3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	SOCS5	SOCS5	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	SOCS6	SOCS6	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	SOS1	SOS1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	SOS2	SOS2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	STAT1	STAT1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	STAT3	STAT3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	TANK	TANK	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	TNF	TNF	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	TNF-R1	TNF-R1	EDTA	Y	Vermont	900
208	OS	Funded	Y	Controls	TNF-R2	TNF-R2	EDTA	Y	Vermont	900
208	OS	Funded	Y	Controls	TOLLIP	TollIP	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	TRADD	TRADD	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	TRAF2	TRAF2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	TRAF3	TRAF3	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	TRAF6	TRAF6	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	TYK2	TYK2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Colorectal Cancer	IL-1A	IL-1Alpha	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IL-1R1	IL1R1	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IL-1R2	IL-1R2	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IL-1RAP	IL1RAP	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IL-1RN	IL-1RN	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IL-6R_DNA	IL-6 R (DNA)	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IL-6SR	IL-6SR	EDTA	Y	Vermont	500
208	OS	Funded	Y	Colorectal Cancer	IL-6ST	IL-6ST	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	IL-6_DNA	IL-6 (DNA)	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	TNF-RSF1A	TNFRSF1A	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Colorectal Cancer	TNF-RSF1B	TNFRSF1B	DNA	N	WFU Zheng	500
208	OS	Funded	Y	Controls	IL-1A	IL-1Alpha	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IL-1R1	IL1R1	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IL-1R2	IL-1R2	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IL-1RAP	IL1RAP	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IL-1RN	IL-1RN	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IL-6R_DNA	IL-6 R (DNA)	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IL-6SR	IL-6SR	EDTA	Y	Vermont	900
208	OS	Funded	Y	Controls	IL-6ST	IL-6ST	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	IL-6_DNA	IL-6 (DNA)	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	TNF-RSF1A	TNFRSF1A	DNA	N	WFU Zheng	900
208	OS	Funded	Y	Controls	TNF-RSF1B	TNFRSF1B	DNA	N	WFU Zheng	900
214	OS	Funded	Y	Controls	ADIP	Adiponectin	EDTA	Y	Harvard-Rifai	184
214	OS	Funded	Y	Controls	ADIP_DNA	Adiponectin (DNA)	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	C-PEPTIDE	C-peptide	EDTA	Y	Pollak	234
214	OS	Funded	Y	Controls	CAGAAB	CagA Ab	EDTA	Y	Harvard-Rifai	184
214	OS	Funded	Y	Controls	CRP	CRP	EDTA	Y	Harvard-Rifai	184
214	OS	Funded	Y	Controls	GH1_DNA	GH1 (DNA)	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	GHR_DNA	GHR (DNA)	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	HGA1C	Hemoglobin A1c from RBC	RBC	RBC	Harvard-Rifai	418
214	OS	Funded	Y	Controls	HPYLAB	Hpylori Ab	EDTA	Y	Harvard-Rifai	184
214	OS	Funded	Y	Controls	IGF-1-DNA	IGF1-DNA	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	IGF-1R	IGF1R	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	IGF-2-DNA	IGF-2-DNA	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	IGF-2R	IGF2R	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	IGFBP-1	IGFBP-1	EDTA	Y	Pollak	418
214	OS	Funded	Y	Controls	IGFBP1-DNA	IGFBP1-DNA	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	IGFBP3-DNA	IGFBP3-DNA	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	IL-10_DNA	IL-10 (DNA)	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	IL1B_DNA	IL-1B (DNA)	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	IL6	IL-6	EDTA	Y	Harvard-Rifai	184
214	OS	Funded	Y	Controls	INSU	Insulin	EDTA	Y	Pollak	234
214	OS	Funded	Y	Controls	IRS1	IRS1	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	IRS2	IRS2	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	LEPTIN	Leptin	EDTA	Y	Harvard-Rifai	184
214	OS	Funded	Y	Controls	METABOL	Metabolomics	EDTA	Y	HCC	184
214	OS	Funded	Y	Controls	NFKB1	NFKB1	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	NFKBIA	NFKBIA	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	NFKBIL1	NFKBIL1	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	PPAR-G2	PPAR-G2	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	PROINSU	Proinsulin	EDTA	Y	Pollak	418
214	OS	Funded	Y	Controls	PTGS1-COX1	PTGS1-COX1	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	PTGS2-COX2	PTGS2-COX2	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	TELO	TELO	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	TGFB_DNA	TGFB-DNA	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	TNF-R2	TNF-R2	EDTA	Y	Harvard-Rifai	184
214	OS	Funded	Y	Controls	VDR	VDR	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	VITD	Vit D 25-OH	EDTA	Y	Harvard-Rifai	184
214	OS	Funded	Y	Pancreas Cancer	ADIP	Adiponectin	EDTA	Y	Harvard-Rifai	92
214	OS	Funded	Y	Pancreas Cancer	ADIP_DNA	Adiponectin (DNA)	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	C-PEPTIDE	C-peptide	EDTA	Y	Pollak	117
214	OS	Funded	Y	Pancreas Cancer	CAGAAB	CagA Ab	EDTA	Y	Harvard-Rifai	92
214	OS	Funded	Y	Pancreas Cancer	CRP	CRP	EDTA	Y	Harvard-Rifai	92
214	OS	Funded	Y	Pancreas Cancer	GH1_DNA	GH1 (DNA)	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	GHR_DNA	GHR (DNA)	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	HGA1C	Hemoglobin A1c from RBC	RBC	RBC	Harvard-Rifai	209
214	OS	Funded	Y	Pancreas Cancer	HPYLAB	Hpylori Ab	EDTA	Y	Harvard-Rifai	92
214	OS	Funded	Y	Pancreas Cancer	IGF-1-DNA	IGF1-DNA	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	IGF-1R	IGF1R	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	IGF-2-DNA	IGF-2-DNA	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	IGF-2R	IGF2R	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	IGFBP-1	IGFBP-1	EDTA	Y	Pollak	209
214	OS	Funded	Y	Pancreas Cancer	IGFBP1-DNA	IGFBP1-DNA	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	IGFBP3-DNA	IGFBP3-DNA	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	IL-10_DNA	IL-10 (DNA)	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	IL1B_DNA	IL-1B (DNA)	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	IL6	IL-6	EDTA	Y	Harvard-Rifai	92
214	OS	Funded	Y	Pancreas Cancer	INSU	Insulin	EDTA	Y	Pollak	117
214	OS	Funded	Y	Pancreas Cancer	IRS1	IRS1	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	IRS2	IRS2	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	LEPTIN	Leptin	EDTA	Y	Harvard-Rifai	92
214	OS	Funded	Y	Pancreas Cancer	METABOL	Metabolomics	EDTA	Y	HCC	92
214	OS	Funded	Y	Pancreas Cancer	NFKB1	NFKB1	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	NFKBIA	NFKBIA	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	NFKBIL1	NFKBIL1	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	PPAR-G2	PPAR-G2	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	PROINSU	Proinsulin	EDTA	Y	Pollak	209
214	OS	Funded	Y	Pancreas Cancer	PTGS1-COX1	PTGS1-COX1	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	PTGS2-COX2	PTGS2-COX2	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	TELO	TELO	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	TGFB_DNA	TGFB-DNA	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	TNF-R2	TNF-R2	EDTA	Y	Harvard-Rifai	92
214	OS	Funded	Y	Pancreas Cancer	VDR	VDR	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	VITD	Vit D 25-OH	EDTA	Y	Harvard-Rifai	92
214	OS	Funded	Y	Controls	IL-1RN	IL-1RN	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	IL-6	IL-6	EDTA	Y	Harvard-Rifai	418
214	OS	Funded	Y	Controls	IL-6_DNA	IL-6 (DNA)	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	IL-8_DNA	IL-8 (DNA)	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Controls	TNF-A_DNA	TNFA (DNA)	DNA	N	Dana-Farber	418
214	OS	Funded	Y	Pancreas Cancer	IL-1RN	IL-1RN	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	IL-6	IL-6	EDTA	Y	Harvard-Rifai	209
214	OS	Funded	Y	Pancreas Cancer	IL-6_DNA	IL-6 (DNA)	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	IL-8_DNA	IL-8 (DNA)	DNA	N	Dana-Farber	209
214	OS	Funded	Y	Pancreas Cancer	TNF-A_DNA	TNFA (DNA)	DNA	N	Dana-Farber	209
224	OS/CT	Funded	Y	Colon Cancer	EXOME CHIP	Exome Chip	DNA	N	TGen	900
224	OS/CT	Funded	Y	Colon Cancer	GWAS	GWAS	DNA	N	TGen	556
224	General population	Funded	Y	Colon Cancer	GWAS	GWAS	DNA	N	Broad Institute	1,309
224	OS/CT	Funded	Y	Controls	EXOME CHIP	Exome Chip	DNA	N	TGen	900
224	OS/CT	Funded	Y	Controls	GWAS	GWAS	DNA	N	TGen	69
224	General population	Funded	Y	Controls	GWAS	GWAS	DNA	N	Broad Institute	1,309
238	OS	Analysis	Y	Controls	ADIP	Adiponectin	Serum	Y	UCLA Mol Edi	1,400
238	OS	Analysis	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	UCLA Mol Edi	1,400
238	OS	Analysis	Y	Controls	FT	Testosterone, free	Serum	Y	UCLA Mol Edi	1,400
238	OS	Analysis	Y	Controls	LEPT-R	Leptin receptor	Serum	Y	UCLA Mol Edi	1,400
238	OS	Analysis	Y	Controls	LEPTIN	Leptin	Serum	Y	UCLA Mol Edi	1,400
238	OS	Analysis	Y	Controls	SHBG	SHBG	Serum	Y	UCLA Mol Edi	1,400
238	OS	Analysis	Y	Controls	TSTO	Testosterone	Serum	Y	UCLA Mol Edi	1,400
238	OS	Analysis	Y	Type 2 Diabetes	ADIP	Adiponectin	Serum	Y	UCLA Mol Edi	700
238	OS	Analysis	Y	Type 2 Diabetes	ESTD	Estradiol (E2)	Serum	Y	UCLA Mol Edi	700
238	OS	Analysis	Y	Type 2 Diabetes	FT	Testosterone, free	Serum	Y	UCLA Mol Edi	700
238	OS	Analysis	Y	Type 2 Diabetes	LEPT-R	Leptin receptor	Serum	Y	UCLA Mol Edi	700
238	OS	Analysis	Y	Type 2 Diabetes	LEPTIN	Leptin	Serum	Y	UCLA Mol Edi	700
238	OS	Analysis	Y	Type 2 Diabetes	SHBG	SHBG	Serum	Y	UCLA Mol Edi	700
238	OS	Analysis	Y	Type 2 Diabetes	TSTO	Testosterone	Serum	Y	UCLA Mol Edi	700
242	OS	Analysis	Y	Controls	IRF4	IRF4	DNA	N	Harvard-Geno	259
242	OS	Analysis	Y	Controls	TELO	TELO	DNA	N	Harvard-Geno	518
242	OS	Analysis	Y	Controls	TERT	TERT	DNA	N	Harvard-Geno	259
242	OS	Analysis	Y	Melanoma of the Skin	IRF4	IRF4	DNA	N	Harvard-Geno	259
242	OS	Analysis	Y	Melanoma of the Skin	TELO	TELO	DNA	N	Harvard-Geno	518
242	OS	Analysis	Y	Melanoma of the Skin	TERT	TERT	DNA	N	Harvard-Geno	259
250	HT	Analysis	Y	Controls	APOE4	Apo E4	DNA	N	NIA	7,479
250	HT	Analysis	Y	Controls	BDNF	BDNF	DNA	N	NIA	7,479
250	HT	Analysis	Y	Controls	COMT	COMT	DNA	N	NIA	7,479
250	HT	Analysis	Y	Controls	WWC1	WWC1	DNA	N	NIA	7,479
254	OS	Analysis	Y	Controls	POT1	POT1	DNA	N	UCLA-Liu	2,620
254	OS	Analysis	Y	Controls	RAP1	RAP1	DNA	N	UCLA-Liu	2,620
254	OS	Analysis	Y	Controls	TEP1	TEP1	DNA	N	UCLA-Liu	2,620
254	OS	Analysis	Y	Controls	TERT	TERT	DNA	N	UCLA-Liu	2,620
254	OS	Analysis	Y	Controls	TIN2	TIN2	DNA	N	UCLA-Liu	2,620
254	OS	Analysis	Y	Controls	TPP1	TPP1	DNA	N	UCLA-Liu	2,620
254	OS	Analysis	Y	Controls	TRF1	TRF1	DNA	N	UCLA-Liu	2,620
254	OS	Analysis	Y	Controls	TRF2	TRF2	DNA	N	UCLA-Liu	2,620
254	OS	Analysis	Y	Type 2 Diabetes	POT1	POT1	DNA	N	UCLA-Liu	1,800
254	OS	Analysis	Y	Type 2 Diabetes	RAP1	RAP1	DNA	N	UCLA-Liu	1,800
254	OS	Analysis	Y	Type 2 Diabetes	TEP1	TEP1	DNA	N	UCLA-Liu	1,800
254	OS	Analysis	Y	Type 2 Diabetes	TERT	TERT	DNA	N	UCLA-Liu	1,800
254	OS	Analysis	Y	Type 2 Diabetes	TIN2	TIN2	DNA	N	UCLA-Liu	1,800
254	OS	Analysis	Y	Type 2 Diabetes	TPP1	TPP1	DNA	N	UCLA-Liu	1,800
254	OS	Analysis	Y	Type 2 Diabetes	TRF1	TRF1	DNA	N	UCLA-Liu	1,800
254	OS	Analysis	Y	Type 2 Diabetes	TRF2	TRF2	DNA	N	UCLA-Liu	1,800
254	OS	Analysis	Y	Controls	OBFC1	OPFC1	DNA	N	UCLA-Liu	2,620
254	OS	Analysis	Y	Controls	TELRT	TELRT	DNA	N	UCLA-Liu	2,620
254	OS	Analysis	Y	Controls	TERC	TERC	DNA	N	UCLA-Liu	2,620
254	OS	Analysis	Y	Type 2 Diabetes	OBFC1	OPFC1	DNA	N	UCLA-Liu	1,800
254	OS	Analysis	Y	Type 2 Diabetes	TELRT	TELRT	DNA	N	UCLA-Liu	1,800
254	OS	Analysis	Y	Type 2 Diabetes	TERC	TERC	DNA	N	UCLA-Liu	1,800
257	OS	Funded	Y	Controls	SNPS 768	SNPs 768 AMD	DNA	N	Case Western	2,852
257	OS	Funded	Y	Eye	SNPS 768	SNPs 768 AMD	DNA	N	Case Western	722
263	General population	Funded	Y	Breast Cancer Invasive	ILLUM OMNI	Illumina Omni Express	DNA	N	Wake Forest	2,690
263	General population	Funded	Y	Controls	ILLUM OMNI	Illumina Omni Express	DNA	N	Wake Forest	1,800
264	General population	Funded	Y	Controls	GWAS	GWAS	DNA	N	UNC Gene Core	3,094
266	General population	Funded	Y	Controls	HGF	HGF	Citrate	Y	Vermont	1,601
266	General population	Funded	Y	Controls	IGF-I	IGF-I	Citrate	Y	Vermont	1,601
266	General population	Funded	Y	Controls	IGFBP-3	IGFBP-3	Citrate	Y	Vermont	1,601
266	General population	Funded	Y	Controls	INSU	Insulin	Citrate	Y	Vermont	1,601
266	General population	Funded	Y	Controls	LEPTIN	Leptin	Citrate	Y	Vermont	1,601
266	General population	Funded	Y	Controls	NGF	NGF	Citrate	Y	Vermont	1,601
266	General population	Funded	Y	Controls	SNPS 100	SNPs 100 AS266	DNA	N	Wake Forest	1,601
266	General population	Funded	Y	Controls	SNPS 7	SNPs 7 AS266	DNA	N	Wake Forest	1,601
266	General population	Funded	Y	Lung Cancer	HGF	HGF	Citrate	Y	Vermont	1,384
266	General population	Funded	Y	Lung Cancer	IGF-I	IGF-I	Citrate	Y	Vermont	1,384
266	General population	Funded	Y	Lung Cancer	IGFBP-3	IGFBP-3	Citrate	Y	Vermont	1,384
266	General population	Funded	Y	Lung Cancer	INSU	Insulin	Citrate	Y	Vermont	1,384
266	General population	Funded	Y	Lung Cancer	LEPTIN	Leptin	Citrate	Y	Vermont	1,384
266	General population	Funded	Y	Lung Cancer	NGF	NGF	Citrate	Y	Vermont	1,384
266	General population	Funded	Y	Lung Cancer	SNPS 100	SNPs 100 AS266	DNA	N	Wake Forest	1,384
266	General population	Funded	Y	Lung Cancer	SNPS 7	SNPs 7 AS266	DNA	N	Wake Forest	1,384
266	General population	Funded	Y	Controls	IL-6	IL-6	Citrate	Y	Vermont	1,601
266	General population	Funded	Y	Lung Cancer	IL-6	IL-6	Citrate	Y	Vermont	1,384
269	General population	Approved	N	Breast Cancer Invasive	GENESEQ	Gene seq	DNA	N	Unassigned	5,679
269	General population	Approved	N	Breast Cancer Invasive	MTDNA	mtDNA	DNA	N	Affymetrix	5,679
269	General population	Approved	N	Controls	GENESEQ	Gene seq	DNA	N	Unassigned	5,679
269	General population	Approved	N	Controls	MTDNA	mtDNA	DNA	N	Affymetrix	5,679
271	General population	Analysis	Y	Controls	AA	FA arachidonic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	ALA	FA alpha linolenic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	DA	FA Docosatraenoic Acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	DHA	FA docosahexaenoic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	DPAN3	FA docosapentaenoic acid n3	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	EPA	FA eicosapentaenoic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	ESD	FA eicosadienoic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	EST	FA eicosatrienoic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	FA 18:4N-3	FA Stearidonic Acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	GLA	FA gamma linolenic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	LA	FA Linoleic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	MA	FA myristic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	OA	FA oleic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	PA	FA Palmitic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	PLA	FA palmitoleic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Controls	SA	FA stearic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	AA	FA arachidonic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	ALA	FA alpha linolenic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	DA	FA Docosatraenoic Acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	DHA	FA docosahexaenoic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	DPAN3	FA docosapentaenoic acid n3	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	EPA	FA eicosapentaenoic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	ESD	FA eicosadienoic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	EST	FA eicosatrienoic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	FA 18:4N-3	FA Stearidonic Acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	GLA	FA gamma linolenic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	LA	FA Linoleic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	MA	FA myristic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	OA	FA oleic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	PA	FA Palmitic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	PLA	FA palmitoleic acid	RBC	RBC	Belury Lab	400
271	General population	Analysis	Y	Hip Fracture	SA	FA stearic acid	RBC	RBC	Belury Lab	400
275	OS	Funded	Y	Breast Cancer Invasive	CREA	CREA	Urine	U	Hormone Lab	260
275	OS	Funded	Y	Breast Cancer Invasive	MELA	Melatonin	Urine	U	Hormone Lab	260
275	OS	Funded	Y	Breast Cancer Invasive	MELA-A	Melatonin-adj	Urine	U	Hormone Lab	260
275	OS	Funded	Y	Controls	CREA	CREA	Urine	U	Hormone Lab	519
275	OS	Funded	Y	Controls	MELA	Melatonin	Urine	U	Hormone Lab	519
275	OS	Funded	Y	Controls	MELA-A	Melatonin-adj	Urine	U	Hormone Lab	519
278	General population	Approved	N	Controls	A2-MACR	a-2-MACR	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Controls	AB1-40	A-beta1-40	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	AB1-42	A-beta1-42	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	ALT	ALT	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	AST	AST	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	BCTX	beta-CTx	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	CRP	CRP	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Controls	DDIM	D-dimers	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Controls	ESEL	E-Selectin	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Controls	ETP	ETP	Citrate	Y	Vermont	1,264
278	General population	Approved	N	Controls	F7	Factor VII	Citrate	Y	Vermont	1,264
278	General population	Approved	N	Controls	F8	FVIII Activity	Citrate	Y	Vermont	1,264
278	General population	Approved	N	Controls	FIBR	Fibrinogen	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Controls	GGT	GGT	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	HDLC	HDLC	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Controls	LPA	LP(a)	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Controls	MMP1	MMP-1	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	MMP10	MMP-10	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	MMP2	MMP-2	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	MMP3	MMP-3	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	MMP7	MMP-7	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	SEPCR	sEPCR	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Controls	TAFI	TAFI	Citrate	Y	Vermont	1,264
278	General population	Approved	N	Controls	TCHO	Cholesterol	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Controls	TFPIFREE	TFPI, free	Citrate	Y	Vermont	1,264
278	General population	Approved	N	Controls	TIMP-1	TIMP-1	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	TIMP-2	TIMP-2	Serum	Y	Vermont	1,264
278	General population	Approved	N	Controls	TRI	Trig	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Hemorrhagic Stroke	A2-MACR	a-2-MACR	EDTA	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	AB1-40	A-beta1-40	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	AB1-42	A-beta1-42	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	ALT	ALT	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	AST	AST	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	BCTX	beta-CTx	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	CRP	CRP	EDTA	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	DDIM	D-dimers	EDTA	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	ESEL	E-Selectin	EDTA	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	ETP	ETP	Citrate	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	F7	Factor VII	Citrate	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	F8	FVIII Activity	Citrate	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	FIBR	Fibrinogen	EDTA	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	GGT	GGT	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	HDLC	HDLC	EDTA	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	LPA	LP(a)	EDTA	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	MMP1	MMP-1	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	MMP10	MMP-10	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	MMP2	MMP-2	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	MMP3	MMP-3	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	MMP7	MMP-7	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	SEPCR	sEPCR	EDTA	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	TAFI	TAFI	Citrate	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	TCHO	Cholesterol	EDTA	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	TFPIFREE	TFPI, free	Citrate	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	TIMP-1	TIMP-1	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	TIMP-2	TIMP-2	Serum	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	TRI	Trig	EDTA	Y	Vermont	632
278	General population	Approved	N	Controls	IL-6	IL-6	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Controls	VWF	vWF	EDTA	Y	Vermont	1,264
278	General population	Approved	N	Hemorrhagic Stroke	IL-6	IL-6	EDTA	Y	Vermont	632
278	General population	Approved	N	Hemorrhagic Stroke	VWF	vWF	EDTA	Y	Vermont	632
282	OS/CT	Funded	Y	Controls	CA-125	CA 125	Serum	Y	TOR	558
282	OS/CT	Funded	Y	Controls	HE4	HE4 Serum marker	Serum	Y	TOR	558
282	OS/CT	Funded	Y	Controls	HE4_MFI	HE4 Serum marker (MFI)	Serum	Y	TOR	558
282	OS/CT	Funded	Y	Controls	MMP7	MMP-7	Serum	Y	TOR	558
282	OS/CT	Funded	Y	Controls	MSLN	Mesothelin	Serum	Y	TOR	558
282	OS/CT	Funded	Y	Controls	MSLN_MFI	Mesothelin (MFI)	Serum	Y	TOR	558
282	OS/CT	Funded	Y	Controls	SLP1	SLP1	Serum	Y	TOR	558
282	OS/CT	Funded	Y	Controls	SLP1_MFI	SLP1 (MFI)	Serum	Y	TOR	558
282	OS/CT	Funded	Y	Ovarian Cancer	CA-125	CA 125	Serum	Y	TOR	280
282	OS/CT	Funded	Y	Ovarian Cancer	HE4	HE4 Serum marker	Serum	Y	TOR	280
282	OS/CT	Funded	Y	Ovarian Cancer	HE4_MFI	HE4 Serum marker (MFI)	Serum	Y	TOR	280
282	OS/CT	Funded	Y	Ovarian Cancer	MMP7	MMP-7	Serum	Y	TOR	280
282	OS/CT	Funded	Y	Ovarian Cancer	MSLN	Mesothelin	Serum	Y	TOR	280
282	OS/CT	Funded	Y	Ovarian Cancer	MSLN_MFI	Mesothelin (MFI)	Serum	Y	TOR	280
282	OS/CT	Funded	Y	Ovarian Cancer	SLP1	SLP1	Serum	Y	TOR	280
282	OS/CT	Funded	Y	Ovarian Cancer	SLP1_MFI	SLP1 (MFI)	Serum	Y	TOR	280
284	CT	Approved	N	Benign Breast Disease	ADIP	Adiponectin	Serum	Y	Yu	700
284	CT	Approved	N	Benign Breast Disease	CRP	CRP	Serum	Y	Yu	700
284	CT	Approved	N	Benign Breast Disease	ESTD	Estradiol (E2)	Serum	Y	Esoterix	700
284	CT	Approved	N	Benign Breast Disease	INSU	Insulin	Serum	Y	Yu	700
284	CT	Approved	N	Controls	ADIP	Adiponectin	Serum	Y	Yu	1,400
284	CT	Approved	N	Controls	CRP	CRP	Serum	Y	Yu	1,400
284	CT	Approved	N	Controls	ESTD	Estradiol (E2)	Serum	Y	Esoterix	1,400
284	CT	Approved	N	Controls	INSU	Insulin	Serum	Y	Yu	1,400
285	OS/CT	Approved	N	Breast Cancer	GWAS	GWAS	DNA	N	Unassigned	700
285	OS/CT	Approved	N	Breast Cancer	SNPS 500	SNPS 500	DNA	N	Unassigned	1,000
285	OS/CT	Approved	N	Controls	GWAS	GWAS	DNA	N	Unassigned	700
285	OS/CT	Approved	N	Controls	SNPS 500	SNPS 500	DNA	N	Unassigned	1,000
290	General population	Funded	Y	Breast Cancer Invasive	CREA	CREA	Urine	U	WSLH	508
290	General population	Funded	Y	Breast Cancer Invasive	HEAVY MET	Heavy Metals Panel	Urine	U	WSLH	508
290	General population	Funded	Y	Controls	CREA	CREA	Urine	U	WSLH	1,000
290	General population	Funded	Y	Controls	HEAVY MET	Heavy Metals Panel	Urine	U	WSLH	1,000
291	General population	Approved	N	Controls	GLUC	Glucose	EDTA	Y	Harvard-Rifai	286
291	General population	Approved	N	Controls	HGA1C	Hemoglobin A1c from RBC	RBC	RBC	Harvard-Rifai	286
291	General population	Approved	N	Controls	HPV	HPV	EDTA	Y	Unassigned	286
291	General population	Approved	N	Controls	INSU	Insulin	EDTA	Y	Harvard-Rifai	286
291	General population	Approved	N	Larynx Cancer	GLUC	Glucose	EDTA	Y	Harvard-Rifai	33
291	General population	Approved	N	Larynx Cancer	HGA1C	Hemoglobin A1c from RBC	RBC	RBC	Harvard-Rifai	33
291	General population	Approved	N	Larynx Cancer	HPV	HPV	EDTA	Y	Unassigned	33
291	General population	Approved	N	Larynx Cancer	INSU	Insulin	EDTA	Y	Harvard-Rifai	33
291	General population	Approved	N	Oral (Mouth) Cancer	GLUC	Glucose	EDTA	Y	Harvard-Rifai	41
291	General population	Approved	N	Oral (Mouth) Cancer	HGA1C	Hemoglobin A1c from RBC	RBC	RBC	Harvard-Rifai	41
291	General population	Approved	N	Oral (Mouth) Cancer	HPV	HPV	EDTA	Y	Unassigned	41
291	General population	Approved	N	Oral (Mouth) Cancer	INSU	Insulin	EDTA	Y	Harvard-Rifai	41
291	General population	Approved	N	Palate Cancer	GLUC	Glucose	EDTA	Y	Harvard-Rifai	23
291	General population	Approved	N	Palate Cancer	HGA1C	Hemoglobin A1c from RBC	RBC	RBC	Harvard-Rifai	23
291	General population	Approved	N	Palate Cancer	HPV	HPV	EDTA	Y	Unassigned	23
291	General population	Approved	N	Palate Cancer	INSU	Insulin	EDTA	Y	Harvard-Rifai	23
291	General population	Approved	N	Tongue Cancer	GLUC	Glucose	EDTA	Y	Harvard-Rifai	46
291	General population	Approved	N	Tongue Cancer	HGA1C	Hemoglobin A1c from RBC	RBC	RBC	Harvard-Rifai	46
291	General population	Approved	N	Tongue Cancer	HPV	HPV	EDTA	Y	Unassigned	46
291	General population	Approved	N	Tongue Cancer	INSU	Insulin	EDTA	Y	Harvard-Rifai	46
292	OS	Funded	Y	Colorectal Cancer	CML-AGE	CML-AGE	Citrate	Y	DDRC - Baylor	425
292	OS	Funded	Y	Colorectal Cancer	CML-AGE	CML-AGE	Serum	Y	DDRC - Baylor	425
292	OS	Funded	Y	Colorectal Cancer	SRAGE	sRAGE	EDTA	Y	DDRC - Baylor	425
292	OS	Funded	Y	Colorectal Cancer	SRAGE	sRAGE	Serum	Y	DDRC - Baylor	425
292	OS	Funded	Y	Controls	CML-AGE	CML-AGE	Citrate	Y	DDRC - Baylor	791
292	OS	Funded	Y	Controls	CML-AGE	CML-AGE	Serum	Y	DDRC - Baylor	791
292	OS	Funded	Y	Controls	SRAGE	sRAGE	EDTA	Y	DDRC - Baylor	791
292	OS	Funded	Y	Controls	SRAGE	sRAGE	Serum	Y	DDRC - Baylor	791
294	General population	Funded	Y	Controls	ALPL	ALPL	DNA	N	Unassigned	200
294	General population	Funded	Y	Controls	FUT2	FUT2	DNA	N	Unassigned	200
294	General population	Funded	Y	Controls	MTHF-667	MTHF-667	DNA	N	Unassigned	200
294	General population	Funded	Y	Controls	SNPS 1CM	SNPs 1-car met	DNA	N	Unassigned	200
294	General population	Funded	Y	Lung Cancer	ALPL	ALPL	DNA	N	Unassigned	200
294	General population	Funded	Y	Lung Cancer	FUT2	FUT2	DNA	N	Unassigned	200
294	General population	Funded	Y	Lung Cancer	MTHF-667	MTHF-667	DNA	N	Unassigned	200
294	General population	Funded	Y	Lung Cancer	SNPS 1CM	SNPs 1-car met	DNA	N	Unassigned	200
296	General population	Funded	Y	Controls	HBCAB	Hep B c-Ab	Serum	Y	NCI Viral Stg	242
296	General population	Funded	Y	Controls	HBSAG	Hep B s-Ag	Serum	Y	NCI Viral Stg	242
296	General population	Funded	Y	Controls	HCV	Hep CV	Serum	Y	NCI Viral Stg	242
296	General population	Funded	Y	Liver Cancer	HBCAB	Hep B c-Ab	Serum	Y	NCI Viral Stg	121
296	General population	Funded	Y	Liver Cancer	HBSAG	Hep B s-Ag	Serum	Y	NCI Viral Stg	121
296	General population	Funded	Y	Liver Cancer	HCV	Hep CV	Serum	Y	NCI Viral Stg	121
297	OS	Funded	Y	Controls	16-OHE1	Estrone, 16a-OH	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	2-OHE1	Estrone, 2-OH	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ANRO	Androstenedione	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	DHEA	DHEA	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	DHEAS	DHEAS	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTD-16K	Estradiol, 16k	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTD-2MO	Estradiol, 2MO	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTD-2MO-U	Estradiol, 2MO	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTD-2OH	Estradiol, 2OH	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTD-4MO	Estradiol, 4MO	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTD-U	Estradiol, uncong	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTR	Estrone (E1)	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTR-2MO	Estrone, 2-MO	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTR-2MO-U	Estrone, 2-MO uncong	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTR-3MEOH	Estrone, 3-ME-O 3 methyl ether	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTR-4MO	Estrone, 4-MO	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTR-4OH	Estrone, 4OH	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTR-U	Estrone, uncong	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTRIO	Estriol	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTRIO-16E	Estriol, 16-epi	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTRIO-17E	Estriol, 17-epi	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	ESTRIO-U	Estriol, uncong	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Controls	TSTO	Testosterone	Serum	Y	SAIC-Frederick	540
297	OS	Funded	Y	Endometrial Cancer	16-OHE1	Estrone, 16a-OH	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	2-OHE1	Estrone, 2-OH	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ANRO	Androstenedione	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	DHEA	DHEA	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	DHEAS	DHEAS	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTD	Estradiol (E2)	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTD-16K	Estradiol, 16k	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTD-2MO	Estradiol, 2MO	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTD-2MO-U	Estradiol, 2MO	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTD-2OH	Estradiol, 2OH	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTD-4MO	Estradiol, 4MO	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTD-U	Estradiol, uncong	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTR	Estrone (E1)	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTR-2MO	Estrone, 2-MO	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTR-2MO-U	Estrone, 2-MO uncong	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTR-3MEOH	Estrone, 3-ME-O 3 methyl ether	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTR-4MO	Estrone, 4-MO	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTR-4OH	Estrone, 4OH	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTR-U	Estrone, uncong	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTRIO	Estriol	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTRIO-16E	Estriol, 16-epi	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTRIO-17E	Estriol, 17-epi	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	ESTRIO-U	Estriol, uncong	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Endometrial Cancer	TSTO	Testosterone	Serum	Y	SAIC-Frederick	430
297	OS	Funded	Y	Ovarian Cancer	16-OHE1	Estrone, 16a-OH	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	2-OHE1	Estrone, 2-OH	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ANRO	Androstenedione	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	DHEA	DHEA	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	DHEAS	DHEAS	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTD	Estradiol (E2)	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTD-16K	Estradiol, 16k	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTD-2MO	Estradiol, 2MO	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTD-2MO-U	Estradiol, 2MO	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTD-2OH	Estradiol, 2OH	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTD-4MO	Estradiol, 4MO	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTD-U	Estradiol, uncong	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTR	Estrone (E1)	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTR-2MO	Estrone, 2-MO	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTR-2MO-U	Estrone, 2-MO uncong	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTR-3MEOH	Estrone, 3-ME-O 3 methyl ether	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTR-4MO	Estrone, 4-MO	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTR-4OH	Estrone, 4OH	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTR-U	Estrone, uncong	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTRIO	Estriol	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTRIO-16E	Estriol, 16-epi	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTRIO-17E	Estriol, 17-epi	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	ESTRIO-U	Estriol, uncong	Serum	Y	SAIC-Frederick	240
297	OS	Funded	Y	Ovarian Cancer	TSTO	Testosterone	Serum	Y	SAIC-Frederick	240
301	General population	Funded	Y	Controls	GWAS	GWAS	DNA	N	NCI Genotype	400
301	General population	Funded	Y	Controls	TAQMAN	TAQM	DNA	N	NCI Genotype	400
301	General population	Funded	Y	Lymphoma Non Hodgkins	GWAS	GWAS	DNA	N	NCI Genotype	1,004
301	General population	Funded	Y	Lymphoma Non Hodgkins	TAQMAN	TAQM	DNA	N	NCI Genotype	1,004
302	OS	Approved	N	Controls	ESTD	Estradiol (E2)	Serum	Y	Unassigned	474
302	OS	Approved	N	Controls	SHBG	SHBG	Serum	Y	Unassigned	474
302	OS	Approved	N	Controls	TSTO	Testosterone	Serum	Y	Unassigned	474
302	OS	Approved	N	Ischemic Stroke	ESTD	Estradiol (E2)	Serum	Y	Unassigned	474
302	OS	Approved	N	Ischemic Stroke	SHBG	SHBG	Serum	Y	Unassigned	474
302	OS	Approved	N	Ischemic Stroke	TSTO	Testosterone	Serum	Y	Unassigned	474
305	General population	Approved	N	Controls	VITD	Vit D 25-OH	Serum	Y	Heartland	471
307	General population	Approved	N	CHD	MET450K	Methylation at 450K	DNA	N	Unassigned	559
307	General population	Approved	N	Controls	MET450K	Methylation at 450K	DNA	N	Unassigned	1,677
311	General population	Approved	N	Bladder Cancer	MET450K	Methylation at 450K	DNA	N	Unassigned	600
311	General population	Approved	N	Bladder Cancer	METGLOB	Global Methylation	DNA	N	Song Lab	600
311	General population	Approved	N	Controls	MET450K	Methylation at 450K	DNA	N	Unassigned	600
311	General population	Approved	N	Controls	METGLOB	Global Methylation	DNA	N	Song Lab	600
315	CT	Approved	N	Controls	AIMS	AIMS	DNA	N	Unassigned	8,600
315	CT	Approved	N	Controls	MET10	Methylation at 10	DNA	N	Unassigned	4,300
315	CT	Approved	N	Controls	MET450K	Methylation at 450K	DNA	N	Unassigned	4,300
316	OS	Funded	Y	Breast Cancer Invasive	ARRAY	Anti Microarray	EDTA	Y	FH-P.Lampe	1,288
316	OS	Funded	Y	Controls	ARRAY	Anti Microarray	EDTA	Y	FH-P.Lampe	1,288
318	OS	Approved	N	Any Adjudicated Fracture	CREA	CREA	Urine	U	Unassigned	978
318	OS	Approved	N	Any Adjudicated Fracture	NA2	Sodium	Urine	U	Unassigned	978
318	OS	Approved	N	Any Adjudicated Fracture	VITD	Vit D 25-OH	Serum	Y	Unassigned	978
318	OS	Approved	N	Controls	CREA	CREA	Urine	U	Unassigned	978
318	OS	Approved	N	Controls	NA2	Sodium	Urine	U	Unassigned	978
318	OS	Approved	N	Controls	VITD	Vit D 25-OH	Serum	Y	Unassigned	978
318	OS	Approved	N	Any Adjudicated Fracture	CREA	CREA	Serum	Y	Synarc	978
318	OS	Approved	N	Controls	CREA	CREA	Serum	Y	Synarc	978
320	HT	Approved	N	Controls	GAFI	Gamma` Fibrinogen	Citrate	Y	Unassigned	450
320	HT	Approved	N	DVT/PE	GAFI	Gamma` Fibrinogen	Citrate	Y	Unassigned	450
321	General population	Approved	N	Breast Cancer Invasive	16-OHE1	16-OHE1	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	16-OHE2	16-OHE2	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OCH3E2	2-OCH3E2	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OH3OCH3E1	2-OH-3-OCH3E1	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OH3OCH3E2	2-OH-3-OCH3E2	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHC3E1	2-OCH3E1	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE1-1CYS	2-OHE1-1-Cys	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE1-1SG	2-OHE1-1-SG	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE1-4CYS	2-OHE1-4-Cys	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE11NAC	2-OHE1-1-NAcCys	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE14NAC	2-OHE1-4-NAcCys	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE16N3AD	2-OHE1-6-N3Ade	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE2-1SG	2-OHE2-1-SG	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE2-4SG	2-OHE2-4-SG	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE214CYS	2-OHE2-(1+4)-Cys	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE21NAC	2-OHE2-1-NAcCys	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE24NAC	2-OHE2-4-NAcCys	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	2OHE26N3AD	2-OHE2-6-N3Ade	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	4OHE1-2CYS	4-OHE1-2-Cys	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	4OHE1-2SG	4-OHE1-2-SG	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	4OHE11N3AD	4-OHE1-1-N3Ade	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	4OHE11N7GU	4-OHE1-1-N7Gua	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	4OHE12NACY	4-OHE1-2-NAcCys	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	4OHE2-2CYS	4-OHE2-2-cys	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	4OHE2-2SG	4-OHE2-2-SG	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	4OHE21N3AD	4-OHE2-1-N3Ade	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	4OHE21N7GU	4-OHE2-1-N7Gua	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	4OHE22NACY	4-OHE2-2-NAcCys	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	ANRO	ANRO	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	ESTD	ESTD (E2)	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	ESTD-2OH	ESTD-2OH	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	ESTD-4MO	Estradiol, 4MO	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	ESTD-4OH	ESTD-4OH	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	ESTR	ESTR	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	ESTR-2OH	ESTR-2OH	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	ESTR-4MO	Estrone, 4-MO	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	ESTR-4OH	ESTR-4OH	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	ESTS	ESTS	Urine	U	Cavalieri	352
321	General population	Approved	N	Breast Cancer Invasive	TSTO	Testosterone	Urine	U	Cavalieri	352
321	General population	Approved	N	Controls	16-OHE1	16-OHE1	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	16-OHE2	16-OHE2	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OCH3E2	2-OCH3E2	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OH3OCH3E1	2-OH-3-OCH3E1	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OH3OCH3E2	2-OH-3-OCH3E2	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHC3E1	2-OCH3E1	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE1-1CYS	2-OHE1-1-Cys	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE1-1SG	2-OHE1-1-SG	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE1-4CYS	2-OHE1-4-Cys	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE11NAC	2-OHE1-1-NAcCys	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE14NAC	2-OHE1-4-NAcCys	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE16N3AD	2-OHE1-6-N3Ade	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE2-1SG	2-OHE2-1-SG	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE2-4SG	2-OHE2-4-SG	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE214CYS	2-OHE2-(1+4)-Cys	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE21NAC	2-OHE2-1-NAcCys	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE24NAC	2-OHE2-4-NAcCys	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	2OHE26N3AD	2-OHE2-6-N3Ade	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	4OHE1-2CYS	4-OHE1-2-Cys	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	4OHE1-2SG	4-OHE1-2-SG	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	4OHE11N3AD	4-OHE1-1-N3Ade	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	4OHE11N7GU	4-OHE1-1-N7Gua	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	4OHE12NACY	4-OHE1-2-NAcCys	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	4OHE2-2CYS	4-OHE2-2-cys	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	4OHE2-2SG	4-OHE2-2-SG	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	4OHE21N3AD	4-OHE2-1-N3Ade	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	4OHE21N7GU	4-OHE2-1-N7Gua	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	4OHE22NACY	4-OHE2-2-NAcCys	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	ANRO	ANRO	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	ESTD	ESTD (E2)	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	ESTD-2OH	ESTD-2OH	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	ESTD-4MO	Estradiol, 4MO	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	ESTD-4OH	ESTD-4OH	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	ESTR	ESTR	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	ESTR-2OH	ESTR-2OH	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	ESTR-4MO	Estrone, 4-MO	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	ESTR-4OH	ESTR-4OH	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	ESTS	ESTS	Urine	U	Cavalieri	704
321	General population	Approved	N	Controls	TSTO	Testosterone	Urine	U	Cavalieri	704
322	General population	Approved	N	Breast Cancer Invasive	4-ABP HGB	4-ABP hemoglobin adducts	RBC	RBC	U-Minn	500
322	General population	Approved	N	Breast Cancer Invasive	AIMS	AIMS	DNA	N	BMGC	500
322	General population	Approved	N	Breast Cancer Invasive	COTININE	Cotinine	EDTA	Y	U-Minn	500
322	General population	Approved	N	Breast Cancer Invasive	PHET	PheT	EDTA	Y	U-Minn	500
322	General population	Approved	N	Breast Cancer Invasive	SNPS-27	SNPs 27	DNA	N	BMGC	500
322	General population	Approved	N	Controls	4-ABP HGB	4-ABP hemoglobin adducts	RBC	RBC	U-Minn	1,000
322	General population	Approved	N	Controls	AIMS	AIMS	DNA	N	BMGC	1,000
322	General population	Approved	N	Controls	COTININE	Cotinine	EDTA	Y	U-Minn	1,000
322	General population	Approved	N	Controls	PHET	PheT	EDTA	Y	U-Minn	1,000
322	General population	Approved	N	Controls	SNPS-27	SNPs 27	DNA	N	BMGC	1,000
327	General population	Approved	N	Controls	RETI	Retinol	Serum	Y	PHS Biomarkers	300
327	General population	Approved	N	Controls	RETI-E	Retinol Esters	Serum	Y	PHS Biomarkers	300
327	General population	Approved	N	Controls	VITD	Vit D 25-OH	Serum	Y	PHS Biomarkers	300
327	General population	Approved	N	Lung Cancer	RETI	Retinol	Serum	Y	PHS Biomarkers	300
327	General population	Approved	N	Lung Cancer	RETI-E	Retinol Esters	Serum	Y	PHS Biomarkers	300
327	General population	Approved	N	Lung Cancer	VITD	Vit D 25-OH	Serum	Y	PHS Biomarkers	300
331	General population	Approved	N	Any Adjudicated Fracture	CAD	Cadmium	EDTA	Y	WSLH	400
331	General population	Approved	N	Any Adjudicated Fracture	LEAD	lead	EDTA	Y	WSLH	400
331	General population	Approved	N	Any Adjudicated Fracture	MER	Mercury	EDTA	Y	WSLH	400
331	General population	Approved	N	Controls	CAD	Cadmium	EDTA	Y	WSLH	400
331	General population	Approved	N	Controls	LEAD	lead	EDTA	Y	WSLH	400
331	General population	Approved	N	Controls	MER	Mercury	EDTA	Y	WSLH	400
332	OS	Funded	Y	CHD	BIOMARK1	Biomarker 1	Serum	Y	Aviir	700
332	OS	Funded	Y	CHD	BIOMARK2	Biomarker 2	Serum	Y	Aviir	700
332	OS	Funded	Y	CHD	BIOMARK3	Biomarker 3	Serum	Y	Aviir	700
332	OS	Funded	Y	CHD	BIOMARK4	Biomarker 4	Serum	Y	Aviir	700
332	OS	Funded	Y	CHD	BIOMARK5	Biomarker 5	Serum	Y	Aviir	700
332	OS	Funded	Y	CHD	BIOMARK6	Biomarker 6	Serum	Y	Aviir	700
332	OS	Funded	Y	CHD	BIOMARK7	Biomarker 7	Serum	Y	Aviir	700
332	OS	Funded	Y	Controls	BIOMARK1	Biomarker 1	Serum	Y	Aviir	700
332	OS	Funded	Y	Controls	BIOMARK2	Biomarker 2	Serum	Y	Aviir	700
332	OS	Funded	Y	Controls	BIOMARK3	Biomarker 3	Serum	Y	Aviir	700
332	OS	Funded	Y	Controls	BIOMARK4	Biomarker 4	Serum	Y	Aviir	700
332	OS	Funded	Y	Controls	BIOMARK5	Biomarker 5	Serum	Y	Aviir	700
332	OS	Funded	Y	Controls	BIOMARK6	Biomarker 6	Serum	Y	Aviir	700
332	OS	Funded	Y	Controls	BIOMARK7	Biomarker 7	Serum	Y	Aviir	700
343	HT	Funded	Y	CHD	B2M	B2M	Citrate	Y	Hanash	40
343	HT	Funded	Y	CHD	CFD	CFD	Citrate	Y	Hanash	20
343	HT	Funded	Y	CHD	GPX3	GPX3	Citrate	Y	Hanash	20
343	HT	Funded	Y	CHD	HPX	HPX	Citrate	Y	Hanash	20
343	HT	Funded	Y	CHD	IGF-2	Insulin growth factor 2	Citrate	Y	Hanash	20
343	HT	Funded	Y	CHD	IGFBP-1	IGFBP-1	Citrate	Y	Hanash	20
343	HT	Funded	Y	CHD	IGFBP-2	IGFBP-2	Citrate	Y	Hanash	20
343	HT	Funded	Y	CHD	IGFBP-6	IGFBP-6	Citrate	Y	Hanash	20
343	HT	Funded	Y	CHD	ORM1	ORM1	Citrate	Y	Hanash	20
343	HT	Funded	Y	CHD	THBS1	THBS1	Citrate	Y	Hanash	20
343	HT	Funded	Y	Controls	B2M	B2M	Citrate	Y	Hanash	84
343	HT	Funded	Y	Controls	CFD	CFD	Citrate	Y	Hanash	42
343	HT	Funded	Y	Controls	GPX3	GPX3	Citrate	Y	Hanash	42
343	HT	Funded	Y	Controls	HPX	HPX	Citrate	Y	Hanash	42
343	HT	Funded	Y	Controls	IGF-2	Insulin growth factor 2	Citrate	Y	Hanash	42
343	HT	Funded	Y	Controls	IGFBP-1	IGFBP-1	Citrate	Y	Hanash	42
343	HT	Funded	Y	Controls	IGFBP-2	IGFBP-2	Citrate	Y	Hanash	42
343	HT	Funded	Y	Controls	IGFBP-6	IGFBP-6	Citrate	Y	Hanash	42
343	HT	Funded	Y	Controls	ORM1	ORM1	Citrate	Y	Hanash	42
343	HT	Funded	Y	Controls	THBS1	THBS1	Citrate	Y	Hanash	42
343	HT	Funded	Y	Stroke	B2M	B2M	Citrate	Y	Hanash	44
343	HT	Funded	Y	Stroke	CFD	CFD	Citrate	Y	Hanash	22
343	HT	Funded	Y	Stroke	GPX3	GPX3	Citrate	Y	Hanash	22
343	HT	Funded	Y	Stroke	HPX	HPX	Citrate	Y	Hanash	22
343	HT	Funded	Y	Stroke	IGF-2	Insulin growth factor 2	Citrate	Y	Hanash	22
343	HT	Funded	Y	Stroke	IGFBP-1	IGFBP-1	Citrate	Y	Hanash	22
343	HT	Funded	Y	Stroke	IGFBP-2	IGFBP-2	Citrate	Y	Hanash	22
343	HT	Funded	Y	Stroke	IGFBP-6	IGFBP-6	Citrate	Y	Hanash	22
343	HT	Funded	Y	Stroke	ORM1	ORM1	Citrate	Y	Hanash	22
343	HT	Funded	Y	Stroke	THBS1	THBS1	Citrate	Y	Hanash	22
343	HT	Funded	Y	CHD	IGFBP-4	IGFBP-4	Citrate	Y	Hanash	20
343	HT	Funded	Y	Controls	IGFBP-4	IGFBP-4	Citrate	Y	Hanash	42
343	HT	Funded	Y	Stroke	IGFBP-4	IGFBP-4	Citrate	Y	Hanash	22
344	HT	Approved	N	Breast Cancer Invasive	ADIP	Adiponectin	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	BIN2	BIN2	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	CALR	CALR	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	CP	CP	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	CST6	CST6	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	DSTN	DSTN	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	FETB	FETB	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	HPX	HPX	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	PCOLCE	PCOLCE	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	PFN1	PFN1	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	PPIA	PPIA	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	TAG IN	TagIn	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	THBS1	THBS1	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Breast Cancer Invasive	THBS4	THBS4	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	ADIP	Adiponectin	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	BIN2	BIN2	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	CALR	CALR	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	CP	CP	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	CST6	CST6	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	DSTN	DSTN	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	FETB	FETB	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	HPX	HPX	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	PCOLCE	PCOLCE	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	PFN1	PFN1	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	PPIA	PPIA	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	TAG IN	TagIn	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	THBS1	THBS1	EDTA	Y	Hanash	1,172
344	HT	Approved	N	Controls	THBS4	THBS4	EDTA	Y	Hanash	1,172
346	OS	Approved	N	Controls	VITD	Vit D 25-OH	Serum	Y	Unassigned	700
346	OS	Approved	N	Melanoma of the Skin	VITD	Vit D 25-OH	Serum	Y	Unassigned	700
351	OS	Approved	N	Controls	ILLUM 450K	Illumina 450 K Beadchip	DNA	N	Columbia -Bio	386
351	OS	Approved	N	Controls	MET	GeneSpecificMethylation	Citrate	Y	Columbia -Bio	386
351	OS	Approved	N	Controls	METGENO	Genomic Methylation	Citrate	Y	Columbia -Bio	386
351	OS	Approved	N	Controls	METGENO	Genomic Methylation	DNA	N	Columbia -Bio	386
351	OS	Approved	N	Ovarian Cancer	ILLUM 450K	Illumina 450 K Beadchip	DNA	N	Columbia -Bio	386
351	OS	Approved	N	Ovarian Cancer	MET	GeneSpecificMethylation	Citrate	Y	Columbia -Bio	386
351	OS	Approved	N	Ovarian Cancer	METGENO	Genomic Methylation	Citrate	Y	Columbia -Bio	386
351	OS	Approved	N	Ovarian Cancer	METGENO	Genomic Methylation	DNA	N	Columbia -Bio	386
354	General population	Approved	N	Controls	MET450K	Methylation at 450K	DNA	N	Unassigned	2,971
362	General population	Approved	N	Controls	ADIP	Adiponectin	Serum	Y	Unassigned	760
362	General population	Approved	N	Controls	CML-AGE	CML-AGE	Citrate	Y	Unassigned	760
362	General population	Approved	N	Controls	LEPTIN	Leptin	Serum	Y	Unassigned	760
362	General population	Approved	N	Controls	MCP-1	MCP-1	Serum	Y	Unassigned	760
362	General population	Approved	N	Controls	PAI1	PAI-1	Serum	Y	Unassigned	760
362	General population	Approved	N	Controls	SNPS 192	SNPs 192	DNA	N	Unassigned	760
362	General population	Approved	N	Controls	SRAGE	sRAGE	Serum	Y	Unassigned	760
362	General population	Approved	N	Pancreas Cancer	ADIP	Adiponectin	Serum	Y	Unassigned	380
362	General population	Approved	N	Pancreas Cancer	CML-AGE	CML-AGE	Citrate	Y	Unassigned	380
362	General population	Approved	N	Pancreas Cancer	LEPTIN	Leptin	Serum	Y	Unassigned	380
362	General population	Approved	N	Pancreas Cancer	MCP-1	MCP-1	Serum	Y	Unassigned	380
362	General population	Approved	N	Pancreas Cancer	PAI1	PAI-1	Serum	Y	Unassigned	380
362	General population	Approved	N	Pancreas Cancer	SNPS 192	SNPs 192	DNA	N	Unassigned	380
362	General population	Approved	N	Pancreas Cancer	SRAGE	sRAGE	Serum	Y	Unassigned	380
BA01	OS/CT	Funded	Y	Controls	AIM-1536	AIM-1536	DNA	N	Seldin Lab	800
BA01	OS/CT	Funded	Y	Controls	AIM-768	AIM-768	DNA	N	Seldin Lab	950
BA01	OS/CT	Funded	Y	Controls	AIM-96	AIM-96	DNA	N	Seldin Lab	21,100
BA01	General population	Funded	Y	Hip Fracture	AIM-1536	AIM-1536	DNA	N	Seldin Lab	950
BA01	OS/CT	Funded	Y	Hip Fracture	AIM-768	AIM-768	DNA	N	Seldin Lab	950
BA01	General population	Funded	Y	Hip Fracture	AIM-96	AIM-96	DNA	N	Seldin Lab	950
BA02	OS	Analysis	Y	Breast Cancer	SNPS 10K	SNPs 10K	DNA	N	Perlegen	2,242
BA02	OS	Analysis	Y	Controls	SNPS 10K	SNPs 10K	DNA	N	Perlegen	2,242
BA03	General population	Analysis	Y	Controls	GWAS	GWAS	DNA	N	TGen	2,250
BA03	General population	Analysis	Y	Hip Fracture	GWAS	GWAS	DNA	N	TGen	2,250
BA04	OS	Analysis	Y	Breast Cancer	PROTEOM	Proteomics	EDTA	Y	Hanash	800
BA04	OS	Analysis	Y	CHD	PROTEOM	Proteomics	EDTA	Y	Hanash	800
BA04	OS	Analysis	Y	Controls	PROTEOM	Proteomics	EDTA	Y	Hanash	2,400
BA04	OS	Analysis	Y	Stroke	PROTEOM	Proteomics	EDTA	Y	Hanash	800
BA05	OS	Analysis	Y	Breast Cancer	PROTEOM	Proteomics	EDTA	Y	Hanash	930
BA05	OS	Analysis	Y	Controls	PROTEOM	Proteomics	EDTA	Y	Hanash	930
BA06	OS	Funded	Y	Breast Cancer	CRP	CRP	Citrate	Y	WFU Nicklas	719
BA06	OS	Funded	Y	Breast Cancer	IMMUN-INFL	Immun-Inflm Array	DNA	N	WFU Zheng	719
BA06	OS	Funded	Y	Colorectal Cancer	CRP	CRP	Citrate	Y	WFU Nicklas	600
BA06	OS	Funded	Y	Colorectal Cancer	IMMUN-INFL	Immun-Inflm Array	DNA	N	WFU Zheng	600
BA06	OS	Funded	Y	Controls	CRP	CRP	Citrate	Y	WFU Nicklas	2,120
BA06	OS	Funded	Y	Controls	IMMUN-INFL	Immun-Inflm Array	DNA	N	WFU Zheng	2,120
BA06	OS	Funded	Y	Lung Cancer	CRP	CRP	Citrate	Y	WFU Nicklas	564
BA06	OS	Funded	Y	Lung Cancer	IMMUN-INFL	Immun-Inflm Array	DNA	N	WFU Zheng	564
BA06	OS	Funded	Y	Breast Cancer	TNF-A	TNF-A	Citrate	Y	WFU Nicklas	719
BA06	OS	Funded	Y	Colorectal Cancer	TNF-A	TNF-A	Citrate	Y	WFU Nicklas	600
BA06	OS	Funded	Y	Controls	TNF-A	TNF-A	Citrate	Y	WFU Nicklas	2,120
BA06	OS	Funded	Y	Lung Cancer	TNF-A	TNF-A	Citrate	Y	WFU Nicklas	564
BA07	HRT	Funded	Y	CHD	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	753
BA07	HRT	Funded	Y	CHD	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	753
BA07	HRT	Funded	Y	CHD	FE2	Estradiol, free	Serum	Y	Hormone Lab	753
BA07	HRT	Funded	Y	CHD	SHBG	SHBG	Serum	Y	Hormone Lab	753
BA07	HRT	Funded	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	873
BA07	HRT	Funded	Y	Controls	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	873
BA07	HRT	Funded	Y	Controls	FE2	Estradiol, free	Serum	Y	Hormone Lab	873
BA07	HRT	Funded	Y	Controls	SHBG	SHBG	Serum	Y	Hormone Lab	873
BA07	HRT	Funded	Y	DVT/PE	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	422
BA07	HRT	Funded	Y	DVT/PE	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	422
BA07	HRT	Funded	Y	DVT/PE	FE2	Estradiol, free	Serum	Y	Hormone Lab	422
BA07	HRT	Funded	Y	DVT/PE	SHBG	SHBG	Serum	Y	Hormone Lab	422
BA07	HRT	Funded	Y	Fracture - Not Hip or Spine	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	830
BA07	HT	Funded	Y	Fracture - Not Hip or Spine	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	830
BA07	HRT	Funded	Y	Fracture - Not Hip or Spine	FE2	Estradiol, free	Serum	Y	Hormone Lab	830
BA07	HRT	Funded	Y	Fracture - Not Hip or Spine	SHBG	SHBG	Serum	Y	Hormone Lab	830
BA07	HRT	Funded	Y	Stroke	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	534
BA07	HRT	Funded	Y	Stroke	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	534
BA07	HRT	Funded	Y	Stroke	FE2	Estradiol, free	Serum	Y	Hormone Lab	534
BA07	HRT	Funded	Y	Stroke	SHBG	SHBG	Serum	Y	Hormone Lab	534
BA07	HRT	Funded	Y	Vertebral Fracture	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	204
BA07	HRT	Funded	Y	Vertebral Fracture	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	204
BA07	HRT	Funded	Y	Vertebral Fracture	FE2	Estradiol, free	Serum	Y	Hormone Lab	204
BA07	HRT	Funded	Y	Vertebral Fracture	SHBG	SHBG	Serum	Y	Hormone Lab	204
BA08	OS	Analysis	Y	CHD	DK	DK	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 14:0	FA Myristic Acid FA 14:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 14:1	FA Myristoleic Acid FA 14:1	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 15:0	FA Pentanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 16:0	FA Palmitic Acid FA 16:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 16:1N-7	FA Palmitoleic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 16:1N-9	FA 7-Hexadecenoic Acid 16:1n-9	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 18:0	FA Stearic Acid FA 18:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 18:1N-7	FA Vaccenic Acid FA 18:1n-7	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 18:1N-9	FA Oleic Acid FA 18:1n-9	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 18:1T	FA Elaidic Acid FA 18:1T	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 18:2N-6	FA Linoleic Acid FA 18:2N-6	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 18:2T	FA All 18:2 trans	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 18:3N-3	FA Alpha Linolenic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 18:3N-6	FA Gamma Linolenic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 20:0	FA Arachidic Acid FA 20:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 20:1N-9	FA Eicosanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 20:2N-6	FA Eicosadienoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 20:3N-6	FA Eicosatrienioc Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 20:4N-6	FA Arachidonic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 20:5N-3	FA Eicosapentanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 22:0	FA Behenic Acid FA 22:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 22:4N-6	FA Docosatetranoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 22:5N-3	FA Docosapentanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 22:5N-6	FA Docosapentanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 22:6N-3	FA Docosahexanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 24:0	FA Tetracosanoic Acid FA 24:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA 24:1N-9	FA Tetracosenoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	FA12:0	FA Lauric Acid FA 12:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	MUFA	Monounsaturated Fatty Acids	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	PUFA	Polyunsaturated Fatty acids	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	SFA	Saturated Fatty Acids	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	CHD	VTK	Vit K	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	DK	DK	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 14:0	FA Myristic Acid FA 14:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 14:1	FA Myristoleic Acid FA 14:1	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 15:0	FA Pentanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 16:0	FA Palmitic Acid FA 16:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 16:1N-7	FA Palmitoleic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 16:1N-9	FA 7-Hexadecenoic Acid 16:1n-9	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 18:0	FA Stearic Acid FA 18:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 18:1N-7	FA Vaccenic Acid FA 18:1n-7	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 18:1N-9	FA Oleic Acid FA 18:1n-9	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 18:1T	FA Elaidic Acid FA 18:1T	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 18:2N-6	FA Linoleic Acid FA 18:2N-6	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 18:2T	FA All 18:2 trans	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 18:3N-3	FA Alpha Linolenic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 18:3N-6	FA Gamma Linolenic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 20:0	FA Arachidic Acid FA 20:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 20:1N-9	FA Eicosanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 20:2N-6	FA Eicosadienoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 20:3N-6	FA Eicosatrienioc Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 20:4N-6	FA Arachidonic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 20:5N-3	FA Eicosapentanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 22:0	FA Behenic Acid FA 22:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 22:4N-6	FA Docosatetranoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 22:5N-3	FA Docosapentanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 22:5N-6	FA Docosapentanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 22:6N-3	FA Docosahexanoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 24:0	FA Tetracosanoic Acid FA 24:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA 24:1N-9	FA Tetracosenoic Acid	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	FA12:0	FA Lauric Acid FA 12:0	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	MUFA	Monounsaturated Fatty Acids	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	PUFA	Polyunsaturated Fatty acids	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	SFA	Saturated Fatty Acids	Citrate	Y	Tufts	1,224
BA08	OS	Analysis	Y	Controls	VTK	Vit K	Citrate	Y	Tufts	1,224
BA09	OS	Analysis	Y	Any Adjudicated Fracture	CTX	CTx	Serum	Y	Synarc	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	Cystatin-C	Cystatin-C	Serum	Y	U Minn Med Ctr	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	FE2	Estradiol, free	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	FT	Testosterone, free	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	FT_AT	Testosterone, bioavail	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	IL-10	IL-10	Serum	Y	Vermont	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	PINP	PINP	Serum	Y	Synarc	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	PTH	PTH	EDTA	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	SHBG	SHBG	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	TNF-R1	TNF-R1	Serum	Y	Vermont	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	TNF-R2	TNF-R2	Serum	Y	Vermont	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	TSTO	Testosterone	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	VITD	Vit D 25-OH	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	VITDBIND	VitD Binding	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Controls	CTX	CTx	Serum	Y	Synarc	1,132
BA09	OS	Analysis	Y	Controls	Cystatin-C	Cystatin-C	Serum	Y	U Minn Med Ctr	1,132
BA09	OS	Analysis	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Controls	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Controls	FE2	Estradiol, free	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Controls	FT	Testosterone, free	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Controls	FT_AT	Testosterone, bioavail	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Controls	IL-10	IL-10	Serum	Y	Vermont	1,132
BA09	OS	Analysis	Y	Controls	PINP	PINP	Serum	Y	Synarc	1,132
BA09	OS	Analysis	Y	Controls	PTH	PTH	EDTA	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Controls	SHBG	SHBG	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Controls	TNF-R1	TNF-R1	Serum	Y	Vermont	1,132
BA09	OS	Analysis	Y	Controls	TNF-R2	TNF-R2	Serum	Y	Vermont	1,132
BA09	OS	Analysis	Y	Controls	TSTO	Testosterone	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Controls	VITD	Vit D 25-OH	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Controls	VITDBIND	VitD Binding	Serum	Y	Hormone Lab	1,132
BA09	OS	Analysis	Y	Any Adjudicated Fracture	IL-6SR	IL-6SR	Serum	Y	Vermont	1,132
BA09	OS	Analysis	Y	Controls	IL-6SR	IL-6SR	Serum	Y	Vermont	1,132
BA10	OS	Funded	Y	Breast Cancer	ADIP	Adiponectin	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Breast Cancer	CRP	CRP	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Breast Cancer	HGF	HGF	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Breast Cancer	IL6	IL-6	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Breast Cancer	LEPTIN	Leptin	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Breast Cancer	PAI1	PAI-1	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Breast Cancer	RES	Resistin	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Breast Cancer	TNFA	TNF-A	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Colorectal Cancer	ADIP	Adiponectin	Citrate	Y	Vermont	500
BA10	OS	Funded	Y	Colorectal Cancer	CRP	CRP	Citrate	Y	Vermont	500
BA10	OS	Funded	Y	Colorectal Cancer	HGF	HGF	Citrate	Y	Vermont	500
BA10	OS	Funded	Y	Colorectal Cancer	IL6	IL-6	Citrate	Y	Vermont	500
BA10	OS	Funded	Y	Colorectal Cancer	LEPTIN	Leptin	Citrate	Y	Vermont	500
BA10	OS	Funded	Y	Colorectal Cancer	PAI1	PAI-1	Citrate	Y	Vermont	500
BA10	OS	Funded	Y	Colorectal Cancer	RES	Resistin	Citrate	Y	Vermont	500
BA10	OS	Funded	Y	Colorectal Cancer	TNFA	TNF-A	Citrate	Y	Vermont	500
BA10	OS	Funded	Y	Controls	ADIP	Adiponectin	Citrate	Y	Vermont	1,870
BA10	OS	Funded	Y	Controls	CRP	CRP	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Controls	HGF	HGF	Citrate	Y	Vermont	1,870
BA10	OS	Funded	Y	Controls	IL6	IL-6	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Controls	LEPTIN	Leptin	Citrate	Y	Vermont	1,870
BA10	OS	Funded	Y	Controls	PAI1	PAI-1	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Controls	RES	Resistin	Citrate	Y	Vermont	1,870
BA10	OS	Funded	Y	Controls	TNFA	TNF-A	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Endometrial Cancer	ADIP	Adiponectin	Citrate	Y	Vermont	300
BA10	OS	Funded	Y	Endometrial Cancer	CRP	CRP	Citrate	Y	Vermont	300
BA10	OS	Funded	Y	Endometrial Cancer	HGF	HGF	Citrate	Y	Vermont	300
BA10	OS	Funded	Y	Endometrial Cancer	IL6	IL-6	Citrate	Y	Vermont	300
BA10	OS	Funded	Y	Endometrial Cancer	LEPTIN	Leptin	Citrate	Y	Vermont	300
BA10	OS	Funded	Y	Endometrial Cancer	PAI1	PAI-1	Citrate	Y	Vermont	300
BA10	OS	Funded	Y	Endometrial Cancer	RES	Resistin	Citrate	Y	Vermont	300
BA10	OS	Funded	Y	Endometrial Cancer	TNFA	TNF-A	Citrate	Y	Vermont	300
BA10	OS	Funded	Y	Stroke	ADIP	Adiponectin	Citrate	Y	Vermont	970
BA10	OS	Funded	Y	Stroke	CRP	CRP	Citrate	Y	Vermont	0
BA10	OS	Funded	Y	Stroke	HGF	HGF	Citrate	Y	Vermont	970
BA10	OS	Funded	Y	Stroke	IL6	IL-6	Citrate	Y	Vermont	0
BA10	OS	Funded	Y	Stroke	LEPTIN	Leptin	Citrate	Y	Vermont	970
BA10	OS	Funded	Y	Stroke	PAI1	PAI-1	Citrate	Y	Vermont	0
BA10	OS	Funded	Y	Stroke	RES	Resistin	Citrate	Y	Vermont	970
BA10	OS	Funded	Y	Stroke	TNFA	TNF-A	Citrate	Y	Vermont	0
BA10	OS	Funded	Y	Breast Cancer	IL-6	IL-6	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Breast Cancer	TNF-A	TNF-A	Citrate	Y	Vermont	900
BA10	OS	Funded	Y	Colorectal Cancer	IL-6	IL-6	Citrate	Y	Vermont	500
BA10	OS	Funded	Y	Colorectal Cancer	TNF-A	TNF-A	Citrate	Y	Vermont	500
BA10	OS	Funded	Y	Controls	IL-6	IL-6	Citrate	Y	Vermont	1,870
BA10	OS	Funded	Y	Controls	TNF-A	TNF-A	Citrate	Y	Vermont	1,870
BA10	OS	Funded	Y	Endometrial Cancer	IL-6	IL-6	Citrate	Y	Vermont	300
BA10	OS	Funded	Y	Endometrial Cancer	TNF-A	TNF-A	Citrate	Y	Vermont	300
BA10	OS	Funded	Y	Stroke	IL-6	IL-6	Citrate	Y	Vermont	970
BA10	OS	Funded	Y	Stroke	TNF-A	TNF-A	Citrate	Y	Vermont	970
BA11	OS	Funded	Y	CHD	ADIP	Adiponectin	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	CHD	CRP	CRP	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	CHD	GLUC	Glucose	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	CHD	HDLC	HDLC	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	CHD	LDLC	LDLC	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	CHD	LEPTIN	Leptin	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	CHD	RES	Resistin	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	CHD	TCHO	Cholesterol	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	CHD	TNF-R1	TNF-R1	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	CHD	TNF-R2	TNF-R2	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	CHD	TRI	Trig	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	Controls	ADIP	Adiponectin	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	Controls	CRP	CRP	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	Controls	GLUC	Glucose	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	Controls	HDLC	HDLC	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	Controls	LDLC	LDLC	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	Controls	LEPTIN	Leptin	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	Controls	RES	Resistin	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	Controls	TCHO	Cholesterol	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	Controls	TNF-R1	TNF-R1	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	Controls	TNF-R2	TNF-R2	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	Controls	TRI	Trig	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	CHD	IL-1B	IL-1B	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	CHD	IL-6	IL-6	EDTA	Y	Harvard-Rifai	601
BA11	OS	Funded	Y	Controls	IL-1B	IL-1B	EDTA	Y	Harvard-Rifai	1,332
BA11	OS	Funded	Y	Controls	IL-6	IL-6	EDTA	Y	Harvard-Rifai	1,332
BA12	HT	Funded	Y	Breast Cancer	16-OHE1	Estrone, 16a-OH	Serum	Y	Immuna	900
BA12	HT	Funded	Y	Breast Cancer	2-OHE1	Estrone, 2-OH	Serum	Y	Immuna	900
BA12	HT	Funded	Y	Controls	16-OHE1	Estrone, 16a-OH	Serum	Y	Immuna	1,800
BA12	HT	Funded	Y	Controls	2-OHE1	Estrone, 2-OH	Serum	Y	Immuna	1,800
BA12	HT	Funded	Y	Hip Fracture	16-OHE1	Estrone, 16a-OH	Serum	Y	Immuna	370
BA12	HT	Funded	Y	Hip Fracture	2-OHE1	Estrone, 2-OH	Serum	Y	Immuna	370
BA13	OS	Funded	Y	Controls	CXCL13	CXCL13	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	EBV EA-D	EBV-EAD IGg	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	EBV EBNA-1	EBV EBNA-1	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	EBV LOAD	EBV DNA Load	DNA	N	UW-Virology	487
BA13	OS	Funded	Y	Controls	EBV LOAD 2	EBV Load 2	DNA	N	UW-Virology	487
BA13	OS	Funded	Y	Controls	EBV VCA IG	EBV VCA IGg	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	GM-CSF	GM-CSF	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	IFNG	interferon, gamma	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	IL-10	IL-10	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	IL-12P70	IL-12p70	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	IL-13	IL-13	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	IL-2	IL-2	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	IL-4	IL-4	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	IL-5	IL-5	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	IL-7	Interleukin-7	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	IL-8	Interleukin-8	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	SCD23	sCD23	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	SCD27	sCD27	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	SCD30	sCD30	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	SCD44	sCD44	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	CXCL13	CXCL13	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	EBV EA-D	EBV-EAD IGg	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	EBV EBNA-1	EBV EBNA-1	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	EBV LOAD	EBV DNA Load	DNA	N	UW-Virology	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	EBV LOAD 2	EBV Load 2	DNA	N	UW-Virology	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	EBV VCA IG	EBV VCA IGg	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	GM-CSF	GM-CSF	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	IFNG	interferon, gamma	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	IL-10	IL-10	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	IL-12P70	IL-12p70	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	IL-13	IL-13	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	IL-2	IL-2	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	IL-4	IL-4	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	IL-5	IL-5	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	IL-7	Interleukin-7	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	IL-8	Interleukin-8	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	SCD23	sCD23	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	SCD27	sCD27	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	SCD30	sCD30	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	SCD44	sCD44	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	IL-1B	IL-1B	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	IL-6	IL-6	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Controls	TNF-A	TNF-A	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	IL-1B	IL-1B	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	IL-6	IL-6	Serum	Y	UCLA-Martinez	487
BA13	OS	Funded	Y	Lymphoma Non Hodgkins	TNF-A	TNF-A	Serum	Y	UCLA-Martinez	487
BA14	General population	Funded	Y	CHD	CARE SNPS	CARE SNPs	DNA	N	TGen	3,594
BA14	General population	Funded	Y	Controls	CARE SNPS	CARE SNPs	DNA	N	TGen	4,361
BA14	General population	Funded	Y	DVT/PE	CARE SNPS	CARE SNPs	DNA	N	TGen	632
BA14	General population	Funded	Y	Stroke	CARE SNPS	CARE SNPs	DNA	N	TGen	2,887
BA15	OS	Funded	Y	Controls	PROTEOM	Proteomics	EDTA	Y	FH-McIntosh	225
BA15	OS	Funded	Y	Ovarian Cancer	PROTEOM	Proteomics	EDTA	Y	FH-McIntosh	225
BA16	OS	Funded	Y	Controls	ARRAY	Anti Microarray	EDTA	Y	FH-Hingorani	280
BA16	OS	Funded	Y	Controls	SCFV	scFV	EDTA	Y	FH-Hingorani	40
BA16	OS	Funded	Y	Pancreas Cancer	ARRAY	Anti Microarray	EDTA	Y	FH-Hingorani	280
BA16	OS	Funded	Y	Pancreas Cancer	SCFV	scFV	EDTA	Y	FH-Hingorani	40
BA17	OS	Funded	Y	Controls	PROTEOM	Proteomics	EDTA	Y	Hanash	640
BA17	OS	Funded	Y	Lung Cancer	PROTEOM	Proteomics	EDTA	Y	Hanash	640
BA18	OS/CT	Funded	Y	Controls	DKK1	DKK1	Serum	Y	OSU - Pinzone	400
BA18	OS/CT	Funded	Y	Controls	OPG	OPG	Serum	Y	OSU	400
BA18	OS/CT	Funded	Y	Controls	PTH	PTH	Serum	Y	OSU	400
BA18	General population	Funded	Y	Controls	SNPS 12K	SNPs 12K	DNA	N	TGen	7,900
BA18	General population	Funded	Y	Controls	SNPS 1536	SNPs 1536	DNA	N	TGen	7,900
BA18	General population	Funded	Y	Controls	SNPS 384 F	SNPs 384 Fr	DNA	N	TGen	7,900
BA18	OS/CT	Funded	Y	Controls	SRANKL	sRANKL	Serum	Y	OSU	400
BA18	OS/CT	Funded	Y	Controls	TNF-R1	TNF-R1	Serum	Y	Vermont	400
BA18	OS/CT	Funded	Y	Controls	TNF-R2	TNF-R2	Serum	Y	Vermont	400
BA18	General population	Funded	Y	Hip Fracture	DKK1	DKK1	Serum	Y	OSU - Pinzone	400
BA18	General population	Funded	Y	Hip Fracture	OPG	OPG	Serum	Y	OSU	400
BA18	General population	Funded	Y	Hip Fracture	PTH	PTH	Serum	Y	OSU	400
BA18	General population	Funded	Y	Hip Fracture	SNPS 12K	SNPs 12K	DNA	N	TGen	400
BA18	General population	Funded	Y	Hip Fracture	SNPS 1536	SNPs 1536	DNA	N	TGen	400
BA18	General population	Funded	Y	Hip Fracture	SNPS 384 F	SNPs 384 Fr	DNA	N	TGen	400
BA18	General population	Funded	Y	Hip Fracture	SRANKL	sRANKL	Serum	Y	OSU	400
BA18	General population	Funded	Y	Hip Fracture	TNF-R1	TNF-R1	Serum	Y	Vermont	400
BA18	General population	Funded	Y	Hip Fracture	TNF-R2	TNF-R2	Serum	Y	Vermont	400
BA19	HT	Funded	Y	Controls	FATTY_ACID	Fatty Acid Profile	RBC	RBC	USD- Sanford	7,371
BA20	OS/CT	Funded	Y	Controls	A-CCP P/N	Anti-CCP pos/neg	Serum	Y	Holers-Colorado	9,988
BA20	OS/CT	Funded	Y	Controls	ANA	ANA	Serum	Y	Holers-Colorado	9,988
BA20	OS/CT	Funded	Y	Controls	ANA P/N	ANA pos/neg	Serum	Y	Holers-Colorado	9,988
BA20	OS/CT	Funded	Y	Controls	ANTI-CCP	Anti-CCP	Serum	Y	Holers-Colorado	9,988
BA20	OS/CT	Funded	Y	Controls	APOA1	ApoA1	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	APOA1 CIT	ApoA1 CIT	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	APOE	APOE	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	APOE 277	Apolipo E277-296	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	APOE CIT	APOE CIT	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	BIGLY	BIGlycan 247-266	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	CCP	CCP	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	CLUST	Clusterin 231	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	CRP	CRP(hs)	EDTA	Y	Vermont	600
BA20	OS/CT	Funded	Y	Controls	DDIM	D-dimers	EDTA	Y	Vermont	600
BA20	OS/CT	Funded	Y	Controls	ENO1A	ENO1A cyclic	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	FIBR	Fibrinogen	EDTA	Y	Vermont	600
BA20	OS/CT	Funded	Y	Controls	FIBR	Fibrinogen	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	FIBRA	Fibrinogen A-CIT	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	FIBRA211	Fibrinogen A 211-230	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	FIBRA41	Fibrinogen A 41-60	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	FIBRA556	Fibrinogen A 556-575	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	FIBRA616	Fibrinogen A 616-635	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	FILA	Filaggrin 48-65	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	G-CSF	G-CSF	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	GM-CSF	GM-CSF	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	H2A	H2A/a 1-20	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	H2B	H2B/a 62-81	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	HIST	Histones2B	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	HLA-DR	HLA-DR	DNA	N	Pitts-Trucco	2,993
BA20	OS/CT	Funded	Y	Controls	HSP60	HSP60	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	ICAM-1	ICAM-1	EDTA	Y	Vermont	600
BA20	OS/CT	Funded	Y	Controls	IFNG	interferon, gamma	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	IL-10	IL-10	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	IL-12P70	IL-12p70	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	IL-13	IL-13	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	IL-17	IL-17	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	IL-2	IL-2	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	IL-4	IL-4	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	IL-5	IL-5	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	IL-6	IL-6	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	IL-7	IL-7	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	IL-8	IL-8	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	IL1B	IL-1B	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	MCP-1	MCP-1	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	MIP-1B	MIP-1B	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	NMR_LIPID	NMR Lipids	EDTA	Y	LipoScience	600
BA20	OS/CT	Funded	Y	Controls	RF	Rheumatoid Factor	Serum	Y	Holers-Colorado	9,988
BA20	OS/CT	Funded	Y	Controls	RF P/N	Rheumatoid Factor pos/neg	Serum	Y	Holers-Colorado	9,988
BA20	OS/CT	Funded	Y	Controls	TNF-A	TNF-A	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	VCAM1	VCAM-1	EDTA	Y	Vermont	600
BA20	OS/CT	Funded	Y	Controls	VIM	Vimentin-CIT	EDTA	Y	Robinson Lab	2,993
BA20	OS/CT	Funded	Y	Controls	VIM58	Vimentin 58-77	EDTA	Y	Robinson Lab	2,993
BA20	General population	Funded	Y	Controls	IL-1B	IL-1B	EDTA	Y	Robinson Lab	9,988
BA21	CT	Funded	Y	Colorectal Cancer	CRP	CRP	Serum	Y	Hormone Lab	400
BA21	CT	Funded	Y	Colorectal Cancer	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	400
BA21	CT	Funded	Y	Colorectal Cancer	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	400
BA21	CT	Funded	Y	Colorectal Cancer	ESTR	Estrone (E1)	Serum	Y	Hormone Lab	400
BA21	CT	Funded	Y	Colorectal Cancer	FE2	Estradiol, free	Serum	Y	Hormone Lab	400
BA21	CT	Funded	Y	Colorectal Cancer	IGFFREE	IGF Free	Serum	Y	Hormone Lab	400
BA21	CT	Funded	Y	Colorectal Cancer	INSU	Insulin	Serum	Y	Hormone Lab	400
BA21	CT	Funded	Y	Colorectal Cancer	PROG	Progesterone	Serum	Y	Hormone Lab	400
BA21	CT	Funded	Y	Colorectal Cancer	SHBG	SHBG	Serum	Y	Hormone Lab	400
BA21	CT	Funded	Y	Controls	CRP	CRP	Serum	Y	Hormone Lab	800
BA21	CT	Funded	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	800
BA21	CT	Funded	Y	Controls	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	800
BA21	CT	Funded	Y	Controls	ESTR	Estrone (E1)	Serum	Y	Hormone Lab	800
BA21	CT	Funded	Y	Controls	FE2	Estradiol, free	Serum	Y	Hormone Lab	800
BA21	CT	Funded	Y	Controls	IGFFREE	IGF Free	Serum	Y	Hormone Lab	800
BA21	CT	Funded	Y	Controls	INSU	Insulin	Serum	Y	Hormone Lab	800
BA21	CT	Funded	Y	Controls	PROG	Progesterone	Serum	Y	Hormone Lab	800
BA21	CT	Funded	Y	Controls	SHBG	SHBG	Serum	Y	Hormone Lab	800
BA22	OS	Funded	Y	CHD	ACAM	LP-LPA2	EDTA	Y	Harvard-Rifai	933
BA22	OS	Funded	Y	CHD	APOA1	Apo A1	EDTA	Y	Harvard-Rifai	933
BA22	OS	Funded	Y	CHD	APOB	Apo B	EDTA	Y	Harvard-Rifai	933
BA22	OS	Funded	Y	CHD	CRP	CRP	EDTA	Y	Harvard-Rifai	933
BA22	OS	Funded	Y	CHD	HDLC	HDLC	EDTA	Y	Harvard-Rifai	933
BA22	OS	Funded	Y	CHD	HGA1C	Hemoglobin A1c from RBC	RBC	RBC	Harvard-Rifai	120
BA22	OS	Funded	Y	CHD	LPA	Lp(a)	EDTA	Y	Harvard-Rifai	933
BA22	OS	Funded	Y	CHD	PLAC	LP-PLA2	EDTA	Y	Harvard-Rifai	933
BA22	OS	Funded	Y	CHD	PROB	ProBNP	EDTA	Y	Harvard-Rifai	933
BA22	OS	Funded	Y	CHD	TCHO	Cholesterol	EDTA	Y	Harvard-Rifai	933
BA22	OS	Funded	Y	CHD	TPA	tPA	EDTA	Y	Harvard-Rifai	933
BA22	OS	Funded	Y	Controls	ACAM	LP-LPA2	EDTA	Y	Harvard-Rifai	2,000
BA22	OS	Funded	Y	Controls	APOA1	Apo A1	EDTA	Y	Harvard-Rifai	2,000
BA22	OS	Funded	Y	Controls	APOB	Apo B	EDTA	Y	Harvard-Rifai	2,000
BA22	OS	Funded	Y	Controls	CRP	CRP	EDTA	Y	Harvard-Rifai	2,000
BA22	OS	Funded	Y	Controls	HDLC	HDLC	EDTA	Y	Harvard-Rifai	2,000
BA22	OS	Funded	Y	Controls	HGA1C	Hemoglobin A1c from RBC	RBC	RBC	Harvard-Rifai	0
BA22	OS	Funded	Y	Controls	LPA	Lp(a)	EDTA	Y	Harvard-Rifai	2,000
BA22	OS	Funded	Y	Controls	PLAC	LP-PLA2	EDTA	Y	Harvard-Rifai	2,000
BA22	OS	Funded	Y	Controls	PROB	ProBNP	EDTA	Y	Harvard-Rifai	2,000
BA22	OS	Funded	Y	Controls	TCHO	Cholesterol	EDTA	Y	Harvard-Rifai	2,000
BA22	OS	Funded	Y	Controls	TPA	tPA	EDTA	Y	Harvard-Rifai	2,000
BA22	OS	Funded	Y	Known Other Cause	ACAM	LP-LPA2	EDTA	Y	Harvard-Rifai	289
BA22	OS	Funded	Y	Known Other Cause	APOA1	Apo A1	EDTA	Y	Harvard-Rifai	289
BA22	OS	Funded	Y	Known Other Cause	APOB	Apo B	EDTA	Y	Harvard-Rifai	289
BA22	OS	Funded	Y	Known Other Cause	CRP	CRP	EDTA	Y	Harvard-Rifai	289
BA22	OS	Funded	Y	Known Other Cause	HDLC	HDLC	EDTA	Y	Harvard-Rifai	289
BA22	OS	Funded	Y	Known Other Cause	HGA1C	Hemoglobin A1c from RBC	RBC	RBC	Harvard-Rifai	148
BA22	OS	Funded	Y	Known Other Cause	LPA	Lp(a)	EDTA	Y	Harvard-Rifai	289
BA22	OS	Funded	Y	Known Other Cause	PLAC	LP-PLA2	EDTA	Y	Harvard-Rifai	289
BA22	OS	Funded	Y	Known Other Cause	PROB	ProBNP	EDTA	Y	Harvard-Rifai	289
BA22	OS	Funded	Y	Known Other Cause	TCHO	Cholesterol	EDTA	Y	Harvard-Rifai	289
BA22	OS	Funded	Y	Known Other Cause	TPA	tPA	EDTA	Y	Harvard-Rifai	289
BA22	OS	Funded	Y	Stroke	ACAM	LP-LPA2	EDTA	Y	Harvard-Rifai	812
BA22	OS	Funded	Y	Stroke	APOA1	Apo A1	EDTA	Y	Harvard-Rifai	812
BA22	OS	Funded	Y	Stroke	APOB	Apo B	EDTA	Y	Harvard-Rifai	812
BA22	OS	Funded	Y	Stroke	CRP	CRP	EDTA	Y	Harvard-Rifai	812
BA22	OS	Funded	Y	Stroke	HDLC	HDLC	EDTA	Y	Harvard-Rifai	812
BA22	OS	Funded	Y	Stroke	HGA1C	Hemoglobin A1c from RBC	RBC	RBC	Harvard-Rifai	101
BA22	OS	Funded	Y	Stroke	LPA	Lp(a)	EDTA	Y	Harvard-Rifai	812
BA22	OS	Funded	Y	Stroke	PLAC	LP-PLA2	EDTA	Y	Harvard-Rifai	812
BA22	OS	Funded	Y	Stroke	PROB	ProBNP	EDTA	Y	Harvard-Rifai	812
BA22	OS	Funded	Y	Stroke	TCHO	Cholesterol	EDTA	Y	Harvard-Rifai	812
BA22	OS	Funded	Y	Stroke	TPA	tPA	EDTA	Y	Harvard-Rifai	812
M03	OS	Complete	Y	Breast Cancer	SNPS 30K	SNPs 30K	DNA	N	NCI Genotype	2,956
M03	OS	Complete	Y	Controls	SNPS 30K	SNPs 30K	DNA	N	NCI Genotype	2,956
M04	General population	Analysis	Y	Controls	GWAS	GWAS	DNA	N	NCI Genotype	283
M04	General population	Analysis	Y	Pancreas Cancer	GWAS	GWAS	DNA	N	NCI Genotype	283
M05	General population	Analysis	Y	Controls	GWAS	GWAS	DNA	N	Affymetrix	12,007
M06	OS/CT	Funded	Y	Breast Cancer Invasive	SNPS 384	SNPs 384 Ca	DNA	N	TGen	1,867
M06	OS/CT	Funded	Y	CHD	AIMS	AIMS	DNA	N	TGen	4,274
M06	OS/CT	Funded	Y	CHD	SNPS 96	SNPs 96	DNA	N	TGen	4,274
M06	OS/CT	Funded	Y	Colorectal Cancer	SNPS 384	SNPs 384 Ca	DNA	N	TGen	1,319
M06	OS/CT	Funded	Y	Controls	AIMS	AIMS	DNA	N	TGen	16,000
M06	OS/CT	Funded	Y	Controls	METABO	Metabochip	DNA	N	TGen	2,151
M06	OS/CT	Funded	Y	Controls	SNPS 384	SNPs 384 Ca	DNA	N	TGen	6,090
M06	OS/CT	Funded	Y	Controls	SNPS 384 E	SNPs 384 EKG	DNA	N	TGen	6,000
M06	OS/CT	Funded	Y	Controls	SNPS 96	SNPs 96	DNA	N	TGen	9,990
M06	OS/CT	Funded	Y	Endometrial Cancer	SNPS 384	SNPs 384 Ca	DNA	N	TGen	1,014
M06	OS/CT	Funded	Y	Lung Cancer	SNPS 384	SNPs 384 Ca	DNA	N	TGen	1,688
M06	OS/CT	Funded	Y	Lymphoma Non Hodgkins	SNPS 384	SNPs 384 Ca	DNA	N	TGen	776
M06	OS/CT	Funded	Y	Melanoma of the Skin	SNPS 384	SNPs 384 Ca	DNA	N	TGen	1,020
M06	OS/CT	Funded	Y	Ovarian Cancer	SNPS 384	SNPs 384 Ca	DNA	N	TGen	667
M06	OS/CT	Funded	Y	Stroke	AIMS	AIMS	DNA	N	TGen	3,455
M06	OS/CT	Funded	Y	Stroke	SNPS 96	SNPs 96	DNA	N	TGen	3,455
M06	OS/CT	Funded	Y	Type 2 Diabetes	AIMS	AIMS	DNA	N	TGen	4,000
M06	OS/CT	Funded	Y	Type 2 Diabetes	SNPS 96	SNPs 96	DNA	N	TGen	4,000
M08	General population	Funded	Y	Bladder Cancer	GWAS	GWAS	DNA	N	NCI Genotype	420
M08	General population	Funded	Y	Bladder Cancer	TAQMAN	TAQM	DNA	N	NCI Genotype	840
M08	General population	Funded	Y	Controls	GWAS	GWAS	DNA	N	NCI Genotype	420
M08	General population	Funded	Y	Controls	TAQMAN	TAQM	DNA	N	NCI Genotype	840
M09	OS/CT	Funded	Y	Controls	FINE MAP	Fine Mapping	DNA	N	NCI Genotype	579
M09	General population	Funded	Y	Controls	GWAS	GWAS	DNA	N	NCI Genotype	298
M09	General population	Funded	Y	Controls	TAQMAN	TAQM	DNA	N	NCI Genotype	298
M09	OS/CT	Funded	Y	Kidney Cancer	FINE MAP	Fine Mapping	DNA	N	NCI Genotype	579
M09	General population	Funded	Y	Kidney Cancer	GWAS	GWAS	DNA	N	NCI Genotype	299
M09	General population	Funded	Y	Kidney Cancer	TAQMAN	TAQM	DNA	N	NCI Genotype	299
M11	OS/CT	Funded	Y	Controls	GWAS	GWAS	DNA	N	SAIC-Frederick	346
M11	OS/CT	Funded	Y	Controls	HPYL	Hpylori	Serum	Y	Karolinska	290
M11	OS/CT	Funded	Y	Controls	PEP1	PEP1	Serum	Y	Karolinska	290
M11	OS/CT	Funded	Y	Controls	PEP2	PEP2	Serum	Y	Karolinska	290
M11	OS/CT	Funded	Y	Controls	TELO	TELO	DNA	N	Harvard-Geno	346
M11	OS/CT	Funded	Y	Esophagus Cancer	GWAS	GWAS	DNA	N	SAIC-Frederick	28
M11	OS/CT	Funded	Y	Esophagus Cancer	TELO	TELO	DNA	N	Harvard-Geno	28
M11	OS/CT	Funded	Y	Stomach Cancer	GWAS	GWAS	DNA	N	SAIC-Frederick	145
M11	OS/CT	Funded	Y	Stomach Cancer	HPYL	Hpylori	Serum	Y	Karolinska	145
M11	OS/CT	Funded	Y	Stomach Cancer	PEP1	PEP1	Serum	Y	Karolinska	145
M11	OS/CT	Funded	Y	Stomach Cancer	PEP2	PEP2	Serum	Y	Karolinska	145
M11	OS/CT	Funded	Y	Stomach Cancer	TELO	TELO	DNA	N	Harvard-Geno	145
M11	General population	Funded	Y	Controls	36 B4 CT	36 B4 CT	DNA	N	Harvard-Geno	346
M11	General population	Funded	Y	Controls	TELCT	TELCT	DNA	N	Harvard-Geno	346
M11	General population	Funded	Y	Controls	TELO EXP	TELO exp ddCT	DNA	N	Harvard-Geno	346
M11	General population	Funded	Y	Esophagus Cancer	36 B4 CT	36 B4 CT	DNA	N	Harvard-Geno	28
M11	General population	Funded	Y	Esophagus Cancer	TELCT	TELCT	DNA	N	Harvard-Geno	28
M11	General population	Funded	Y	Esophagus Cancer	TELO EXP	TELO exp ddCT	DNA	N	Harvard-Geno	28
M11	General population	Funded	Y	Stomach Cancer	36 B4 CT	36 B4 CT	DNA	N	Harvard-Geno	145
M11	General population	Funded	Y	Stomach Cancer	TELCT	TELCT	DNA	N	Harvard-Geno	145
M11	General population	Funded	Y	Stomach Cancer	TELO EXP	TELO exp ddCT	DNA	N	Harvard-Geno	145
M12	DM	Funded	Y	Controls	FRUC	fructose	24Hr Urine	N	FH-J.Lampe	900
M12	DM	Funded	Y	Controls	SUCR	sucrose	24Hr Urine	N	FH-J.Lampe	900
M13	OS	Funded	Y	CHD	FINE MAP	Fine Mapping	DNA	N	Unassigned	744
M13	HRT	Funded	Y	CHD	GWAS	GWAS	DNA	N	Broad Institute	517
M13	OS	Funded	Y	Controls	FINE MAP	Fine Mapping	DNA	N	Unassigned	3,821
M13	HRT	Funded	Y	Controls	GWAS	GWAS	DNA	N	Broad Institute	2,431
M13	OS	Funded	Y	DVT/PE	FINE MAP	Fine Mapping	DNA	N	Unassigned	600
M13	HRT	Funded	Y	DVT/PE	GWAS	GWAS	DNA	N	Broad Institute	313
M13	OS	Funded	Y	Stroke	FINE MAP	Fine Mapping	DNA	N	Unassigned	600
M13	HRT	Funded	Y	Stroke	GWAS	GWAS	DNA	N	Broad Institute	349
M13	OS	Funded	Y	Type 2 Diabetes	FINE MAP	Fine Mapping	DNA	N	Unassigned	1,080
M13	HRT	Funded	Y	Type 2 Diabetes	GWAS	GWAS	DNA	N	Broad Institute	1,078
M16	OS	Funded	Y	Stroke	GWAS+E	GWAS + exome	DNA	N	CIDR	844
M18	OS/CT	Funded	Y	Breast Cancer	SNPS 30	SNPS 30	DNA	N	Harvard-Geno	4,446
M18	OS/CT	Funded	Y	Controls	SNPS 30	SNPS 30	DNA	N	Harvard-Geno	4,554
M24	General population	Funded	Y	Clinical MI	EXOMIC SEQ	Exomic Sequencing	DNA	N	UW-Genome	161
M24	OS/CT	Funded	Y	Controls	EXOMIC SEQ	Exomic Sequencing	DNA	N	UW-Genome	774
M24	OS/CT	Funded	Y	Stroke	EXOMIC SEQ	Exomic Sequencing	DNA	N	UW-Genome	266
M24	OS/CT	Funded	Y	Stroke	SNPS FEW	SNPs Replication	DNA	N	Unassigned	400
M24	General population	Funded	Y	Type 2 Diabetes	EXOMIC SEQ	Exomic Sequencing	DNA	N	UW-Genome	165
M24	OS/CT	Funded	Y	Type 2 Diabetes	SNPS FEW	SNPs Replication	DNA	N	Unassigned	400
M24	General population	Funded	Y	Clinical MI	EXOME CHIP	Exome Chip	DNA	N	Broad Institute	161
M24	General population	Funded	Y	Clinical MI	EXOME CHIP	Exome Chip	DNA	N	UW-Genome	161
M24	General population	Funded	Y	Controls	EXOME CHIP	Exome Chip	DNA	N	Broad Institute	1,865
M24	General population	Funded	Y	Controls	EXOME CHIP	Exome Chip	DNA	N	UW-Genome	1,865
M24	General population	Funded	Y	Stroke	EXOME CHIP	Exome Chip	DNA	N	Broad Institute	770
M24	General population	Funded	Y	Stroke	EXOME CHIP	Exome Chip	DNA	N	UW-Genome	770
M24	General population	Funded	Y	Type 2 Diabetes	EXOME CHIP	Exome Chip	DNA	N	Broad Institute	165
M24	General population	Funded	Y	Type 2 Diabetes	EXOME CHIP	Exome Chip	DNA	N	UW-Genome	165
M24	General population	Funded	Y	Clinical MI	EXOMIC SEQ	exomic seq	DNA	N	U Texas HGC	161
M24	General population	Funded	Y	Controls	EXOMIC SEQ	exomic seq	DNA	N	U Texas HGC	1,865
M24	General population	Funded	Y	Stroke	EXOMIC SEQ	exomic seq	DNA	N	U Texas HGC	770
M24	General population	Funded	Y	Type 2 Diabetes	EXOMIC SEQ	exomic seq	DNA	N	U Texas HGC	165
M26	OS/CT	Funded	Y	Colorectal Cancer	EXOMIC SEQ	Exomic Sequencing	DNA	N	CIDR	115
M26	OS/CT	Funded	Y	Controls	EXOMIC SEQ	Exomic Sequencing	DNA	N	CIDR	30
W01	CT	Funded	Y	Controls	ACAR	Carotene, alpha	Serum	Y	PPD	3,800
W01	CT	Funded	Y	Controls	ATOC	Tocopherol, alpha	Serum	Y	PPD	3,800
W01	CT	Funded	Y	Controls	BCAR	Carotene, beta	Serum	Y	PPD	3,800
W01	CT	Funded	Y	Controls	BCXA	Cryptoxan, beta	Serum	Y	PPD	3,800
W01	CT	Funded	Y	Controls	F7AG	FVII Ag	Citrate	Y	PPD	3,800
W01	CT	Funded	Y	Controls	F7C	FVII Conc	Citrate	Y	PPD	3,800
W01	CT	Funded	Y	Controls	FIBR	Fibrinogen	Citrate	Y	PPD	3,800
W01	CT	Funded	Y	Controls	GLUC	Glucose	Serum	Y	PPD	3,800
W01	CT	Funded	Y	Controls	GTOC	Tocopherol, gamma	Serum	Y	PPD	3,800
W01	CT	Funded	Y	Controls	HDL2	HDL2	EDTA	Y	PPD	3,800
W01	CT	Funded	Y	Controls	HDL3	HDL3	EDTA	Y	PPD	3,800
W01	CT	Funded	Y	Controls	HDLC	HDLC	EDTA	Y	PPD	3,800
W01	CT	Funded	Y	Controls	INSU	Insulin	Serum	Y	PPD	3,800
W01	CT	Funded	Y	Controls	LDLC	LDLC	EDTA	Y	PPD	3,800
W01	CT	Funded	Y	Controls	LPA	Lp(a)	EDTA	Y	PPD	3,800
W01	CT	Funded	Y	Controls	LYCP	Lycopene	Serum	Y	PPD	3,800
W01	CT	Funded	Y	Controls	LZXA	Lutein+Zeax	Serum	Y	PPD	3,800
W01	CT	Funded	Y	Controls	RETI	Retinol	Serum	Y	PPD	3,800
W01	CT	Funded	Y	Controls	TCHO	Cholesterol	EDTA	Y	PPD	3,800
W01	CT	Funded	Y	Controls	TRI	Trig	EDTA	Y	PPD	3,800
W02	OS	Complete	Y	Controls	ACAR	Carotene, alpha	Serum	Y	PPD	800
W02	OS	Complete	Y	Controls	ATOC	Tocopherol, alpha	Serum	Y	PPD	800
W02	OS	Complete	Y	Controls	BCAR	Carotene, beta	Serum	Y	PPD	800
W02	OS	Complete	Y	Controls	BCXA	Cryptoxan, beta	Serum	Y	PPD	800
W02	OS	Complete	Y	Controls	F7AG	FVII Ag	Citrate	Y	PPD	800
W02	OS	Complete	Y	Controls	F7C	FVII Conc	Citrate	Y	PPD	800
W02	OS	Complete	Y	Controls	FIBR	Fibrinogen	Citrate	Y	PPD	800
W02	OS	Complete	Y	Controls	GLUC	Glucose	Serum	Y	PPD	800
W02	OS	Complete	Y	Controls	GTOC	Tocopherol, gamma	Serum	Y	PPD	800
W02	OS	Complete	Y	Controls	HDL2	HDL2	EDTA	Y	PPD	800
W02	OS	Complete	Y	Controls	HDL3	HDL3	EDTA	Y	PPD	800
W02	OS	Complete	Y	Controls	HDLC	HDLC	EDTA	Y	PPD	800
W02	OS	Complete	Y	Controls	INSU	Insulin	Serum	Y	PPD	800
W02	OS	Complete	Y	Controls	LDLC	LDLC	EDTA	Y	PPD	800
W02	OS	Complete	Y	Controls	LPA	Lp(a)	EDTA	Y	PPD	800
W02	OS	Complete	Y	Controls	LYCP	Lycopene	Serum	Y	PPD	800
W02	OS	Complete	Y	Controls	LZXA	Lutein+Zeax	Serum	Y	PPD	800
W02	OS	Complete	Y	Controls	RETI	Retinol	Serum	Y	PPD	800
W02	OS	Complete	Y	Controls	TCHO	Cholesterol	EDTA	Y	PPD	800
W02	OS	Complete	Y	Controls	TRI	Trig	EDTA	Y	PPD	800
W04	CaD	Complete	Y	Controls	VITD	Vit D 25-OH	Serum	Y	SKB	448
W05	DM	Complete	Y	Controls	ALBU	Albumin	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	ANRO	Androstenedione	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	DHEA	DHEA	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	DHES	DHES	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	DHT	DHT	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	ESTB_PCT	Estradiol, bioavail (%)	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	ESTDBIO	Estradiol, bioavail	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	ESTR	Estrone (E1)	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	ESTS	Estrone sulfate	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	PROG	Progesterone	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	PROL	Prolactin	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	SHBG	SHBG	Serum	Y	Esoterix	300
W05	DM	Complete	Y	Controls	TSTO	Testosterone	Serum	Y	Esoterix	300
W06	HT	Complete	Y	CHD	AT3	ATIII	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	CRP	CRP	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	DDIM	D-dimers	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	ESEL	E-Selectin	EDTA	Y	PPD	402
W06	HT	Complete	Y	CHD	ESR1	ESR1	DNA	N	Herrington	402
W06	HT	Complete	Y	CHD	ESR2	ESR2	DNA	N	Herrington	402
W06	HT	Complete	Y	CHD	F1_2	F1+2	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	F5LE	FV Leiden	DNA	N	Leiden	402
W06	HT	Complete	Y	CHD	F8	FVIII Activity	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	F9C	FIX Conc	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	FIBR	Fibrinogen	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	GP3A-P1A	GP3A-P1A	DNA	N	Herrington	402
W06	HT	Complete	Y	CHD	GPIBA	GPIba	DNA	N	Herrington	402
W06	HT	Complete	Y	CHD	HDL2	HDL2	EDTA	Y	PPD	402
W06	HT	Complete	Y	CHD	HDL3	HDL3	EDTA	Y	PPD	402
W06	HT	Complete	Y	CHD	HDLC	HDLC	EDTA	Y	PPD	402
W06	HT	Complete	Y	CHD	HOMC	Homocysteine	EDTA	Y	PPD	402
W06	HT	Complete	Y	CHD	HR2	FV-HR2	DNA	N	Leiden	402
W06	HT	Complete	Y	CHD	ITGA2807CT	ITGA2807CT	DNA	N	Herrington	402
W06	HT	Complete	Y	CHD	LDLC	LDLC	EDTA	Y	PPD	402
W06	HT	Complete	Y	CHD	LIPO-PT	Lipo-particles	EDTA	Y	PPD	402
W06	HT	Complete	Y	CHD	LPA	Lp(a)	EDTA	Y	PPD	402
W06	HT	Complete	Y	CHD	MMP9	MMP-9	Serum	Y	PPD	402
W06	HT	Complete	Y	CHD	MTHF	MTHFR	DNA	N	Leiden	402
W06	HT	Complete	Y	CHD	NMR_LIPID	NMR Lipids	EDTA	Y	LipoScience	402
W06	HT	Complete	Y	CHD	PAI1	PAI-1	DNA	N	Leiden	402
W06	HT	Complete	Y	CHD	PAIA	PAI-1 Ag	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	PAP	PAP	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	PRO2	PRO2	DNA	N	Leiden	402
W06	HT	Complete	Y	CHD	PROA	Prothrombin Ag	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	PROT	PROT	DNA	N	Leiden	402
W06	HT	Complete	Y	CHD	PRTC	Protein C	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	PRTS	Protein S Total	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	PRTSFREE	Protein S Free	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	TAFI	TAFI	Citrate	Y	Vermont	402
W06	HT	Complete	Y	CHD	TCHO	Cholesterol	EDTA	Y	PPD	402
W06	HT	Complete	Y	CHD	TRI	Trig	EDTA	Y	PPD	402
W06	HT	Complete	Y	CHD	V34L	FXIII val34leu	DNA	N	Leiden	402
W06	HT	Complete	Y	CHD	VWF	vWF	Citrate	Y	Vermont	402
W06	HT	Complete	Y	Controls	AT3	ATIII	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	CRP	CRP	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	DDIM	D-dimers	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	ESEL	E-Selectin	EDTA	Y	PPD	877
W06	HT	Complete	Y	Controls	ESR1	ESR1	DNA	N	Herrington	877
W06	HT	Complete	Y	Controls	ESR2	ESR2	DNA	N	Herrington	877
W06	HT	Complete	Y	Controls	F1_2	F1+2	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	F5LE	FV Leiden	DNA	N	Leiden	877
W06	HT	Complete	Y	Controls	F8	FVIII Activity	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	F9C	FIX Conc	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	FIBR	Fibrinogen	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	GP3A-P1A	GP3A-P1A	DNA	N	Herrington	877
W06	HT	Complete	Y	Controls	GPIBA	GPIba	DNA	N	Herrington	877
W06	HT	Complete	Y	Controls	HDL2	HDL2	EDTA	Y	PPD	877
W06	HT	Complete	Y	Controls	HDL3	HDL3	EDTA	Y	PPD	877
W06	HT	Complete	Y	Controls	HDLC	HDLC	EDTA	Y	PPD	877
W06	HT	Complete	Y	Controls	HOMC	Homocysteine	EDTA	Y	PPD	877
W06	HT	Complete	Y	Controls	HR2	FV-HR2	DNA	N	Leiden	877
W06	HT	Complete	Y	Controls	ITGA2807CT	ITGA2807CT	DNA	N	Herrington	877
W06	HT	Complete	Y	Controls	LDLC	LDLC	EDTA	Y	PPD	877
W06	HT	Complete	Y	Controls	LIPO-PT	Lipo-particles	EDTA	Y	PPD	877
W06	HT	Complete	Y	Controls	LPA	Lp(a)	EDTA	Y	PPD	877
W06	HT	Complete	Y	Controls	MMP9	MMP-9	Serum	Y	PPD	877
W06	HT	Complete	Y	Controls	MTHF	MTHFR	DNA	N	Leiden	877
W06	HT	Complete	Y	Controls	NMR_LIPID	NMR Lipids	EDTA	Y	LipoScience	877
W06	HT	Complete	Y	Controls	PAI1	PAI-1	DNA	N	Leiden	877
W06	HT	Complete	Y	Controls	PAIA	PAI-1 Ag	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	PAP	PAP	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	PRO2	PRO2	DNA	N	Leiden	877
W06	HT	Complete	Y	Controls	PROA	Prothrombin Ag	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	PROT	PROT	DNA	N	Leiden	877
W06	HT	Complete	Y	Controls	PRTC	Protein C	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	PRTS	Protein S Total	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	PRTSFREE	Protein S Free	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	TAFI	TAFI	Citrate	Y	Vermont	877
W06	HT	Complete	Y	Controls	TCHO	Cholesterol	EDTA	Y	PPD	877
W06	HT	Complete	Y	Controls	TRI	Trig	EDTA	Y	PPD	877
W06	HT	Complete	Y	Controls	V34L	FXIII val34leu	DNA	N	Leiden	877
W06	HT	Complete	Y	Controls	VWF	vWF	Citrate	Y	Vermont	877
W06	HT	Complete	Y	DVT/PE	AT3	ATIII	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	CRP	CRP	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	DDIM	D-dimers	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	ESEL	E-Selectin	EDTA	Y	PPD	223
W06	HT	Complete	Y	DVT/PE	ESR1	ESR1	DNA	N	Herrington	223
W06	HT	Complete	Y	DVT/PE	ESR2	ESR2	DNA	N	Herrington	223
W06	HT	Complete	Y	DVT/PE	F1_2	F1+2	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	F5LE	FV Leiden	DNA	N	Leiden	223
W06	HT	Complete	Y	DVT/PE	F8	FVIII Activity	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	F9C	FIX Conc	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	FIBR	Fibrinogen	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	GP3A-P1A	GP3A-P1A	DNA	N	Herrington	223
W06	HT	Complete	Y	DVT/PE	GPIBA	GPIba	DNA	N	Herrington	223
W06	HT	Complete	Y	DVT/PE	HDL2	HDL2	EDTA	Y	PPD	223
W06	HT	Complete	Y	DVT/PE	HDL3	HDL3	EDTA	Y	PPD	223
W06	HT	Complete	Y	DVT/PE	HDLC	HDLC	EDTA	Y	PPD	223
W06	HT	Complete	Y	DVT/PE	HOMC	Homocysteine	EDTA	Y	PPD	223
W06	HT	Complete	Y	DVT/PE	HR2	FV-HR2	DNA	N	Leiden	223
W06	HT	Complete	Y	DVT/PE	ITGA2807CT	ITGA2807CT	DNA	N	Herrington	223
W06	HT	Complete	Y	DVT/PE	LDLC	LDLC	EDTA	Y	PPD	223
W06	HT	Complete	Y	DVT/PE	LIPO-PT	Lipo-particles	EDTA	Y	PPD	223
W06	HT	Complete	Y	DVT/PE	LPA	Lp(a)	EDTA	Y	PPD	223
W06	HT	Complete	Y	DVT/PE	MMP9	MMP-9	Serum	Y	PPD	223
W06	HT	Complete	Y	DVT/PE	MTHF	MTHFR	DNA	N	Leiden	223
W06	HT	Complete	Y	DVT/PE	NMR_LIPID	NMR Lipids	EDTA	Y	LipoScience	223
W06	HT	Complete	Y	DVT/PE	PAI1	PAI-1	DNA	N	Leiden	223
W06	HT	Complete	Y	DVT/PE	PAIA	PAI-1 Ag	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	PAP	PAP	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	PRO2	PRO2	DNA	N	Leiden	223
W06	HT	Complete	Y	DVT/PE	PROA	Prothrombin Ag	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	PROT	PROT	DNA	N	Leiden	223
W06	HT	Complete	Y	DVT/PE	PRTC	Protein C	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	PRTS	Protein S Total	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	PRTSFREE	Protein S Free	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	TAFI	TAFI	Citrate	Y	Vermont	223
W06	HT	Complete	Y	DVT/PE	TCHO	Cholesterol	EDTA	Y	PPD	223
W06	HT	Complete	Y	DVT/PE	TRI	Trig	EDTA	Y	PPD	223
W06	HT	Complete	Y	DVT/PE	V34L	FXIII val34leu	DNA	N	Leiden	223
W06	HT	Complete	Y	DVT/PE	VWF	vWF	Citrate	Y	Vermont	223
W06	HT	Complete	Y	Stroke	AT3	ATIII	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	CRP	CRP	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	DDIM	D-dimers	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	ESEL	E-Selectin	EDTA	Y	PPD	272
W06	HT	Complete	Y	Stroke	ESR1	ESR1	DNA	N	Herrington	272
W06	HT	Complete	Y	Stroke	ESR2	ESR2	DNA	N	Herrington	272
W06	HT	Complete	Y	Stroke	F1_2	F1+2	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	F5LE	FV Leiden	DNA	N	Leiden	272
W06	HT	Complete	Y	Stroke	F8	FVIII Activity	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	F9C	FIX Conc	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	FIBR	Fibrinogen	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	GP3A-P1A	GP3A-P1A	DNA	N	Herrington	272
W06	HT	Complete	Y	Stroke	GPIBA	GPIba	DNA	N	Herrington	272
W06	HT	Complete	Y	Stroke	HDL2	HDL2	EDTA	Y	PPD	272
W06	HT	Complete	Y	Stroke	HDL3	HDL3	EDTA	Y	PPD	272
W06	HT	Complete	Y	Stroke	HDLC	HDLC	EDTA	Y	PPD	272
W06	HT	Complete	Y	Stroke	HOMC	Homocysteine	EDTA	Y	PPD	272
W06	HT	Complete	Y	Stroke	HR2	FV-HR2	DNA	N	Leiden	272
W06	HT	Complete	Y	Stroke	ITGA2807CT	ITGA2807CT	DNA	N	Herrington	272
W06	HT	Complete	Y	Stroke	LDLC	LDLC	EDTA	Y	PPD	272
W06	HT	Complete	Y	Stroke	LIPO-PT	Lipo-particles	EDTA	Y	PPD	272
W06	HT	Complete	Y	Stroke	LPA	Lp(a)	EDTA	Y	PPD	272
W06	HT	Complete	Y	Stroke	MMP9	MMP-9	Serum	Y	PPD	272
W06	HT	Complete	Y	Stroke	MTHF	MTHFR	DNA	N	Leiden	272
W06	HT	Complete	Y	Stroke	NMR_LIPID	NMR Lipids	EDTA	Y	LipoScience	272
W06	HT	Complete	Y	Stroke	PAI1	PAI-1	DNA	N	Leiden	272
W06	HT	Complete	Y	Stroke	PAIA	PAI-1 Ag	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	PAP	PAP	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	PRO2	PRO2	DNA	N	Leiden	272
W06	HT	Complete	Y	Stroke	PROA	Prothrombin Ag	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	PROT	PROT	DNA	N	Leiden	272
W06	HT	Complete	Y	Stroke	PRTC	Protein C	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	PRTS	Protein S Total	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	PRTSFREE	Protein S Free	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	TAFI	TAFI	Citrate	Y	Vermont	272
W06	HT	Complete	Y	Stroke	TCHO	Cholesterol	EDTA	Y	PPD	272
W06	HT	Complete	Y	Stroke	TRI	Trig	EDTA	Y	PPD	272
W06	HT	Complete	Y	Stroke	V34L	FXIII val34leu	DNA	N	Leiden	272
W06	HT	Complete	Y	Stroke	VWF	vWF	Citrate	Y	Vermont	272
W06	HT	Complete	Y	CHD	IL-6	IL-6	EDTA	Y	PPD	402
W06	HT	Complete	Y	Controls	IL-6	IL-6	EDTA	Y	PPD	877
W06	HT	Complete	Y	DVT/PE	IL-6	IL-6	EDTA	Y	PPD	223
W06	HT	Complete	Y	Stroke	IL-6	IL-6	EDTA	Y	PPD	272
W07	General population	Complete	Y	Breast Cancer	GWAS POOLE	Pooled GWAS	DNA	N	Perlegen	2,145
W07	General population	Complete	Y	CHD	GWAS POOLE	Pooled GWAS	DNA	N	Perlegen	2,119
W07	General population	Complete	Y	Controls	GWAS POOLE	Pooled GWAS	DNA	N	Perlegen	6,479
W07	General population	Complete	Y	Stroke	GWAS POOLE	Pooled GWAS	DNA	N	Perlegen	2,215
W09	HT	Analysis	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	750
W09	HT	Analysis	Y	Controls	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	750
W09	HT	Analysis	Y	Controls	FE2	Estradiol, free	Serum	Y	Hormone Lab	750
W09	HT	Analysis	Y	Controls	SHBG	SHBG	Serum	Y	Hormone Lab	750
W09	HRT	Analysis	Y	Hip Fracture	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	248
W09	HRT	Analysis	Y	Hip Fracture	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	248
W09	HRT	Analysis	Y	Hip Fracture	FE2	Estradiol, free	Serum	Y	Hormone Lab	248
W09	HRT	Analysis	Y	Hip Fracture	SHBG	SHBG	Serum	Y	Hormone Lab	248
W09	HRT	Analysis	Y	Fracture, Non-spine	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	750
W09	HRT	Analysis	Y	Fracture, Non-spine	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	750
W09	HRT	Analysis	Y	Fracture, Non-spine	FE2	Estradiol, free	Serum	Y	Hormone Lab	750
W09	HRT	Analysis	Y	Fracture, Non-spine	SHBG	SHBG	Serum	Y	Hormone Lab	750
W10	HT	Funded	Y	Breast Cancer	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Breast Cancer	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Breast Cancer	ESTR	Estrone (E1)	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Breast Cancer	ESTS	Estrone sulfate	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Breast Cancer	FE2	Estradiol, free	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Breast Cancer	FT	Testosterone, free	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Breast Cancer	FT_AT	Testosterone, bioavail	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Breast Cancer	PROG	Progesterone	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Breast Cancer	SHBG	SHBG	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Breast Cancer	TSTO	Testosterone	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Controls	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Controls	ESTR	Estrone (E1)	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Controls	ESTS	Estrone sulfate	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Controls	FE2	Estradiol, free	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Controls	FT	Testosterone, free	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Controls	FT_AT	Testosterone, bioavail	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Controls	PROG	Progesterone	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Controls	SHBG	SHBG	Serum	Y	Hormone Lab	755
W10	HT	Funded	Y	Controls	TSTO	Testosterone	Serum	Y	Hormone Lab	755
W11	HT	Funded	Y	Controls	APC-ETP	APC-ETP	Citrate	Y	Univ Maastricht	326
W11	HT	Funded	Y	Controls	ERB-1730AG	ERB-1730AG	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	ESR1	ESR1	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	ESR1_1989	ESR1 -1989	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	ESR2	ESR2	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	ESR2A1730G	ESR2-A1730G	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	EX1_30	ESR1 ex1 +30 T/C	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	GLUC	Glucose	Serum	Y	PPD	326
W11	HT	Funded	Y	Controls	GP3A-P1A	GP3A-P1A	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	GPIBA	GPIba	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	GPIBAM145T	GPIba M145T	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	INSU	Insulin	Serum	Y	PPD	326
W11	HT	Funded	Y	Controls	ITGA2807CT	ITGA2807CT	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	IVS1_1415	ESR1 IVS1 -1415 C/T	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	IVS1_1505	ESR1 IVS1 -1505 A/G	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	IVS1_354	ESR1 IVS1 -354 A/G	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	IVS1_401	ESR1 IVS1 -401 C/T	DNA	N	Herrington	326
W11	HT	Funded	Y	Controls	LT_APC	LT_APC	Citrate	Y	Univ Maastricht	326
W11	HT	Funded	Y	Controls	NAPCSR	NAPCSR	Citrate	Y	Univ Maastricht	326
W11	HT	Funded	Y	Controls	TFPIACT	TFPI activity	Citrate	Y	Oslo	326
W11	HT	Funded	Y	Controls	TFPIFREE	TFPI, free	Citrate	Y	Oslo	326
W11	HT	Funded	Y	Controls	TFPITOT	TFPI, total	Citrate	Y	Oslo	326
W11	HT	Funded	Y	Stroke	APC-ETP	APC-ETP	Citrate	Y	Univ Maastricht	326
W11	HT	Funded	Y	Stroke	ERB-1730AG	ERB-1730AG	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	ESR1	ESR1	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	ESR1_1989	ESR1 -1989	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	ESR2	ESR2	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	ESR2A1730G	ESR2-A1730G	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	EX1_30	ESR1 ex1 +30 T/C	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	GLUC	Glucose	Serum	Y	PPD	326
W11	HT	Funded	Y	Stroke	GP3A-P1A	GP3A-P1A	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	GPIBA	GPIba	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	GPIBAM145T	GPIba M145T	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	INSU	Insulin	Serum	Y	PPD	326
W11	HT	Funded	Y	Stroke	ITGA2807CT	ITGA2807CT	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	IVS1_1415	ESR1 IVS1 -1415 C/T	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	IVS1_1505	ESR1 IVS1 -1505 A/G	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	IVS1_354	ESR1 IVS1 -354 A/G	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	IVS1_401	ESR1 IVS1 -401 C/T	DNA	N	Herrington	326
W11	HT	Funded	Y	Stroke	LT_APC	LT_APC	Citrate	Y	Univ Maastricht	326
W11	HT	Funded	Y	Stroke	NAPCSR	NAPCSR	Citrate	Y	Univ Maastricht	326
W11	HT	Funded	Y	Stroke	TFPIACT	TFPI activity	Citrate	Y	Oslo	326
W11	HT	Funded	Y	Stroke	TFPIFREE	TFPI, free	Citrate	Y	Oslo	326
W11	HT	Funded	Y	Stroke	TFPITOT	TFPI, total	Citrate	Y	Oslo	326
W14	Ht	Analysis	Y	CHD	APC-ETP	APC-ETP	Citrate	Y	Univ Maastricht	220
W14	HT	Analysis	Y	CHD	GLUC	Glucose	Serum	Y	PPD	390
W14	HT	Analysis	Y	CHD	INSU	Insulin	Serum	Y	PPD	390
W14	HT	Analysis	Y	CHD	LT_APC	LT_APC	Citrate	Y	Univ Maastricht	220
W14	HRT	Analysis	Y	CHD	NAPCSR	NAPCSR	Citrate	Y	Univ Maastricht	220
W14	HRT	Analysis	Y	CHD	TFPIACT	TFPI activity	Citrate	Y	Oslo	220
W14	HRT	Analysis	Y	CHD	TFPIFREE	TFPI, free	Citrate	Y	Oslo	220
W14	HRT	Analysis	Y	CHD	TFPITOT	TFPI, total	Citrate	Y	Oslo	220
W14	HRT	Analysis	Y	Controls	APC-ETP	APC-ETP	Citrate	Y	Univ Maastricht	710
W14	HT	Analysis	Y	Controls	GLUC	Glucose	Serum	Y	PPD	880
W14	HT	Analysis	Y	Controls	INSU	Insulin	Serum	Y	PPD	880
W14	HRT	Analysis	Y	Controls	LT_APC	LT_APC	Citrate	Y	Univ Maastricht	710
W14	HRT	Analysis	Y	Controls	NAPCSR	NAPCSR	Citrate	Y	Univ Maastricht	710
W14	HRT	Analysis	Y	Controls	TFPIACT	TFPI activity	Citrate	Y	Oslo	710
W14	HRT	Analysis	Y	Controls	TFPIFREE	TFPI, free	Citrate	Y	Oslo	710
W14	HRT	Analysis	Y	Controls	TFPITOT	TFPI, total	Citrate	Y	Oslo	710
W14	HT	Analysis	Y	DVT/PE	APC-ETP	APC-ETP	Citrate	Y	Univ Maastricht	220
W14	HT	Analysis	Y	DVT/PE	GLUC	Glucose	Serum	Y	PPD	220
W14	HT	Analysis	Y	DVT/PE	INSU	Insulin	Serum	Y	PPD	220
W14	HT	Analysis	Y	DVT/PE	LT_APC	LT_APC	Citrate	Y	Univ Maastricht	220
W14	HT	Analysis	Y	DVT/PE	NAPCSR	NAPCSR	Citrate	Y	Univ Maastricht	220
W14	HT	Analysis	Y	DVT/PE	TFPIACT	TFPI activity	Citrate	Y	Oslo	220
W14	HT	Analysis	Y	DVT/PE	TFPIFREE	TFPI, free	Citrate	Y	Oslo	220
W14	HT	Analysis	Y	DVT/PE	TFPITOT	TFPI, total	Citrate	Y	Oslo	220
W14	HT	Analysis	Y	Stroke	APC-ETP	APC-ETP	Citrate	Y	Univ Maastricht	270
W14	HT	Analysis	Y	Stroke	GLUC	Glucose	Serum	Y	PPD	270
W14	HT	Analysis	Y	Stroke	INSU	Insulin	Serum	Y	PPD	270
W14	HT	Analysis	Y	Stroke	LT_APC	LT_APC	Citrate	Y	Univ Maastricht	270
W14	HT	Analysis	Y	Stroke	NAPCSR	NAPCSR	Citrate	Y	Univ Maastricht	270
W14	HT	Analysis	Y	Stroke	TFPIACT	TFPI activity	Citrate	Y	Oslo	270
W14	HT	Analysis	Y	Stroke	TFPIFREE	TFPI, free	Citrate	Y	Oslo	270
W14	HT	Analysis	Y	Stroke	TFPITOT	TFPI, total	Citrate	Y	Oslo	270
W15	CaD	Complete	Y	Colorectal Cancer	VITD	Vit D 25-OH	Serum	Y	DiaSorin	334
W15	CaD	Complete	Y	Controls	VITD	Vit D 25-OH	Serum	Y	DiaSorin	1,830
W15	CaD	Complete	Y	Hip Fracture	VITD	Vit D 25-OH	Serum	Y	DiaSorin	360
W15	CaD	Complete	Y	Lower End of Humerus Fracture	VITD	Vit D 25-OH	Serum	Y	DiaSorin	853
W15	CaD	Complete	Y	Vertebral Fracture	VITD	Vit D 25-OH	Serum	Y	DiaSorin	283
W18	HT	Analysis	Y	Controls	ESTD	Estradiol (E2)	Serum	Y	Hormone Lab	240
W18	HT	Analysis	Y	Controls	ESTDBIO	Estradiol, bioavail (FE2+AE2)	Serum	Y	Hormone Lab	240
W18	HT	Analysis	Y	Controls	ESTR	Estrone (E1)	Serum	Y	Hormone Lab	240
W18	HT	Analysis	Y	Controls	FE2	Estradiol, free	Serum	Y	Hormone Lab	240
W18	HT	Analysis	Y	Controls	FT	Testosterone, free	Serum	Y	Hormone Lab	240
W18	HT	Analysis	Y	Controls	FT_AT	Testosterone, bioavail	Serum	Y	Hormone Lab	240
W18	HT	Analysis	Y	Controls	PROG	Progesterone	Serum	Y	Hormone Lab	240
W18	HT	Analysis	Y	Controls	SHBG	SHBG	Serum	Y	Hormone Lab	240
W18	HT	Analysis	Y	Controls	TSTO	Testosterone	Serum	Y	Hormone Lab	240
W19	HT	Complete	Y	Controls	PROTEOM	Proteomics	Serum	Y	Hanash	200
W20	OS	Complete	Y	Colorectal Cancer	PROTEOM	Proteomics	EDTA	Y	Hanash	200
W20	OS	Complete	Y	Controls	PROTEOM	Proteomics	EDTA	Y	Hanash	240
W22	CaD	Complete	Y	Controls	VITD	Vit D 25-OH	Serum	Y	Heartland	600
W24	CaD	Analysis	Y	Breast Cancer	VITD	Vit D 25-OH	Serum	Y	DiaSorin	1,081
W24	CaD	Analysis	Y	Controls	VITD	Vit D 25-OH	Serum	Y	DiaSorin	1,081
W34	General population	Funded	Y	Controls	SNPS 5.4K	SNPs 5.4K	DNA	N	Perlegen	2,096
W34	General population	Funded	Y	Stroke	SNPS 5.4K	SNPs 5.4K	DNA	N	Perlegen	2,096
W39	HT	Complete	Y	CHD	27HC	Chol, 27-OH	Serum	Y	Baylor-ACRL	359
W39	HT	Complete	Y	Controls	27HC	Chol, 27-OH	Serum	Y	Baylor-ACRL	820
W40	HT	Complete	Y	Controls	ACE	ACE	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	AHSG	AHSG	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	CCL16	CCL16	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	CP	CP	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	F10	FX	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	F9	FIX	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	GC	VitD Binding	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	ICAM-1	ICAM-1	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	IGF-I	IGF-I	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	IGFBP-1	IGFBP-1	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	IGFBP-2	IGFBP-2	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	IGFBP-3	IGFBP-3	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	IGFBP-4	IGFBP-4	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	IGFBP-6	IGFBP-6	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	MCAM	MCAM	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	MMP2	MMP-2	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	NOV	NOV	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	PROZ	Protein Z	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	TFF3	TFF3	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	VTNBIS	VTNbis	Serum	Y	Hanash	100
W40	HT	Complete	Y	Controls	KNG1	KNG1	Serum	Y	Hanash	100
W43	HT E+P	Complete	Y	Breast Cancer	GENESEQ	Gene seq	DNA	N	Perlegen	60
W43	HT E+P	Complete	Y	Controls	GENESEQ	Gene seq	DNA	N	Perlegen	60
W44	HT	Funded	Y	Controls	ACE	ACE	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	AGTASE	AGTASE	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	ANG	ANG	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	APOD	Apo D	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	APOF	Apolipoprotein F	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	B2M	B2M	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	CAPPT	CAPPT	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	CCL18	CCL18	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	CP	CP	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	CSF1	CSF1	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	F10	FX	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	ICAM-1	ICAM-1	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	IGF-I	IGF-I	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	IGFBP-1	IGFBP-1	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	IGFBP-2	IGFBP-2	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	IGFBP-4	IGFBP-4	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	LCN2	LCN2	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	LGALS3BP	LGALS3BP	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	LYVE1	LYVE1	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	MCAM	MCAM	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	MCSF1	MCSF1	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	MMP2	MMP-2	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	NOV	NOV	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	PARC	PARCq	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	RNASE4	RNASE4	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	TFF3	TFF3	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	THBS1	THBS1	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	TNC	TNC	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	VTNBIS	VTNbis	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	XLKD1	XLKD1	Serum	Y	Hanash	50
W44	HT	Funded	Y	Controls	KNG1	KNG1	Serum	Y	Hanash	50
W45	OS	Funded	Y	Colon Cancer	ADAMTS13	ADAMTS13	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	APP	Amyloid Precursor Protein	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	CEA	CEA	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	ENO1	ENO1	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	IGFBP-1	IGFBP-1	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	IGFBP-2	IGFBP-2	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	IGFBP-6	IGFBP-6	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	LGALS3BP	LGALS3BP	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	LRG1	LRG1	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	LTF	LTF	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	MAPRE1	MAPRE1	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	MMP2	MMP-2	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	NID1	NID1	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	PKM2	PKM2	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	PPBP	PPBP	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	PPIA	PPIA	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Colon Cancer	SPARC	SPARC	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	ADAMTS13	ADAMTS13	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	APP	Amyloid Precursor Protein	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	CEA	CEA	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	ENO1	ENO1	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	IGFBP-1	IGFBP-1	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	IGFBP-2	IGFBP-2	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	IGFBP-6	IGFBP-6	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	LGALS3BP	LGALS3BP	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	LRG1	LRG1	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	LTF	LTF	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	MAPRE1	MAPRE1	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	MMP2	MMP-2	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	NID1	NID1	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	PKM2	PKM2	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	PPBP	PPBP	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	PPIA	PPIA	Citrate	Y	Hanash	100
W45	OS	Funded	Y	Controls	SPARC	SPARC	Citrate	Y	Hanash	100
W54	General population	Funded	Y	Controls	CREA	CREA	Serum	Y	UMMC	12,008
W54	General population	Funded	Y	Controls	CRP	CRP	Serum	Y	UMMC	12,008
W54	General population	Funded	Y	Controls	GLUC	Glucose	Serum	Y	UMMC	12,008
W54	General population	Funded	Y	Controls	INSU	Insulin	Serum	Y	UMMC	12,008
W54	General population	Funded	Y	Controls	TCHO	Cholesterol	Serum	Y	UMMC	12,008
W54	General population	Funded	Y	Controls	TRI	Trig	Serum	Y	UMMC	12,008
W54	General population	Funded	Y	Controls	HDLC	HDLC	Serum	Y	UMMC	12,008
W54	General population	Funded	Y	Controls	LDLC	LDLC	Serum	Y	UMMC	12,008
W57	OS/CT	Complete	Y	CHD	B2M	B2M	Citrate	Y	Hanash	356
W57	OS/CT	Complete	Y	CHD	IGFBP-4	IGFBP-4	Citrate	Y	Hanash	356
W57	OS/CT	Complete	Y	Stroke	B2M	B2M	Citrate	Y	Hanash	348
W57	OS/CT	Complete	Y	Stroke	IGFBP-4	IGFBP-4	Citrate	Y	Hanash	348
W58	HT	Funded	Y	Controls	CREA	CREA	EDTA	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	CREA	CREA	Serum	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	CRP	CRP	EDTA	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	CRP	CRP	Serum	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	GLUC	Glucose	EDTA	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	GLUC	Glucose	Serum	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	INSU	Insulin	EDTA	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	INSU	Insulin	Serum	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	TCHO	Cholesterol	EDTA	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	TCHO	Cholesterol	Serum	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	TRI	Trig	EDTA	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	TRI	Trig	Serum	Y	UMMC	10,254
W58	HT	Funded	Y	Controls	HDLC	HDLC	EDTA	Y	UMMC

Biospecimen analytes by outcome and study // <![CDATA[ _spBodyOnLoadFunctionNames.push("setupPageDescriptionCallout"); // ]]>

​Biospecimen Analytes by Outcome and Study ID

Biospecimen analytes by outcome and study

Biospecimen Analytes by Outcome and Study ID